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Abstract 
Energy generating processes like the citric acid cycle are a pivotal part of me-
tabolism.  Members of the 2-oxoacid dehydrogenase multienzyme complex 
(OADHC) superfamily feed into and act within the citric acid cycle.  OADHCs 
are composed of three enzymes: 2-oxoacid decarboxylase (E1), dihydroli-
poamide acyltransferase (E2) and dihydrolipoamide dehydrogenase (E3).  Co-
valent attachment of lipoic acid (LA) to E2 is essential for overall OADHC activ-
ity.  Although thought to be absent in Archaea, it has recently been found that 
Thermoplasma acidophilum has all the components for an active recombinant 
OADHC (Heath et al., 2007).  Recent studies have further suggested that Tp. 
acidophilum may have an enzyme to covalently attach LA to E2 (Sun et al., 
2007; McManus et al., 2006). 
 
This work describes the cloning and recombinant expression of the Thermo-
plasma lipoate protein ligase (Tp. LplA), its C-terminal domain and a fusion pro-
tein composed of the above two proteins.  Both proteins are required for lipoyla-
tion of E2 in vitro.  For the first time, in vivo lipoylation of E2 in Tp. acidophilum 
cell cultures is also being reported. 
 
The effect of lipoylation and temperature on the Thermoplasma OADHC as-
sembly has also been studied.  This study revealed the temperature depend-
ence of the E2 core and the whole complex assembly.  These findings are in 
line with the optimum growth temperature of Tp. acidophilum. Dynamic light 
scattering and analytical ultracentrifugation were used to determine the molecu-
lar mass of whole OADHC.  The molecular mass was determined to be 5 MDa 
with an octahedral geometry of the E2 core. 
 
The results of this work strengthen the assumption that these enzyme systems 
may have had or potentially have a role in the Archaea.  This may hold further 
clues to the evolutionary relationship between the three kingdoms of life and the 
role of OADHCs/lipoylation in the Archaea.  The temperature dependent as-
sembly of the complex and thermostability of these proteins may also provide a 
model to study thermostability and protein-protein interactions at high tempera-
tures.
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CHAPTER 1 
INTRODUCTION 
 
1.1 The superfamily of 2-oxoacid dehydrogenase multienzyme com-
plexes 
2-oxoacid dehydrogenase multienzyme complexes (OADHCs) are large protein 
assemblies ranging in size between 106 to 107 Da.  They catalyze key reactions 
in intermediary metabolism and have been shown to regulate the cellular redox 
state by directly influencing the NADH/NAD+ ratio (Günther et al., 2005; Bunik, 
2003).  Members of the OADHC superfamily are the pyruvate dehydrogenase 
complex (PDHC), which links glycolysis with the citric acid cycle by catalyzing 
the conversion of pyruvate to acetyl-CoA, the 2-oxoglutarate dehydrogenase 
complex (OGDHC) which catalyses the conversion of 2-oxoglutarate to suc-
cinyl-CoA within the citric acid cycle, and the branched-chain 2-oxoacid dehy-
drogenase complex (BCOADHC), which oxidatively decarboxylates the 
branched-chain 2-oxoacids produced by the transamination of valine, leucine 
and isoleucine (Fig. 1.1) (Perham and Packman 1989; Yeaman 1989). 
 
 
 
Fig. 1.1 Reactions catalyzed by the PDHC, OGDHC and BCOADHC.  The main com-
mon feature is the oxidative decarboxylation of 2-oxoacids. 
 
 
The PDHC, OGDHC and BCOADHC are made up of multiple copies of three 
component enzymes: a 2-oxoacid decarboxylase (E1), a dihydrolipoamide acyl-
transferase (E2) and a dihydrolipoamide dehydrogenase (E3).  The substrate 
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specificity of each complex is determined by E1 and E2, whereas E3 is often 
the same gene product in different OADHCs (Danson et al., 2004).  The 
components E1, E2, and E3 assemble into a striking architecture dominated by 
the E2 core to which E1 and E3 bind non-covalently.  The E2 core can either be 
composed of 24 or 60 E2 polypeptide chains arranged in an octahedral or ico-
sahedral symmetry, respectively (Fig. 1.2). 
 
125Å
237Å
A
B
 
 
Fig. 1.2 Structures of the octahedral and icosahedral E2 inner cores (acyltransferase 
domains) of pyruvate dehydrogenase (PDH) complexes.  A: E2 core of the Azotobacter 
vinelandii PDH complex; left to right, twofold, threefold, and fourfold views.  B: E2 core 
of the Bacillus stearothermophilus PDH complex; left to right, twofold, threefold, and 
fivefold views. In both instances, the three different subunits of a trimer are in different 
colours, most readily seen on the threefold views (taken from Perham, 2000). 
 
 
The quaternary structure of the E2 core is made possible by the compact 
subunit binding domain, which contains the binding sites for E1 and E3 as well 
as the catalytic site for transacylation.  The E2 component of OADHCs contains 
one, two or three distinct lipoyl domains.  Each of these domains has a distinct 
lysine residue to which the co-factor lipoic acid (LA) is attached covalently via 
an amide linkage between the carboxyl group of LA and the ε-amino group of 
the lysine residue forming a lipoamide moiety (Cronan et al., 2005; Stepp et al., 
1981) (Fig. 1.3). 
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Fig. 1.3 Lipoic acid and the E2 lipoyl domain.  A: Lipoamide moiety attached to the 
lipoyl lysine of the E2 lipoyl domain.  B: The overall structure of the E. coli OGDHC E2 
lipoyl domain; the lysine residue to which LA is attached is indicated (adapted from 
Perham, 2000). 
 
 
2 - oxoacid
Decarboxlated 
intermediate
ylated 
 
 
Fig. 1.4 General reaction scheme of the PDHC, OGDHC, and BCOADHC.  This dia-
gram illustrates the central role of the lipoyl moiety, able to take on the decarboxylated 
intermediate and passing it on to E2.  The cofactors for E1, E2 and E3 are thiamine 
diphosphate (ThDP), lipoic acid and flavin adenine dinucleotide (FAD), respectively 
(adapted from Milne et al., 2002). 
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The lipoamide moiety attached to the lipoyl domain is the key for the overall en-
zymatic activity of the OADHCs as it allows the specific transfer of reaction in-
termediates between the different enzyme active sites (Fig. 1.4) (Perham, 
1991).  The initial 2-oxoacid substrate is decarboxylated by E1.  The consecu-
tive steps are best visualized by considering the LA as a swinging arm that 
binds the decarboxylated intermediate via its reactive disulfide group.  LA picks 
up the intermediate directly from the E1 active site.  Then LA moves on and 
passes this intermediate to the active site of E2.  In the final reaction step, LA 
interacts with the active site of E3 to allow regenerative oxidation of its reduced 
disulfide bond. 
 
This mechanism copes well with the distance between different active sites 
within the multienzyme complex with high specificity while ensuring that the 
substrates and intermediates are protected during the whole reaction cycle.  
This has led to the well accepted concepts of active site coupling, substrate 
channelling and the “hot potato hypothesis” (Perham, 1991 and references 
therein; Miles et al., 1988; Danson et al., 1978a; Danson et al., 1978b; Stanley 
et al., 1981; Perham, 1975).  Protein interactions that ensure specificity in the 
recognition of the lipoyl domain by E1 or E3 have been characterised for the 
Bacillus stearothermophilus PDHC (Fries et al., 2007; Howard et al., 2000). 
 
1.2 Lipoic acid and 2-oxoacid dehydrogenase multienzyme complexes 
Lipoic acid (LA) was first isolated and named by Lester Reed in 1951 (Reed et 
al., 1951; Kresge et al., 2006).  LA is also known as 1,2-dithiolane-3-pentanoic 
acid and can exist in its reduced form as dihydrolipoic acid (DHLA) (Fig. 1.5).  
The ability of LA to cycle between its different redox states makes it an essential 
cofactor in enzymatic reactions involved in oxidative and single carbon metabo-
lism (Cronan et al., 2005; Zhao et al., 2003).  The naturally occurring R-isomer 
of LA is present in most prokaryotic and eukaryotic organisms as a physiologi-
cal substrate whereas the S-isomer can only be synthesized chemically (Self et 
al., 2000; Cronan et al., 2005; Oehring and Bisswanger, 1992). 
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Fig. 1.5 Structure of lipoic acid and its reduced derivative dihydrolipoic acid (DHLA).  
The red star indicates the chiral centre of the two structures. 
 
 
The model organism in which the synthesis of LA and lipoylation of proteins has 
been well studied is Escherichia coli.  In E. coli protein bound LA can be derived 
from exogenous and/or endogenous stores using three enzymes: lipoate protein 
ligase (LplA), lipoic acid synthase (LipA) and octanoyl-acyl carrier protein 
(ACP):protein-N-octanoyltransferase (LipB) (Fig. 1.6).  In the endogenous 
pathway LipB and LipA act consecutively to attach an octanoyl moiety to the 
enzyme’s lipoyl domain and convert the octanoyl group into a lipoyl moiety re-
spectively.  In the exogenous pathway LplA first catalyzes the activation of exo-
genously supplied LA to lipoyl-AMP and then catalyzes the covalent attachment 
of LA to a protein lipoyl domain (Fig. 1.6).  Despite the assumption that the 
three lipoylation enzymes are restricted to specific pathways, experiments with 
E. coli mutants showed that the enzymes are not mutually exclusive.  LplA can 
bypass LipB activity by using octanoic acid as a substrate (Morris et al., 1994; 
Zhao et al., 2003; Cronan et al., 2005) and LplA is able to use octanoyl-ACP as 
its substrate with low efficiency (Jordan and Cronan, 2003). 
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Fig. 1.6 Synthesis and attachment of LA in E. coli.  The rectangle represents the E. coli 
cell.  Octanoic acid and LA enter the cell by diffusion.  Inside the cell, LA is attached to 
the lipoyl domain of the E2 of OADHCs (red ellipse).  The enzymes LipB and LipA act 
in sequence and can use both endogenously or exogenously derived octanoic acid.  In 
the endogenous pathway octanoic acid is presented on acyl carrier protein (blue el-
lipse) (adapted from Cronan et al., 2005). 
 
 
 
 
 
 
 
 12 
1.3 Archaeal 2-oxoacid dehydrogenase multienzyme complexes? 
Archaea are classified as one of the three domains of life based on their rRNA 
sequence and cell membrane composition (Forterre et al., 2002; Brown, 2003).  
Molecular analyses have shown that archaea share a common ancestral branch 
with eukarya although their metabolism more closely resembles that of bacteria 
(Pace, 2006; Forterre et al., 2002; Chan et al., 1997) (Fig. 1.7). 
 
 
 
Fig. 1.7 Rooted universal phylogenetic tree showing the three domains based upon 
16S (or 18S) rRNA sequences (from Woese et al., 1990).  The position of the root was 
determined by comparing paralogous gene sequences that diverged from each other 
before the three primary lineages emerged from their common ancestral condition 
(Iwabe et al., 1989) (Jürgens, 2002). 
 
 
Analyses of archaeal species have indicated that oxidative decarboxylation of 
pyruvate and 2-oxoglutarate under aerobic conditions is catalysed by ‘anaero-
bic’ 2-oxoacid ferredoxin oxidoreductases (OAFORs) instead of ‘aerobic’ 
OADHCs; therefore OADHCs are not needed in the Archaea (Danson et al., 
2004; Kerscher et al., 1982; Kerscher and Oesterhelt, 1981; Witzmann and 
Bisswanger, 1998).  OAFORs are simpler and smaller in structure than 
OADHCs and utilize ferredoxin instead of NAD+ as physiological electron ac-
ceptor (Park et al., 2006; Danson et al., 1984).  Based on substrate specificity, 
OAFORs can be divided into pyruvate ferredoxin oxidoreductase (POR), 2-
oxoglutarate ferredoxin oxidoreductase (GOR), and 2-oxoisovalerate ferredoxin 
oxidoreductase (VOR), which catalyse the same oxidative decarboxylation as 
the PDHC, OGDHC and BCOADHC, respectively.  The importance of OAFORs 
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has been supported by a recent comparison of the 28 fully sequenced archaeal 
genomes, which revealed the presence of three to four OAFORs per genome 
(van Ooyen and Soppa, 2007).  Nonetheless, the genes encoding OADHC 
components were discovered in archaea but the physiological significance of 
these enzymes has often been questioned (Bryant et al., 2006; McManus, et al., 
2006; Kim et al., 2005; Heath et al. 2004; Jolley et al., 2000).   In vivo E3 activity 
has been detected in the halophilic archaea (Danson et al., 1984; Jolley et al., 
1996) as well as in Thermoplasma acidophilum (Danson et al., 2004 and refer-
ences therein) but no OADHC activity has so far been reported.  The finding of 
E3 activity in the absence of whole complex activity cannot be construed as 
clear evidence for the presence of archaeal OADHCs, especially as E3 has 
other characterized roles that are not associated with the OADHCs (Håkansson 
and Smith, 2007; Smith et al., 2002 and references therein). 
 
In light of the above, a question emerges as to why oadhc genes are found in 
archaeal genomes.  The three oadhc operons from Haloferax volcanii have 
sparked interest in the protein evolution of archaeal OADHCs, though their sub-
strate specificity and novel activities still remain unknown.  One oadhc operon 
from H. volcanii was shown to be transcribed but no in vivo OADHC activity 
could ever be detected (Al Mailem et al., 2008; Jolley et al., 2000).  The second 
H. volcanii operon, which only contains genes for the E1α and E1β subunits and 
an isolated lipoyl domain (Wanner and Soppa, 2002) and the third H. volcanii 
oadhc operon lacking a gene for E3 (van Ooyen and Soppa, 2007), have a role 
in nitrate-respirative growth, but their exact role and substrate specificity have 
not been elucidated yet. 
 
More recently, it was shown that the recombinant Tp. acidophilum E1, encoded 
by the E1α and E1β genes which are part of a potential oadhc operon, had de-
carboxylase activity with the 2-oxoacids 3-methyl-2-oxopentanoate, 4-methyl-2-
oxopentanoate, 3-methyl-2-oxobutanoate and pyruvate (Heath et al., 2004).  
Analyses of all recombinant proteins encoded in this operon showed that they 
form an active BCOADHC with an octahedral E2 core (Heath et al., 2007, Caro-
line Heath, Ph.D. thesis, 2006).  From these data a pressing question emerges: 
If the BCOADHC operon of Tp. acidophilum codes for a functional multienzyme 
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complex, why can no in vivo activity be detected?  This question becomes even 
more intriguing in light of a recent proteomics analysis of Tp. acidophilum (Sun 
et al., 2007).  This study employing glycerol gradient ultracentrifugation identi-
fied a complex of E1 and E2 (> 1 MDa) in Tp. acidophilum cells.  This complex 
did not contain E3, although E3 was found in the cells.  This is in agreement 
with reports of E3 activity in Tp. acidophilum cell extracts (Smith et al., 1987).  
Sun et al. (2007) do not discuss the absence of the E3 component from the E1-
E2 complex.  In B. stearothermophilus E1 and E3 bind mutually exclusive to E2 
and E1 has approximately a two-fold higher affinity for E2 than E3 (Jung et al., 
2002 and 2003).  The absence of E3 in the purified Thermoplasma complex 
may be explained by the purification process and/or the affinity constants which 
favour E1 over E3 binding to E2.  A biophysical characterization of the Tp. aci-
dophilum BCOADHC assembly is addressed in the current thesis (chapter 10). 
 
The presence of oadhc genes in archaea could be explained by lateral gene 
transfer from bacteria (Wanner and Soppa, 2002).  Although it is accepted that 
the oadhc genes could be remnants of a gene transfer (reviewed by Brown, 
2003), the general notion is that these genes have been retained for a purpose, 
as it is less likely for organisms with small genomes to accumulate “non-
functional” DNA.  An alternatively hypothesis is, that the common ancestor of 
bacteria and archaea possessed oadhc genes, and they were only retained in 
aerobic species (Heath et al., 2004; van Ooyen and Soppa, 2007). 
 
1.4 Lipoylation – a new twist in the story 
Recombinant expression of the Tp. acidophilum BCOADHC components re-
vealed that yield of active complex was hindered by the inability of the expres-
sion host to execute lipoylation of the archaeal E2 under standard growth condi-
tions.  Only under specific growth conditions, in which cultures were supple-
mented with 0.2 mM LA, grown at 30°C for 20 h in darkness and not induced 
with IPTG, was E. coli capable of lipoylating up to 50% of the recombinant E2 
(Heath et al., 2007).  Hence, attention was drawn to the Tp. acidophilum inher-
ent lipoylation system.  BLASTP searches using the E. coli LipA, LipB and LplA 
sequences revealed the presence of a putative LplA gene in Tp. acidophilum.  
Since then, two independent groups have been able to crystallize the Thermo-
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plasma LplA (Tp. LplA) (McManus et al., 2006; Kim et al., 2005).  Both groups 
agree that the Tp. LplA is a lipoate protein ligase, but whereas McManus et al. 
(2006) could not detect any in vitro LplA activity, Kim et al. (2005) observed a 
conversion of LA to lipoyl-AMP, the first catalytic step of LplA, within the crystal 
structure and concluded from this that the Thermoplasma LplA may be catalyti-
cally active.  Notably, both groups also point out the fact that the Tp. LplA is ap-
proximately 90 amino acids shorter than most other studied LplAs, possibly 
missing a C-terminal domain.  Further BLASTP searches revealed a gene ex-
actly upstream of the Thermoplasma LplA, ta0513m, coding for a protein se-
quence that aligns very well with the C-terminal domain of other known LplAs, 
but the ta0513m gene product has not been studied yet (McManus et al., 2006). 
 
1.5 Aims of the project 
It has been known for some time that Tp. acidophilum has the oadhc genes or-
ganized in an operon, which, if recombinantly expressed, yield a functional mul-
tienzyme complex.  Recently, a proteomics study revealed the presence of the 
complex components in Thermoplasma cell lysate (Sun et al., 2007), but no 
report of an in vivo activity of the complex has yet been shown.  With the open 
questions regarding the activity of the innate Tp. acidophilum lipoylation ma-
chinery, the aim of this work was to investigate its activity.  This involves the 
cloning, expression, purification and characterisation of the lipoate protein li-
gase as well as a second protein encoded by ta0513m, which has been indi-
cated to have a possible role in lipoylation.  Moreover, the assembly of the 
Thermoplasma BCOADHC will be studied to confirm if its complex architecture 
follows a certain stoichiometry like eukaryotic and prokaryotic OADHCs. 
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CHAPTER 2 
MATERIALS 
 
2.1 Chemicals 
 
Chemical Chemical Supplier 
Acetonitrile (HPLC grade) Fisher Scientific Ltd., Loughborough, UK  
Agarose Sigma-Aldrich Company Ltd., Gillingham, UK 
Ammonium sulphate Sigma-Aldrich Company Ltd., Gillingham, UK 
Ampicillin Melford Laboratories Ltd., Suffolk, UK 
Bovine serum albumin (BSA) New England Biolabs Ltd., Hitchin, UK 
Bromophenol blue Sigma-Aldrich Company Ltd., Gillingham, UK 
Carbenicillin Sigma-Aldrich Company Ltd., Gillingham, UK 
CHAPS Melford Laboratories Ltd., Suffolk, UK 
Chloramphenicol Sigma-Aldrich Company Ltd., Gillingham, UK 
Dithiothreitol (DTT) Melford Laboratories Ltd., Suffolk, UK 
dNTPs Bioline Ltd. (London, UK)  
EDTA Sigma-Aldrich Company Ltd., Gillingham, UK 
Ethanol (AR grade) Fisher Scientific Ltd., Loughborough, UK  
Ethidium bromide Sigma-Aldrich Company Ltd., Gillingham, UK 
Glacial acetic acid Fisher Scientific Ltd., Loughborough, UK 
Glycerol  Fisher Scientific Ltd., Loughborough, UK 
Isopropyl-1-thio-ß-galactopyranoside 
(IPTG) 
Melford Laboratories Ltd., Suffolk, UK  
Kanamycin sulphate Melford Laboratories Ltd, Suffolk, UK 
D,L Lipoic acid Sigma-Aldrich Company Ltd., Gillingham, UK 
Methanol Fisher Scientific Ltd., Loughborough, UK 
2-(N-Morpholino)ethanesulfonic acid 
(MES) 
Melford Laboratories Ltd., Suffolk, UK 
3-(N-Morpholino)propanesulfonic acid 
(MOPS) 
Melford Laboratories Ltd., Suffolk, UK 
Sodium chloride Sigma-Aldrich Company Ltd., Gillingham, UK 
Sodium dodecylsulphate (SDS) Sigma-Aldrich Company Ltd., Gillingham, UK 
Trifluoroacetic acid (TFA) (Certified) Fisher Scientific Ltd., Loughborough, UK 
Tris base Melford Laboratories Ltd., Suffolk, UK 
Trypton Melford Laboratories Ltd., Suffolk, UK 
Yeast Extract Melford Laboratories Ltd., Suffolk, UK 
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Triton-X100 Fisher Scientific Ltd., Loughborough, UK 
Tween-20 Sigma-Aldrich Company Ltd., Gillingham, UK 
Helmanex II solution Hellma GmbH & Co, Müllheim, Germany 
 
2.2 Molecular biology reagents 
 
Reagent Reagent Supplier 
Phusion polymerase New England Biolabs Ltd., Hitchin, UK 
E. coli BL21(DE3) Novagen-Merck, Nottingham, UK 
E. coli Rosetta(DE3)  Novagen-Merck, Nottingham, UK 
E. coli ArcticExpressTM(DE3) Stratagene Europe, Netherlands 
E. coli ArcticExpressTM(DE3)RIL Stratagene Europe, Netherlands 
Restriction digest enzymes New England Biolabs Ltd., Hitchin, UK 
Promega, Southampton, UK 
Blue/orange ready-to-use 6x loading 
dye 
Promega, Southampton, UK 
E. coli JM109 cells Promega, Southampton, UK 
pGEM-T Easy vector Promega, Southampton, UK 
Primers MWG Biotech, Ebersberg, Germany 
T4 DNA ligase Promega, Southampton, UK 
Taq polymerase  Genesys, Camberley, UK 
QIAEX II Gel Extraction Kit Qiagen, Crawley, UK 
QIAprep Spin Miniprep Kit Qiagen, Crawley, UK 
PCR purification kit Qiagen, Crawley, UK 
pET expression vectors Novagen-Merck, Nottingham, UK 
Hyperladder I and IV Bioline Ltd., London, UK  
PageRuler™ Unstained Protein Ladder Fermentas, York, UK 
 
2.3 Protein purification reagents 
 
Reagent Reagent Supplier 
Bis-Tris and Tris-Glycine precast gels Invitrogen Ltd., Paisley, UK 
HBS-EP buffer  GE Healthcare UK Ltd., Bucks., UK 
Heparing Sepharose Fast Flow, 5 ml GE Healthcare UK Ltd., Bucks., UK 
HiLoad 16/10 Q Sepharose High Per-
formance 20 ml column 
Amersham Pharmacia 
  
 18 
HisTrap FF, HisTrap HP chromatogra-
phy columns 
GE Healthcare UK Ltd., Bucks., UK 
NSB reducer GE Healthcare UK Ltd., Bucks., UK 
NuPAGE electrophoresis system Invitrogen Ltd., Paisley, UK 
Protein standards Bio-Rad (Hemel Hempstead, UK) /  
Invitrogen / GE Healthcare 
HiTrap Q FF, ionexchange chromatog-
raphy columns 
GE Healthcare UK Ltd., Bucks., UK 
Resource Q column  GE Healthcare UK Ltd., Bucks., UK 
Sensor CM5 chips GE Healthcare UK Ltd., Bucks., UK 
PD10 columns GE Healthcare UK Ltd., Bucks., UK 
Silver stain kit  Fermentas, York, UK 
Superdex 200 10/300 column Amersham Pharmacia 
Bis-Tris and Tris-Glycine precast gels Invitrogen Ltd., Paisley, UK 
Bradford assay reagent  Bio-Rad, Hemel Hempstead, UK 
Heparin Sepharose FF  Amersham Pharmacia 
HiLoad 16/10 Q Sepharose High Per-
formance  
Amersham Pharmacia 
HiLoad 16:60 Superdex 75 prep grade  Amersham Pharmacia 
NuPAGE electrophoresis system Invitrogen Ltd., Paisley, UK 
Pre-stained Protein standards Invitrogen Ltd., Paisley, UK 
SnakeSkinTM dialysis tubing Pierce, Thermofisher Scientific Inc., UK 
Whatman® Anotop 10, 0.02 µm filter Fisher Scientific Ltd., Loughborough, UK 
Anti-lipoic acid rabbit antibody Calbiochemm, Nottingham, UK 
Anti-rabbit goat IgG antibody Sigma-Aldrich Company Ltd., Gillingham, UK 
 
2.4 Protein crystallography reagents 
 
Reagent Supplier 
High vacuum grease Dow Corning Corp. U.S.A 
Siliconized circle cover slides 22 mm Hampton Research, U.S.A 
Structure Screen 1 Molecular dimensions Ltd., Suffolk, UK 
Structure Screen 2 Molecular dimensions Ltd., Suffolk, UK 
Tacsimate Hampton Research, U.S.A 
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CHAPTER 3 
General methods and protein purification 
 
3.1 DNA methods 
 
3.1.1 Polymerase chain reaction (PCR) 
Thermoplasma acidophilum genes were PCR amplified from Tp. acidophilum 
genomic DNA (100 µg/µl), kindly provided by Dr Alex Jefferies, University of 
Bath.  PCR reactions with a final volume of 50 µl contained template DNA (100 
ng), forward and reverse primers (0.5 µmol each), Phusion DNA polymerase 
(1U) and 200 µM of each deoxynucleoside triphosphate (dATP, dCTP, dGTP, 
dTTP) in Phusion HF buffer supplied by the manufacturer (New England Bio-
labs).  Controls involved reactions that contained only a single primer or no 
template DNA. 
 
Reactions were carried out in an Eppendorf Mastercycler (Eppendorf, Ger-
many).  A standard cycle comprised: 
Hot start denaturation (98°C) 30 s 
Denaturation (98°C) 10 s 
Annealing (X°C) 30 s 
Extension (72°C) 30 s 
Final extension (72°C) 10 min 
X is the temperature ~ 5°C below the melting temperature (Tm) of the primers. 
 
3.1.2 Agarose gel electrophoresis 
DNA was visualised by gel electrophoresis in 0.8 – 1% (w/v) agarose supple-
mented with 0.5 µg/ml ethidium bromide, made by heat-dissolving in TAE buffer 
[40 mM Tris acetate, pH 8.0, 1 mM EDTA].  DNA samples were prepared for 
electrophoresis by the addition of an appropriate amount of ready-to-load 6x 
loading buffer [0.4% orange G, 0.03% bromophenol blue, 0.03% xylene cyanol 
FF, 15% Ficoll® 400, 10 mM Tris-HCl (pH 7.5) and 50 mM EDTA (pH 8.0)].  
DNA was electrophoresed in TAE buffer at a constant 60-80 V.  Gels were run 
for an amount of time that facilitated adequate band separation; progress of 
DNA through the gel was tracked by following the xylene cyanol dye front.  
30 cycles 
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Ethidium bromide-bound DNA bands were visualised under a UV transillumina-
tor.  The size of fragments was estimated by calibration against DNA molecular 
weight marker run simultaneously on the gel. 
 
3.1.3 DNA gel purification 
DNA bands were excised from agarose gels and then purified using the QIAEX 
II Gel Extraction Kit, following the manufacturer’s protocol (Qiagen, 1999).  DNA 
was eluted in 20 µl of 10 mM Tris-HCl (pH 8.5) and stored at -20°C.  Concentra-
tion of eluted DNA was estimated by electrophoresis of a defined amount of 
sample in an agarose gel (as in section 3.1.2) and comparison with a DNA 
mass ladder (Bioline), run in the gel simultaneously 
 
3.1.4 Growth of Escherichia coli 
Escherichia coli strains were cultured in liquid Luria Bertani (LB) medium ad-
justed to pH 7.0 with NaOH, containing sodium chloride (0.5% w/v), tryptone 
(1.0% w/v) and yeast extract (0.5% w/v); for LB plates, agar (1.5% w/v) was 
added to the above medium.  The medium was supplemented with antibiotic(s) 
when required (ampicillin, 100µg/ml; carbenicillin, 50 µg/ml; kanamycin, 30 
µg/ml; chloramphenicol, 34 µg/ml) as recommended in the Novagen pET Sys-
tem manual (11th edition) for pET vectors, or the Promega manual (1999) for 
pGEM-T vectors. 
 
3.1.5 Growth of Tp. acidophilum cell cultures 
Tp. acidophilum (strain 1728) was purchased from DSMZ – Deutsche 
Sammlung von Mikroorganismen und Zellkulturen GmbH (Braunschweig, 
Germany).  Cell cultures were started from the vacuum-dried cell pellets follow-
ing the supplier’s instructions.  The growth medium composition is given in Ta-
ble 1.  To examine the effect of lipoic acid (LA), cell cultures were supplemented 
with 0.2 mM LA.  The medium was adjusted to pH 1.0 – 2.0 with 10 M H2SO4.  
The starter culture was subcultured five times with and without LA supplement. 
 
 
 
 
 21 
Table 1 Tp. acidophilum growth medium composition 
 
1L DSM 158 medium contains 1L trace element solution in distilled 
H2O contains 
(NH4)2SO4 1.32 g  FeCl3.6 H2O 1.93 g  
KH2PO4 0.372 g  MnCl2.4 H2O 0.18 g  
MgSO4.7 H2O 0.247 g  Na2B4O7.10 H2O 0.45 g  
CaCl2.2 H2O 0.074 g  ZnSO4.7 H2O 22.0 mg  
Yeast extract 
(Difco, stock solu-
tion 10% w/v) 
1.0 g  CuCl2.2 H2O 5.0 mg  
D-glucose (stock 
solution 50% w/v) 
10.0 g Na2MoO4.2 H2O 3.0 mg  
Trace element 
solution 
10 ml  VOSO4.5 H2O 3.8 mg  
  CoSO4.7 H2O 2.0 mg  
 
 
3.1.6 Plasmid DNA purification 
Cells were grown overnight at 37°C in 5 – 10 ml LB medium (section 3.1.4) with 
shaking.  Cells were harvested by centrifugation at 6000 × g for 6 min.  Plasmid 
DNA was extracted using the QIAprep Spin Miniprep Kit following the manu-
facturer’s protocol (Qiagen, 2005).  Plasmids could then be visualised by elec-
trophoresis in a 1.0% agarose gel (section 3.1.2). 
 
3.1.7 A-tailing of blunt-ended PCR products 
Gel-purified PCR fragments generated by Phusion DNA polymerase were A-
tailed using Taq DNA polymerase, following the Promega A-tailing procedure 
protocol (pGEM-T Vector Systems Technical Manual, 1999).  The reaction was 
carried out in 0.5 ml PCR tubes (with low DNA binding capacity) at 70°C for 30 
min. 
 
3.1.8 Sequencing of PCR products 
PCR products were A-tailed (section 3.1.5), ligated into pGEM-T Easy vector 
(section 3.1.9) and plated onto agar plates as per the manufacturer’s instruc-
tions (Promega).  The multiple cloning region of the pGEM-T Easy vector falls 
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within the α-peptide coding region for β-galactosidase.  If grown on agar sup-
plemented with 5-bromo-4-chloro-3-indolyl-ß-D-galactoside (X-Gal), the β-
galactosidase activity is detected by the blue colour of colonies.  Successful 
insertion of PCR products into the pGEM-T Easy multiple cloning site abolishes 
β-galactosidase activity and hence recombinant clones will form white colonies.  
From each ligation reaction, five white colonies with the potentially correct DNA 
insert and one blue colony were selected, inoculated in 10 ml LB medium and 
incubated overnight at 37°C.  From the liquid overnight cultures pGEM-T Easy 
plasmid DNA was purified as described in section 3.1.6.  Plasmid DNA (300 – 
500 ng) was supplied with Sp6 and/or T7 primer and sent for sequencing at the 
University of Bath or to Geneservice Ltd. (Cambridge, U.K). 
 
3.1.9 Cloning: restriction enzyme digests and DNA ligations 
A typical restriction digest contained ≥ 200 ng of plasmid DNA and was per-
formed in 1.5 ml Eppendorf tubes in total volumes that ranged from 10 – 100 µl.  
The number of units of restriction enzyme(s) used depended upon the amount 
of DNA being cut, and was usually 10 – 20 U.  For double digests, a buffer that 
was compatible for both restriction enzymes was used (details of compatibility 
were obtained from the manufacturer’s catalogue).  If enzymes were not com-
patible, a sequential digest was performed.  BSA (100 µg/ml) was added only 
when recommended for an enzyme.  Glycerol concentrations were kept below 
10% (v/v) to avoid star activity.  Reactions were usually incubated for 1 to 3 h at 
37°C.  After incubation, samples were either stored at -20°C, or run on an aga-
rose gel.  Target DNA fragments were excised from the gel and purified using 
the QIAEX II gel extraction kit (section 3.1.3).  ‘Single restriction digestion’ con-
trols were reactions containing only a single restriction enzyme. 
 
Target genes were ligated into cut plasmid vectors using the Promega Rapid 
Ligation Kit following the accompanying protocol.  Reactions (10 µl total volume) 
were carried out in 0.5 ml PCR tubes (with low DNA binding capacity).  In-
sert:vector molar ratios were always calculated according to the Promega Rapid 
Ligation protocol.  In the negative ligation control, no insert DNA was supplied in 
the mixture, whereas the positive ligation control included control insert DNA 
provided by the supplier.  Reaction mixtures were incubated at 4°C overnight. 
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3.1.10 Cloning of the Thermoplasma acidophilum lipoate protein ligase 
(LplA) 
The Tp. acidophilum lipoate protein ligase (Tp. LplA) is encoded by the gene 
ta0514 (see chapter 4).  The forward and reverse primers for the ta0514 gene 
were 
5’-CATATGGAAGGCAGGCTTCTTTTACTAGAAACA-3’ (start codon in bold 
and NdeI restriction site underlined) and 
5’-CGGGATCCCTATACGACCTCTTTCCTCAG-3’ (stop codon in bold and 
BamHI restriction site underlined) respectively.  PCR amplification of Tp. LplA 
from genomic DNA gave one PCR product of the expected size (Fig. 3.1). 
The PCR product was ligated (section 3.1.9) into pGEM-T Easy vector and sent 
for sequencing.  Correct clones were ligated into pET19b via the NdeI and 
BamHI restriction sites to allow the expression of recombinant N-terminal His-
tagged LplA. 
 
kb    1     2    3     4     5
1.0
0.51
 
 
Fig. 3.1 PCR amplification of the Tp. acidophilum LplA DNA sequence (1% agarose 
gel).  Marker sizes are indicated in kilo base pairs.  Lane 1, no DNA; lane 2, no reverse 
primer; lane 3, no forward primer; lane 4, PCR amplification reaction without DMSO; 
lane 5, PCR amplification reaction with DMSO. 
 
 
3.1.11 Cloning of the putative Thermoplasma acidophilum C-terminal do-
main (CTD) of LplA 
The Thermoplasma CTD is encoded by the gene ta0513m (see chapter 4).  The 
forward and reverse primer were 
5’-GCTAGCATGCATATGATGTACAGCAAGAACTGGAAG-3’ (start codon bold 
and NheI restriction site underlined) and 
5’-GGATCCTCAGATCACCCTCAAAGCCTGAATAAAGTC-3’ (stop codon in 
bold and BamHI site underlined) respectively. The PCR reaction gave rise to 
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one product (Fig. 3.2).  The PCR product was ligated (section 3.1.9) into pGEM-
T Easy vector and sent for sequencing.  The correct clone was ligated into 
pET28a for expression of recombinant CTD with an N-terminal His-tag. 
 
For expression of a nontagged version of the CTD, the pET28a plasmid DNA 
containing the putative ctd gene was sequentially digested with NheI and 
BamHI.  The CTD gene insert was gel purified and ligated into linearized pET24 
cut with the same restriction enzymes.  The pET24-CTD plasmid was trans-
formed into BL21(DE3) E. coli cells and selected for the appropriate antibiotic 
resistance. Transformants carrying the correct insert were confirmed by se-
quencing. 
 
kb   1    2    3    4    5  
1.0
0.51
 
 
Fig. 3.2 PCR amplification of Tp. acidophilum CTD DNA sequence (1% agarose gel).  
Marker sizes are indicated in kilo base pairs.  Lane 1, no DNA; lane 2, no reverse 
primer; lane 3, no forward primer; lane 4, PCR amplification reaction without DMSO; 
lane 5, PCR amplification reaction with DMSO. 
 
 
3.1.12 Cloning of the Thermoplasma acidophilum E2 lipoyl domain 
(E2lipD) 
The dihydrolipoyl acyl-transferase (E2) is encoded by the Tp. acidophilum gene 
ta1436.  The E2 component is composed of three domains: the E2 lipoyl do-
main (E2lipD), the peripheral subunit binding domain (PSBD), with which either 
E1 or E3 associates, and the catalytic domain.  To clone only the Thermo-
plasma E2lipD, the forward primer was designed to match the ta1436 gene and 
the reverse primer was designed to match the gene sequence coding for the C-
terminus of the E2lipD and part of the linker region between the lipoyl and pe-
ripheral subunit binding domains (Fig. 3.3). 
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Fig. 3.3 The domain structure of the Tp. acidophilum E2 as predicted from a Pfam A 
search.  The Pfam A search revealed three domains.  The start and end of the domain 
is indicated by the amino acid number below.  The forward primer (FP) and reverse 
primer (RP) are illustrated. 
 
 
The reverse primer was designed to introduce a stop codon at the C-terminal 
end of the E2lipD.  The sequences for the forward and reverse primer were 
5’-CGCCATATGTACGAATTCAAACTGCCAGACATAGG-3’ (start codon in bold 
and NdeI restriction site underlined) and 
5’-CGGGATCCTCAGGTATCGATCTGCAGGAG-3’ (stop codon in bold and 
BamHI restriction site underlined) respectively.  The PCR reaction gave one 
single product of the expected size (Fig. 3.4) that was ligated (section 3.1.9) into 
pGEM-T Easy vector and sent for sequencing. A correct clone was ligated into 
pET19b vector cut with NdeI and BamHI for expression of recombinant E2lipD 
carrying an N-terminal His-tag. 
 
1.0
0.51
kb  1    2     3    4    5
 
 
Fig. 3.4 PCR amplification of Tp. acidophilum E2 lipoyl domain DNA sequence (1% 
agarose gel).  Marker sizes are indicated in kilo base pairs.  Lane 1, no DNA; lane 2, 
no reverse primer; lane 3, no forward primer; lane 4, PCR amplification reaction without 
DMSO; lane 5, PCR amplification reaction with DMSO. 
 
 
3.1.13 Transformation by heat-shock 
All transformations were done using commercially available competent cells of 
various E. coli strains.  Each transformation reaction contained approximately 1 
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ng plasmid DNA to which 10 µl of competent cells were added.  The incubation 
time of competent cells with the DNA on ice, as well as the duration of heat 
shock in a water bath at 42°C, varied between 5 to 20 min, and 30 to 50 s, re-
spectively based on the cell line and the manufacturer’s recommendations.  Af-
ter the heat shock, 500 µl room-temperature LB medium was added, and cells 
were incubated at 37°C for 1.5 – 2 h with shaking.  Cells were spread onto LB 
agar plates containing the appropriate antibiotic.  For blue-white selection of 
transformants containing ligated pGEM-T clones, cells were spread onto LB 
agar plates as per the manufacturer’s instructions. 
 
 
3.2 Protein methods 
 
3.2.1 Non-denaturing and SDS-PAGE 
Non-denaturing PAGE was prepared and carried out as described below, omit-
ting SDS and β-mercaptoethanol in any preparations; also, samples were not 
boiled.  Pre-cast NuPAGE® gels (Invitrogen) were run according to the manu-
facturer’s instructions. 
Gel preparation: A resolving gel (15%) was made by mixing 4 ml of 30% (v/v) 
acrylamide, 2.6 ml buffer [1.0 M Tris-HCl, pH 8.8], 80 µl of 10% (w/v) SDS, and 
distilled water to a final volume of 7.98 ml, and was polymerised by the addition 
of 12 µl of 20% (w/v) ammonium persulphate and 10 µl tetramethylethyl-
enediamine (TEMED).  The stacking gel (4% acrylamide) was made by mixing 
0.625 ml of 30% (v/v) acrylamide, 0.625 ml buffer [1.0 M Tris-HCl, pH 6.8], 50 µl 
of 10% (w/v) SDS, and 3.6 ml distilled water, and was polymerised with the ad-
dition of 15 µl of 20% (w/v) ammonium persulphate and 5 µl TEMED. 
Preparation of protein samples: Samples were prepared for loading by the addi-
tion of an equal volume of 2 x loading buffer [0.05 M Tris-HCl, pH 6.8, 4% (w/v) 
SDS, 20% (w/v) sucrose, 10% (v/v) β-mercaptoethanol, 0.2% (w/v) bromophe-
nol blue].  Samples were heated at 100°C for ~ 3 min and then vortexed vigor-
ously.  Samples were either loaded immediately onto gels, or stored at -20°C 
until use. 
Electrophoresis: Electrophoresis buffer was composed of 0.12 M Tris base, 
9.4% (w/v) glycine, and 0.5% (w/v) SDS.  The gel was stained in Coomassie 
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staining solution [0.25% (w/v) Coomassie Brilliant Blue R250, 45% (v/v) metha-
nol, 45% (v/v) deionised water, 10% (v/v) acetic acid].  Destain solution was 
20% (v/v) methanol, 10% (v/v) acetic acid and 70% (v/v) distilled water. 
 
3.2.2 Optimization of chromatography conditions for protein purification 
The chromatography methods used for protein purification include affinity purifi-
cation, ion exchange, and gel permeation chromatography.  Optimum pH and 
purification resins were tested using the Äkta FPLC purifier scouting settings 
(Amersham Bioscience).  Chromatography columns used include Resource Q, 
HiTrap Q FF, Q Sepharose, Resource S and Heparin Sepharose.  The pH 
range tested was pH 6.0 – 9.0 as well as pH 4.5 – 6.0.  The purification condi-
tions for each protein given in this thesis are based on optimization trials. 
 
3.2.3 Buffer exchange of protein samples 
Proteins were buffer exchanged by either dialysis or by using PD10 desalting 
columns.  SnakeSkinTM dialysis tubing (Pierce) was prepared according to the 
manufacturer’s instructions. Samples were sealed in the dialysis tubing, and the 
tubing was submerged in the desired buffer with a sample to buffer volume ratio 
of 1:25, with at least three changes, at 4°C with gentle stirring  
 
PD10 desalting columns (GE Healthcare) were used to exchange the His-
purification elution buffer for the final storage buffer following the manufacturer’s 
instructions. 
 
3.2.4 Concentrating purified protein samples 
Stirred-tank concentrators (Amicon) were used to concentrate large volumes of 
purified proteins.  Smaller volumes of dilute protein samples were concentrated 
at 4°C using Amicon Ultra-15 or Amicon Ultra-4 centrifugal filter devices (Milli-
pore) according to the manufacturer’s instructions. 
 
3.2.5 Expression and purification of Tp. acidophilum 2-oxoacid decarboxy-
lase (E1) 
The E1α and E1β genes were available pre-cloned in pET19b and pET28a, re-
spectively, by Dr. Caroline Heath, University of Bath (Heath et al., 2004).  The 
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recombinant proteins carry N-terminal His-tags.  For expression, bacterial cell 
cultures were grown at 37°C in LB medium supplemented with the appropriate 
antibiotics to an OD600nm of 0.6 and induced with 1 mM IPTG for 4 h with shak-
ing.  Cells were harvested by centrifuging at 6000 x g for 10 min at 4°C.  The 
harvested cells were sonicated in the running buffer (20 mM sodium phosphate, 
pH 7.4, 0.5 M NaCl) and centrifuged at 70,000 x g for 20 min at 4°C.  The su-
pernatant was subjected to Ni2+ affinity chromatography using a 1 ml HisTrap 
HP column applying a linear gradient of imidazole (0 – 0.5 M) in the running 
buffer.  Fractions containing the recombinant E1αβ were pooled and concen-
trated in Amicon ultra (10 MWC) concentrator devices (Millipore) as per the 
manufacturer’s instructions.  The concentrated samples were desalted using a 
PD10 column (GE Healthcare) (section 3.2.3) by eluting the protein with 20 mM 
sodium phosphate, pH 7.4. 
 
3.2.6 Expression and purification of Tp. acidophilum dihydrolipoyl acyl-
transferase (E2) 
The E2 gene was available pre-cloned in pET28a by Dr. Caroline Heath, Uni-
versity of Bath (Heath et al., 2007).  The recombinant protein carries an N-
terminal His-tag.  For expression of unlipoylated E2, cells were induced with 1 
mM IPTG at 37°C and grown for 4 h.  Soluble lipoylated E2 protein (50% lipoy-
lation) was obtained by expressing the E2 gene in uninduced BL21(DE3) cells 
grown in LB medium supplemented with lipoic acid (0.2 mM), at 30°C for 20 h.  
Harvested cells were resuspended in the running buffer (20 mM sodium phos-
phate, pH 7.4, 0.5 M NaCl), sonicated and centrifuged at 70,000 x g for 20 min 
at 4°C.  The supernatant was subjected to Ni2+ affinity chromatography on a 1 
ml HisTrap HP column applying a linear gradient of imidazole (0 – 0.5 M) in the 
running buffer.  Fractions containing E2 were concentrated using Amicon ultra 
(10 MWC) concentrator devices (Millipore).  Concentrated E2 was buffer ex-
changed (section 3.2.3) into 20 mM sodium phosphate, pH 7.4. 
 
3.2.7 Expression and purification of Tp. acidophilum dihydrolipoamide 
dehydrogenase (E3) 
The E3 gene had been pre-cloned into pET28a and expressed in E. coli 
BL21(DE3) cells (Heath et al., 2007).  The recombinant protein carries an N-
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terminal His-tag.  Cultures were inoculated from glycerol stocks.  Cells were not 
induced with IPTG.  After an OD600nm of ~ 0.6 was reached, expression was al-
lowed for 5 h at 37°C with shaking.  Harvested cells were resuspended and 
sonicated in the running buffer (20 mM sodium phosphate buffer, pH 7.4, 0.5 M 
NaCl, 20 mM imidazole).  The cell lysate was centrifuged at 70,000 x g for 20 
min at 4ºC.  The supernatant was subjected to Ni2+ affinity chromatography on a 
HisTrap HP column applying a linear gradient of imidazole (0 – 2 M) in 20 the 
running buffer.  The protein was buffer exchanged (section 3.2.3) into 20 mM 
sodium phosphate, pH 7.4. 
 
3.2.8 Expression and purification of His-tagged Tp. acidophilum LplA (His-
LplA) 
The pET19b carrying the lpla gene (section 3.1.10) was transformed into Arc-
ticExpress(DE3) E. coli cells (Stratagene).  Cell cultures were grown in LB me-
dium at 37°C using shake flasks until an OD600nm of 0.7 – 0.9 was reached.  Re-
combinant protein was induced with a final concentration of 0.25 mM IPTG and 
incubated for 3 h at 12°C with shaking.  The cells were lysed by sonication in 
running buffer (20 mM Tris-HCl, pH 7.5, 0.3 M NaCl, 20 mM imidazole) in the 
presence of 2% (v/v) Triton-X 100.  The lysate was centrifuged at 70,000 x g for 
20 min at 4°C.  The supernatant was subjected to Ni2+ affinity chromatography 
on a HisTrap FF column (GE Healthcare) applying a linear gradient of imidazole 
(0.02M – 0.5 M) in the running buffer.  Fractions containing His-LplA from the 
first Ni2+ affinity chromatography purification step were pooled, diluted 5-fold in 
running buffer, and re-applied to a 1 ml HisTrap HP column (GE Healthcare) for 
a second cycle of Ni2+ affinity chromatography.  Fractions from the second Ni2+ 
affinity chromatography were again pooled, diluted 10-fold in 50 mM Tris-HCl, 
pH 8.0, and subjected to ion-exchange chromatography using a 1 ml HiTrap Q 
FF column and eluted by applying a linear gradient of NaCl (0 – 0.5 M) in 50 
mM Tris-HCl, pH 8.0.  The protein purification steps are illustrated in Fig. 3.2.  
Protein fractions, > 90% pure (by analysis on gel), were collected and stored in 
elution buffer at -20°C until further use. 
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Fig. 3.2 SDS-PAGE gel showing the different stages of purification of Tp. acidophilum 
His-tagged LplA. His-LplA was purified from a 0.5 L culture grown as described above.  
M, protein marker (kDa); lane 1, LplA from the initial Ni2+ affinity purification; lanes 2 – 
4, fractions of purified LplA from a second Ni2+ affinity purification;  lanes 5 – 7, frac-
tions of purified LplA after anion exchange on Q FF. 
 
 
3.2.9 Expression and purification of Tp. acidophilum nontagged LplA 
(ntLplA) 
The pET3a plasmid carrying the Thermoplasma lpla gene was a kind gift from 
Edward McManus of Prof. Richard Perham’s group, University of Cambridge. 
Details of the construct are described in McManus et al. (2007). 
 
The pET3a-LplA plasmid was transformed into BL21(DE3) E. coli cells following 
the supplier’s instructions.  Cultures were grown to an OD600nm 0.7 – 0.9 and 
induced with 0.5 mM IPTG at 37°C for 3 – 4 h.  Cells were harvested, sonicated 
in 20 mM Tris-HCl, pH 8.5, 0.5% (v/v) Triton X-100, and centrifuged at 75,000 x 
g at 4°C for 20 min.  The supernatant was subjected to anion exchange on Hi-
Trap Q FF applying a linear gradient of NaCl (0 – 0.5 M) in 20 mM Tris-HCl, pH 
8.5, which yielded ~ 60 % pure ntLplA (by analysis on gel).  Fractions contain-
ing the ntLplA protein were diluted 10 fold in 20 mM Tris-HCl, pH 8.5, and the 
anion exchange purification step was repeated, yielding ≥ 80 % pure ntLplA (by 
analysis on gel).  An overview of the protein purification is shown in Fig. 3.3.  
The purified protein was stored in the elution buffer at -20ºC until further use. 
 31 
A                                                B                                             
M 1  2  3  4   5  6 
6   
←   LplA   
kDa   
  
97   
66   
  45   
  
30  
  
  
  
20.1  
  
  
14.1   
M 1 2  3  4  5  6  7  
  
←   LplA   
  
kDa  
  97  
  66  
  
  45  
  
  30   
  
  
  
20.1  
  
  
14.1  
  
 
 
Fig. 3.3 SDS-PAGE gels showing the different stages of purification of non-tagged 
LplA.  M, protein marker (kDa).  A: Initial anion exchange chromatography on HiTrap Q 
FF.  Lane 1, flow-through from Q FF column; lanes 2 – 6, fractions eluted with 
increasing NaCl gradient; lanes 4 – 6, fractions of purified ntLplA.  B: Second anion 
exchange chromatography of ntLplA.  Lane 1, flow through from Q FF column; lanes 2 
– 6, fractions eluted with increasing NaCl gradient; lane 7, ntLplA, concentrated using 
Amicon ultra spin filter devices. 
 
 
3.2.10 Expression and purfication of Tp. acidophilum His-tagged CTD (His-
CTD) 
The pET28a plasmid carrying the ctd gene (section 3.1.11) was transformed 
into ArcticExpress(DE3) E. coli cells (Stratagene) following the manufacturer’s 
instructions.  Cell cultures were grown at 37°C in LB medium using shake 
flasks.  Recombinant protein was induced at OD600nm of 0.7 – 0.9 with 0.25 mM 
IPTG for 4 h at 12°C with shaking.  Cells were sonicated in running buffer (20 
mM Tris-HCl, pH 8.5, 0.3 M NaCl, 20 mM imidazole) with 2% (v/v) Triton X-100 
and centrifuged at 70,000 x g for 20 min at 4°C.  The supernatant was sub-
jected to Ni2+ affinity chromatography on a HisTrap FF column, applying a linear 
imidazole gradient (0 – 0.5 M) in the running buffer.  Initial Ni2+ affinity chroma-
tography yielded ≥ 85% pure His-CTD (by analysis on gel).  Fractions contain-
ing His-CTD from the first Ni2+ affinity chromatography purification step were 
pooled, diluted 5-fold in running buffer, and re-applied to a 1 ml HisTrap HP col-
umn (GE Healthcare) for a second cycle of Ni2+ affinity chromatography, yield-
ing ≥ 95% pure protein (by analysis on gel).  An overview of the protein purifica-
tion is shown in Fig. 3.4.  Protein fractions were pooled and stored in elution 
buffer with 5% (v/v) glycerol at -20°C until further use. 
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Fig. 3.4 SDS-PAGE gels showing the purification steps of His-tagged CTD.  M, protein 
marker (kDa).  A: Induction of recombinant His-CTD in ArcticExpress E. coli cells. Lane 
1, uninduced cells; lane 2, after 4 h induction.  His-CTD indicated by arrow.  B: Con-
secutive Ni2+ affinity purification using a HisTrap FF column.  Lanes 1 – 5, initial Ni2+ 
affinity purification, lanes 6 – 11 second Ni2+ affinity purification.  Lanes 1 and 6, flow 
through from the Ni2+ column. 
 
 
3.2.11 Expression and purification of Thermoplasma nontagged CTD 
(ntCTD) 
The pET24a plasmid carrying the ctd gene (section 3.1.11) was transformed 
into ArcticExpress(RIL) E. coli cells (Stratagene) following the manufacturer’s 
instructions.  Cell cultures were grown at 37°C in LB medium until OD600nm of 
0.7 – 0.9 and induced with 0.25 mM IPTG for 3 – 4 h at 12°C with shaking.  
Cells were harvested, sonicated in 20 mM Tris-HCl, pH 8.5, and centrifuged at 
75,000 x g at 4°C for 20 min.  To enrich ntCTD before ion exchange chromatog-
raphy, the cell lysate was subjected to ammonium sulphate precipitation using 
1.5 M and 2.5 M (NH4)2SO4 as per protocol ([Online] available at 
http://proteincrystallography.org/protein-purification/analytical-ammonium-
sulphate-cut.php, accessed December 16th, 2008).  The majority of the recom-
binant ntCTD was in the 2.5 M (NH4)2SO4 pellet and was buffer exchanged 
(section 3.2.3) into 50 mM Tris-HCl, pH 7.5.  The resulting supernatant was 
subjected to anion exchange chromatography on HiTrap Q FF and the protein 
was eluted with a linear gradient of NaCl (0 – 0.5 M) in 20 mM Tris-HCl, pH 7.5 
(Fig. 3.5). 
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Fig. 3.5 SDS-PAGE gel of purified ntCTD after ammonium sulphate precipitation and 
ion exchange chromatography.  M, protein marker (kDa).  Purification of ntCTD was 
carried out as described (section 3.2.11).  ntCTD indicated by arrow. 
 
 
3.2.12 Expression and purification of Thermoplasma E2 lipoyl domain 
The pET19b plasmid carrying the e2lipd gene (section 3.1.12) was transformed 
into Rosetta(DE3) E. coli cells following the supplier’s protocol and cell cultures 
were grown in LB medium at 37°C.  At OD600nm of 0.6 – 0.9 cells were induced 
with 0.5 mM IPTG and grown for ~ 3 h at 37°C with shaking. Cells were soni-
cated in running buffer (20 mM Tris-HCl, pH 8.0, 0.3 M NaCl, 20 mM imidazole) 
and centrifuged at 70,000 x g for 20 min at 4°C.  The supernatant was sub-
jected to Ni2+ affinity chromatography on HisTrap FF applying a linear gradient 
of imidazole (0 – 0.5 M) in 20 mM Tris-HCl, pH 8.0, 0.3 M NaCl (Fig. 3.6).  Frac-
tions containing the His-tagged E2lipD were pooled, diluted 10-fold in 50 mM 
Tris-HCl, pH 8.0, and reapplied to a HiTrap Q FF column for ion exchange 
chromatography applying a linear gradient of NaCl (0 – 0.5 M) in 50 mM Tris-
HCl, pH 8.0.  Purified E2lipD (≥ 90% pure by analysis on gel) was stored in elu-
tion buffer with 10% (v/v) glycerol at -20°C until further use. 
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Fig. 3.6 SDS-PAGE gel of initial Ni2+ affinity purification of E2lipD.  M, protein marker 
(kDa).  Lane 1, uninduced E2lipD; lane 2, induced E2lipD; lane 3, flow through from the 
Ni2+ column; lanes 4 and 5, fractions containing E2lipD, eluted from Ni2+ column. 
 
 
3.2.13 Expression and purification of the Escherichia coli LplA 
The TM202 plasmid carrying the E. coli LplA gene was a kind gift from Prof. R. 
Perham (University of Cambridge), and was transformed into BL21(DE3) cells 
as per the instructions of the supplier.  Cultures were grown in LB and recombi-
nant protein was induced with 0.5 mM IPTG at OD600nm of 0.6 – 08 for ~ 3 h at 
37°C.  Cells were sonicated in 50 mM Tris-HCl, pH 8.5, and centrifuged at 
70,000 x g for 20 min at 4°C.  The supernatant was subjected to anion ex-
change chromatography on HiTrap Q FF and pure protein was eluted by apply-
ing a linear NaCl gradient (0 – 0.5 M) in 50 mM Tris-HCl, pH 8.5.  Fractions con-
taining purified protein were concentrated, loaded onto a SuperdexTM gel filtra-
tion column (10/300GL) and eluted using isocratic conditions of 20 mM Tris-
HCl, pH 7.5, 300 mM NaCl and stored in elution buffer with 5% (v/v) glycerol at -
20°C until further use. 
 
3.2.14 Expression and purification of the Escherichia coli E2 lipoyl domain 
The pET11c over-expression plasmid carrying the E. coli lipoyl domain was a 
gift from Prof. R. Perham (University of Cambridge), and was transformed into 
BL21(DE3) cells as per the instructions of the supplier.  Cultures were induced 
at OD600nm of 0.6 – 0.8 with 1 mM IPTG for ~ 4 h at 37°C.  Cells were sonicated 
in 50 mM Tris-HCl, pH 7.2, and centrifuged at 70,000 x g for 20 min at 4°C.  The 
supernatant was subjected to anion exchange on HiTrap Q FF column and pure 
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protein eluted by applying a linear NaCl gradient (0 – 0.5 M) in 50 mM Tris-HCl, 
pH 7.2.  Purified E. coli E2 lipoyl domain was stored in elution buffer with 5% 
(v/v) glycerol at -20°C until further use. 
 
3.2.15 Gel shift assay to detect lipoylation 
The lipoylation activity of both His-tagged and nontagged LplA and CTD was 
tested on a simple 15% non-denaturing PAGE gel, which can distinguish be-
tween non-lipoylated and lipoylated E2lipD protein due to the difference in their 
electrophoretic mobilities (Cronan et al., 2005; McManus et al., 2006; Fujiwara 
et al., 1995).  For the assay, all protein components were buffer exchanged 
(section 3.2.3) into 20 mM HEPES, pH 7.5, 150 mM NaCl.  Reaction mixtures 
contained 100 – 250 µg non-lipoylated E2lipD, 40 mM HEPES (pH 7.5), 10 mM 
ATP (omitted in negative controls), 10 mM MgCl2, 20 mM D,L-lipoic acid and 
LplA (10 – 250 µg), CTD (10 – 250 µg) or a mix of both proteins (10 – 250 µg 
each).  The reaction conditions were the same for LplA-CTD Fusion (see chap-
ter 7), adding varying amounts of LplA-CTD Fusion (10 µg – 250 µg) instead of 
LplA and CTD.  Reactions were activated by the addition of ATP and were in-
cubated at room temperature overnight or as stated.  Enzyme assays with li-
poyl-AMP were set up similarly, replacing D,L-lipoic acid with the alternative 
substrate and avoiding ATP. 
 
3.2.16 Synthesis of lipoyl-AMP 
Lipoyl-AMP was prepared as described by Reed et al. (1958) with the modifica-
tion that AMP.H2O instead of AMP.2H2O and DCM in place of acetonitrile were 
used.  A schematic diagram of the synthesis is shown in Fig. 3.7.  The synthetic 
product was analysed by silica thin-layer chromatography (TLC), infrared spec-
troscopy (IR) and nuclear magnetic resonance (NMR) spectroscopy.  The TLC 
was run in methanol-chloroform (1:1 v/v) on TLC Silica gel 60 on aluminium 
(Merck Chemicals) and developed using iodine vapours. 
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+
LA in ice cold ACN
Filter to remove DCU and use Rotovap
Lipoic acid anhydride in DCM
Add AMP in 32% pyridine slowly.
Reaction is allowed to take place over 10 min, 
then the mixture is stirred for further 50 min. 
Reaction stopped with 5 ml ice cold water.
Stirred at room temperature for 30 min
Extraction:
2 x 10 ml cold peroxide free ether
15 ml and 10 ml cold chloroform
EMULSION is formed.
Centrifuge to remove liquid
Sequentially wash with 2 x 5 ml (ice cold) of water, 
absolute ethanol, absolute ether
Dry in vacuo overnight
AMP
Lipoyl-AMP
DCC in ice cold ACN
 
 
Fig. 3.7 Reaction scheme showing the steps involved in lipoyl-AMP synthesis.  LA, 
lipoic acid; DCC, N,N’-dicyclohexylcarbodiimide; DCU, dicyclohexylurea; ACN, acetoni-
trile; DCM, dichloromethane. 
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Infrared spectroscopy was carried out on a Spectrum RX infrared spectrometer 
(Perkin Elmer).  The sample was prepared by mulling (i.e. grinding the solid in 
mineral oil) the reaction product with NujolTM (Trademark of Schering-Plough) 
and the viscous mixture was applied as a thin-layer between KBr windows. 
 
NMR analysis of lipoyl-AMP was performed on a Varian Mercury VX spectrome-
ter operating at a nominal proton frequency of 400 MHz.  For analysis, LA, AMP 
and lipoyl-AMP were dissolved in D2O, CDCl3 and DMSO, respectively.  
1H 
NMR spectra were generated for all compounds.  31P NMR spectra were gener-
ated for AMP and lipoyl-AMP. 
 
3.2.17 Western blot analysis of lipoylated dihydrolipoamide acyltrans-
ferase (E2) 
E2 was purified as described in section 3.2.6.  50 µg of whole E2 was incubated 
with His-LplA (5 µg – 10 µg) and His-CTD (20 µg – 40 µg) (section 3.2.15).  The 
reaction was allowed to proceed overnight and was run on a 15% SDS-PAGE.  
A wet transfer was done using a Mini Blot system (Biorad) and the transfer 
buffer (1 L) contained: 100 ml of 10 x transfer buffer (1.92 M glycine, 0.25 M 
Tris, pH 8.3), 20% (v/v) methanol, 0.0375% (w/v) SDS.  The protein was trans-
ferred onto an Immobilon-P membrane (Millipore) at 100 V for 1 h at 4ºC. Post 
transfer, the membrane was washed in PBS-T saline buffer (2.68 mM KCl, 
136.89 mM NaCl, 10 mM Na2HPO4.2H2O, 1.76 mM KH2PO4, pH 7.4, 0.1% (v/v) 
Tween 20) and non-specific binding sites were blocked with 5% (w/v) instant 
skim-dry milk (Oxoid) in PBS-T for 1 h at room temperature.  All incubation 
steps were done on a gyrating shaker (Janke & Kunkel, Model KS 250, IKA La-
bortechnik).  The membrane was washed thoroughly for 15 min in PBS-T and 
was incubated in 5% (w/v) milk in PBS-T with a 5000-fold dilution of anti-lipoic 
acid antibody (Calbiochem) for 1 h at room temperature.  The membrane was 
washed as before and incubated with anti-rabbit IgG (whole molecule)-
peroxidase antibody developed in goat (Sigma), 5000-fold dilution in 5% (w/v) 
milk in PBS-T for 1 h at room temperature.  After the final incubation, the mem-
brane was washed in PBS-T for 20 min and incubated with Immobilon Western 
Chemiluminescent HRP Substrate (Millipore) for 5 min.  The Western blot was 
developed using X-ray film (Fujitsu) and a developer. 
 38 
3.2.18 Mass Spectrometry 
Mass spectrometry (MS) analysis was done at the University of Bath using a 
micrOTOFTM electrospray time-of-flight (ESI-TOF) mass spectrometer (Bruker 
Daltonik GmbH, Bremen, Germany), which can be used to measure accurate 
mass to 5 ppm externally calibrated.  Lipoylation reactions of E2lipD (1 mg) with 
LplA:CTD in a 1:1 molar ratio were carried out overnight; negative controls con-
tained no ATP.  The reaction mixtures were then dialysed against 20 mM Tris-
HCl, pH 8.5, and 50µl of 50% (v/v) acetonitrile-0.1% formic acid were added to 
100µl of the protein sample prior to analysis.  Samples were analysed by direct 
infusion at 4 µl/min from a syringe pump.  The electrospray source was used in 
positive ion mode, with a dry-gas flow-rate of 4 L/min at 20°C.  The nebuliser 
pressure was set at 0.4 bar, with a capillary voltage of 4500V, a capillary exit of 
180V and a skimmer 1 voltage of 90V.  The ESI-TOF scanned a mass range 
from 250 – 3000 m/z and the average mass spectrum was externally calibrated 
against 5 mM sodium formate clusters using the data processing package 
DataAnalysisTM (Bruker Daltonik GmbH, Bremen, Germany). 
 
3.2.19 Protein concentration estimation 
Protein concentrations were determined by measuring A280nm of protein solu-
tions in 6 M guandine-HCl (Kelly et al., 2005).  Extinction coefficients were cal-
culated from the protein sequence using the ExPASY ProtParam tool (Swiss 
Institute of Bioinformatics). 
 
 
3.3 Biophysical methods 
 
3.3.1 Pull-down assays 
The pull-down assay is an in vitro method that is based on affinity chromatogra-
phy.  It allows confirmation and detection of previously unknown interactions 
between two or more proteins and is complementary to techniques such as 
yeast two-hybrid, enzyme-linked immunosorbant assay (ELISA) and analytical 
ultracentrifugation.  If the nature of the protein-protein interaction is known, this 
technique allows purification of a target protein from an unfractionated cell ex-
tract.  For a pull-down assay, sufficient amounts of pure tagged protein, the bait, 
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are required to capture and “pull-down” the binding partner (the prey).  Prefera-
bly the prey is non-tagged or has a different tag from the bait protein.  The prin-
ciple of pull-down assays has been widely employed to identify and/or confirm 
protein-protein interactions and to complement protein biophysical analyses 
(Promega Protein Interaction Guide (2007), chapter 3, [Online]: Available at 
http://www.promega.com/guides/protein.interactions_guide/protein.interactions_
gde.pdf (accessed December 7th, 2008). 
 
Any formation of a complex between LplA, CTD and E2lipD was analysed by 
employing a pull-down assay.  His-LplA (the bait) was loaded onto a HisTrap FF 
column in buffer A (20 mM Tris-HCl, pH 7.5, 150 mM NaCl) and the column was 
washed with buffer to remove any unbound His-LplA.  ntCTD (the prey) in 20 
mM Tris-HCl, pH 7.5, was also passed over the same column in buffer A fol-
lowed by extensive washing with buffer to remove any unbound ntCTD.  Pro-
tein(s) were then eluted with a linear gradient of imidazole (0 – 0.5 M) in 20 mM 
Tris-HCl, pH 7.5, 0.3 M NaCl, and fractions were analyzed on 15% (w/v) SDS-
PAGE.  The interaction of His-tagged E2LipD with ntLplA or ntCTD was also 
studied in a similar way.  The activity of the purified His-LplA-ntCTD complex 
was tested in gel shift assays as described in section 3.2.15.  Purified com-
plexes were also analyzed using dynamic light scattering (section 3.3.3). 
 
3.3.2 Surface plasmon resonance (SPR) 
All SPR experiments were performed on Biacore® T100 or Biacore® X-100 (GE 
Healthcare) at 25°C in the analyte buffer.  For immobilization of ligands, the 
sensor chip surface was activated with 1-ethyl-3-(3-dimethylaminopropyl) car-
bodiimide (EDC) and N-hydroxysuccinimide (NHS), which had been premixed in 
a 1:1 ratio of equal concentration.  The surface was blocked with ethanolamine 
three times as per the manufacturer’s instructions.  The HBS-EP buffer (GE 
Healthcare) contained 0.01 M HEPES, pH 7.4, 0.15 M NaCl, 3 mM EDTA, 
0.005% (v/v) Surfactant P20. 
 
The CM5 chip has a ~ 100 nm thick surface layer made up of carboxymethy-
lated dextran.  This dextran matrix provides a high surface capacity for immobi-
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lizing many different ligands (Biacore® sensor surface Handbook, edition Octo-
ber 2003). 
 
Ligand penta-His antibody (50 µg/ml) was immobilized onto a CM5 chip in 10 
mM sodium acetate buffer, pH 5.0 yielding RU = 600.  The surface was charged 
with Ni2+ for 60 s before the analyte, His-tagged LplA (100 µg/ml) in HBS-EP 
buffer, was injected for 120 s at a flow rate of 5 µl/min.  ntCTD in the presence 
and absence of 5 mM MgCl2 in HBS-EP buffer was used as a secondary ana-
lyte and passed over the already bound His-LplA.  Similarly, His-tagged E2lipD 
was bound to the penta-His antibody on the CM5 chip.  As analyte, ntLplA (100 
µg/ml) by itself or in the presence of ntCTD (100 µg/ml) was passed over His-
E2lipD ligand. 
 
Ligand ntLplA (50 µg/ml) was immobilized onto a CM5 chip in 10 mM sodium 
acetate buffer, pH 5.0 yielding RU = 567.1.  Analyte was ntCTD (4 mg/ml) in 20 
mM HEPES, pH 7.5, 150 mM NaCl, 5 mM MgCl2.  A serial dilution of ntCTD 
was prepared from the stock solution (4 mg/ml).  ntCTD was injected for 60 s 
(association phase) and dissociation phase was monitored for 600 s at a flow 
rate of 30 µl/min.  Regeneration of the sensor chip surface was achieved by 
using 10 mM NaOH for 30 s. 
 
Ligand ntCTD (50 µg/ml) was immobilized onto a CM5 chip in 10 mM sodium 
acetate buffer, pH 5.0 yielding RU = 400.  Analytes were ntLplA (3 mg/ml) and 
His-E2lipD (4 mg/ml).  A serial dilution of ntLplA was prepared in HBS-EP 
buffer, pH 7.4, 5 mM MgCl2, NSB (non-specific binding reducer; GE Health-
care).  The maximum and minimum concentrations of ntLplA used were 10 
mg/ml and 0.04 mg /ml, respectively.  His-E2lipD was diluted to 0.2 mg/ml in 
HBS-EP buffer, pH 7.4, 5 mM MgCl2, and used as the analyte.  In addition, His-
E2lipD (0.2 mg/ml) and ntLplA (3 mg/ml) were mixed in a ratio of 1:1 and used 
as analyte.  The flow rate was 30 µl/min.  Washing with running buffer regener-
ated the sensor chip surface. 
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3.3.3 Dynamic light scattering (DLS) 
All DLS measurements were performed using a Zetasizer Nano S from Malvern 
Instruments Ltd. (Malvern, UK) using a low volume precision quartz cuvette 
(105.251.005-QS, Hellma UK Ltd.).  Prior to DLS measurements, protein 
solutions (≥ 1 mg/ml) in 20 mM Tris-HCl, pH 8.0 and 0.2 M NaCl solution were 
filtered through a 0.02 µm membrane filter (Whatman® Anotop 10, Fisher 
Scientific) or centrifuged at 13,000 x g for 20 min at 4°C to remove dust 
particles.  DLS measurements were carried out at 25°C or 55°C in triplicate.  
Melting points were determined over a temperature range of 20°C to 70°C. 
 
Analysis of purified OADHC components: All purified protein samples (≥ 1 
mg/ml) were in 20 mM sodium phosphate, pH 7.4.  Purified E1 and E2 were 
filtered through 0.02 µm membrane filters.  Purified E3 was filtered through a 
0.22 µm membrane filter (Millipore®) as E3 filtered through 0.02 µm filters was 
unsuitable for measurement.  Each measurement was done in triplicate.  Two 
operating temperatures were used, 25°C or 55°C.  For measurements at 25°C, 
volumes of 12 – 20 µl were sufficient, whereas for measurements at 55°C at 
least 100 µl of sample was required to counter the effects of evaporation.  The 
complex was assembled in the E1 : E2 : E3 molar ratio of 3 : 1 : 0.1, which has 
been reported to give optimum enzyme activity (Heath et al., 2007).  The con-
centration of assembled complex in DLS was 1 mg/ml.  To measure the effect 
of NaCl on protein oligomerization, samples were heated at 55°C for 10 min in 
the presence or absence of NaCl (0 – 350 mM).  Samples heated without NaCl 
were supplemented with NaCl after they had cooled down to 25°C.  Samples 
were then analysed by DLS at 25°C and 55°C. 
 
Analysis of purified LplA, CTD and LplA-CTD complex: All purified recombinant 
proteins were buffer exchanged into 20 mM Tris-HCl, pH 8.0, 0.2 M NaCl and 
centrifuged at 13,000 x g for 30 min at 20°C.  The protein concentration of puri-
fied His-LplA, His-CTD and ntCTD was approximately 1 mg/ml.  The complex of 
His-LplA and His-CTD was obtained from gel permeation chromatography (sec-
tion 3.3.5). 
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Mr values of proteins were derived from the measured hydrodynamic radii using 
the Protein Utilities feature of the DISPERSION TECHNOLOGY software, version 
4.10, supplied with the instrument. 
 
3.3.4 Analytical ultracentrifugation (AUC) 
All analytical ultracentrifugation experiments were carried out on a Beckman 
XL-A analytical ultracentrifuge (Beckman-Coulter, CA).  Sedimentation velocity 
experiments were carried out at 15 000 r.p.m., and cells were scanned every 5 
min at 280 nm.  For sedimentation velocity analysis of the BCOADHC, the 
buffer was 20 mM sodium phosphate, pH 7.5, 10% (v/v) glycerol and 100 mM 
NaCl. The set temperature on the centrifuge was 40°C, and the solution densi-
ties were directly measured at this temperature using an Anton-Paar DMA 5000 
high-precision density-meter.  Sedimentation velocity distributions were ob-
tained by the c(s) method (Schuck, 2000) using the program Sedfit.  Data were 
then directly fitted using the finite element solution of the Lamm equation in 
Sedfit (Schuck, 1998) to give values of the sedimentation coefficient and of Mr. 
 
3.3.5 Gel permeation chromatography (GPC) 
GPC experiments were performed using a Superdex 200 10/300 GL Tricorn 
column (Amersham Pharmacia).  The column was equilibrated in the running 
buffer 20 mM Tris-HCl, pH 7.5, 150 mM NaCl or running buffer without NaCl.  
The column was calibrated with protein standards (Sigma) in the corresponding 
running buffer.  Prior to loading on the column, proteins were dialyzed into the 
corresponding running buffer with or without NaCl (section 3.2.3).  Proteins 
were eluted with a flow rate of 1 ml/min. 
 
3.3.6 Isothermal titration calorimetry (ITC) 
For ITC, His-CTD and His-LplA were extensively dialysed into 20 mM HEPES, 
pH 7.5, 150 mM NaCl, 5 mM MgCl2 (section 3.2.3) and the final dialysis buffer 
was saved for later use.  Either His-CTD or His-LplA was used in the bomb with 
the other protein as ligand.  Experiments were run at either 25°C or 40°C.  All 
experiments were carried out using a MicroCal VP-ITC calorimeter (MicroCal, 
Northampton, USA). 
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3.3.7 Nuclear magnetic resonance (NMR) spectroscopy 
His-tagged 15N-labelled CTD was produced by expression in M9 minimal me-
dium (Table 2) supplemented with 1g/L 15NH4Cl as the sole nitrogen source.  
The rest of the protocol was the same as described in previous sections for dif-
ferent proteins. 
 
For NMR analysis, purified protein samples were buffer exchanged into different 
buffers (see 3.2.3).  NMR data were acquired at 37°C or 55°C on a Varian Unity 
INOVA spectrometer operating at a nominal proton frequency of 600 MHz, us-
ing a triple resonance 5 mm probe equipped with z-axis pulsed field gradients.  
1H–15N heteronuclear single quantum coherence (HSQC) spectra were gener-
ated and processed using Sparky NMR Assignment and Integration Software 
(T. D. Goddard and D. G. Kneller, SPARKY 3, University of California, San 
Francisco). 
 
Table 2 M9 minimal medium composition 
 
M9 minium medium contains (1L) Trace element solution in distilled H2O, 
adjusted to pH 8.0 (1 L) 
Na2HPO4 6.74 g CaCl2.2H2O 5.5 g 
KH2PO4 3 g MnSO4.H2O 1.4 g 
NaCl 0.05 g CuSO4.5H2O 0.4 g 
15NH4Cl 1.0 g ZnSO4.7H2O 2.2 g 
MgSO4 (1 M) 1.0 ml CoSO4.7H2O 0.45 g 
CaCl2 (1 M) 0.1 ml Na2MoO4.2H2O 0.26 g 
Trace element solution 0.65 ml H3BO4 0.4 g 
Biotin 0.1% w/v KI 0.26 g 
Thiamine 0.1% w/v EDTA 5 g 
D-glucose 20% w/v FeSO4.7H2O 3.75 g 
 
 
3.3.8 Crystal screens 
The His-LplA-ntCTD complex purified from the pull-down assay was used for 
crystallization.  Two different methods were used: 
Hanging drop method:  Three different conditions were tested per well by mixing 
1 µl of protein solution with 1 or 2 µl of reservoir buffer or just 1 µl of protein so-
lution by itself on one glass cover slip.  The coverslip was then inverted and 
sealed over the reservoir well using vacuum grease, and the plate was stored at 
18°C.  The different conditions tested for co-crystallization were 50, 55, 60, 65, 
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70, and 75% tacsimate solutions at pH 7.0 and pH 8.0, Hampton CryoCrystal-
screen Nr. 6 and Nr. 40, and Molecular dimensions crystal screen I, Nr. 17 and 
Nr. 41. 
 
Sitting drop method: Crystal screens were set up using the Phoenix Protein 
crystallography robot (Art Robbin’s instruments).  The whole crystal screen 2, 
except condition 49 and 50, was used and the plate was stored at 16°C. 
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CHAPTER 4 
Gene and protein sequence analysis of 
Thermoplasma acidophilum lipoate protein ligase 
and its putative C-terminal domain 
 
4.1 Introduction 
The characterization of the recombinant BCOADHC from Tp. acidophilum 
showed that specific growth conditions are required for the E. coli host to carry 
out lipoylation of the E2 component (Heath et al., 2007).  As lipoylation is a cru-
cial pre-requisite for the activity of the complex, attention was drawn to the in-
nate Tp. acidophilum lipoylation machinery.  Previous genome analyses 
showed that Tp. acidophilum has one putative lipoate protein ligase (LplA) gene 
and the crystal structure of the encoded Tp. LplA shared similarities with other 
biotinylating/lipoylating enzymes (McManus et al., 2006).  However, in vitro ac-
tivity of recombinant Tp. LplA could not be fully established.  The presence of 
the reaction intermediate lipoyl-AMP as part of the crystal structure indicated at 
least partial enzyme activity (Kim et al., 2005).  Contradictory to this, in vitro li-
poylation assays failed to detect enzyme activity and it was suggested that an 
additional protein/enzyme component might be required for full activity of the 
Tp. LplA (McManus et al., 2006).  This chapter describes the characterisation of 
gene and protein sequences of the putative Tp. LplA and discusses the poten-
tial of exploring a second gene to reconstitute a fully functional lipoate protein 
ligase. 
 
 
4.2. Results 
 
4.2.1 Gene sequence analysis of the Thermoplasma LplA and its putative 
C-terminal domain 
Protein sequences of the E. coli LipA, LipB and LplA and the Thermoplasma 
BCOADHC components were used in BLASTP searches against archaeal ge-
nomes (Table 4.1).  The E. coli protein sequences identified the open reading 
frame (ORF), ta0514, which codes for the putative Tp. LplA.  In an attempt to 
refine the search, the protein sequences of lipoate protein ligases with known 
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crystal structures were included in BLASTP searches.  Using the Streptococcus 
pneumoniae LplA (PDB ID: 1vqz) protein sequence, a second ORF, ta0513m, 
was identified exactly upstream of ta0514.  On the protein level, the Tp. LplA 
was found to align with the N-terminal domain of the S. pneumoniae lipoate pro-
tein ligase, whereas the predicted protein product of ta0513m aligned with the 
C-terminal domain of the S. pneumoniae lipoate protein ligase (Fig. 4.1).  Nota-
bly, the two ORFs, ta0514 and ta0513m, overlap with each other, as the stop 
codon of the ta0513m (TGA) shares the adenine with the start codon of the 
ta0514 (ATG).  From these sequence alignments it appears that both gene 
products might reconstitute a functional Tp. LplA.  The two ORFs were analysed 
for transcription/translation motifs to gain any information that would indicate 
any association.  Based on the sequence alignment with the Sp. pneumoniae 
LplA (Fig. 4.1), ta0514 will be referred to as lpla and ta0513m as ctd and the 
gene products as Tp. LplA and CTD respectively. 
 
Archaea use characteristic transcription initiation signals that help to guide the 
RNA polymerase (Werner, 2007).  The presence of these features in an as-
signed ORF strengthens the hypothesis for its in vivo use.  In archaeal promot-
ers, two major sequence elements have been identified.  The TATA-box, an 
A/T-rich sequence approximately 25 base pairs upstream of the transcription 
start site, is recognized by the TATA-binding protein (TBP), which in turn is re-
quired for RNA polymerase recruitment.  Secondly, the B-recognition element 
(BRE), which is located adjacent and upstream of the TATA box, is recognized 
by transcription factor B (TFB) and determines promoter strength and direction 
of transcription (Bartlett, 2005; Gregor and Pfeifer, 2005; Qureshi and Jackson, 
1998; Kosa et al., 1997; Littlefield et al., 1999).  The archaeal TATA-like box 
sequence is TTTA[A/T].  The TATA box combined with an upstream BRE has 
the consensus of 5`cRnaAntTTTAWAtr3` where R can be any purine, W any 
pyrimidine, n any base, and lower case letter is the most common nucleotide in 
a variable position (Littlefield et al., 1999; Qureshi and Jackson, 1998).  Both 
lpla and ctd comprise a potential TATA-like A box with a BRE adjacent up-
stream of it (Fig. 4.2).  This indicates that the DNA is present in a form accessi-
ble for the translation machinery.  Interestingly, the elements for the lpla gene 
fall within the ctd gene.  
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543121 gctgctatgg cgctaagaaa tctttgcatt tcacagattc caatactgta tccccgtaca
543181 cgtcaaaatg ataataaatg gttctcaatt atactatgca tatgatgtac agcaagaact
543241 ggaaggcgaa gaagggactc ataagggtaa cgctggatct ggacgggaat agaataaagg
543301 acatacacat ttccggagat ttcttcatgt ttccggaaga ttccataaac agactagaag
543361 atatgctgag gggatcgagc attgaaaaga taaacgatat tataagggat ttctataatc
543421 agggcgtgat aactcctggc gtagaacctg aggactttat tcaggctttG AGGgtgatcT
543481 GATGgaaggc aggcttcttt tactagaaac accaggcaac acgcgaatga gccttgctta
543541 tgacgaagcc atataccgca gcttccagta cggtgataag cccatactga gattctacag
543601 acacgacaga tcggtgatca taggctattt ccaggttgca gaggaggagg tagatcttga
543661 ttacatgaag aagaacggaa taatgcttgc caggcgctat accggcggag gcgcagtata
543721 tcatgatctc ggcgatctca acttttcggt tgtgcgatcc agcgatgaca tggacatcac
543781 atcgatgttc aggacgatga atgaggcagt tgtgaattct ctcaggatct tggggctgga
543841 tgcaaggccg ggcgaactca acgatgtttc cataccagtt aacaagaaaa ccgacattat
543901 ggcaggcgag aaaaagataa tgggcgcagc aggtgcgatg agaaagggag ccaaactctg
543961 gcatgcagct atgctggtac acacagatct ggatatgcta tctgccgtgc tgaaggtccc
544021 agatgaaaag ttcagagaca agatcgccaa gagtacaagg gagcgggtgg caaacgtaac
544081 ggacttcgtg gatgtttcca ttgatgaagt gagaaacgcg ctcatcaggg gtttctctga
544141 gacgcttcac atagatttca gggaggatac cataacagaa aaggaagaaa gcctggcacg
544201 ggaactgttt gacaaaaagt acagcactga ggagtggaac atgggcctcc tgaggaaaga
544261 ggtcgtatag gcgcattttt taatttttaa ttttctgatc gtagggacag caatttatgt
*
°
+
 
 
Fig. 4.2 Gene sequences of Tp. acidophilum LplA (ta0514; lpla) and its putative C-
terminal domain (ta0513; ctd).  The gene sequence data are shown as present in the 
genome, including some upstream and downstream sequence data, surrounding the 
two ORFs.  The first base of the start codons of the ctd and lpla gene are indicated by 
a circle and star, respectively.  The stop codon of ctd (TGA) and start codon of lpla 
(ATG) are in capital letters with the shared base (A) in bold.  The lpla stop codon (TAG) 
is indicated by a cross.  The TATA-like A box is shown in bold lower-case letters.  The 
Shine-Dalgarno sequence is shown in bold capital italics.  BRE elements are under-
lined.  Proposed poly-T stop signals underlined by a double line.  Arrows below the 
sequence indicate stems of putative mRNA secondary structure. 
 
 
Like translation initiation signals, the presence of transcription signals is often 
used as an indicator for a functional gene.  An element that aids translation ini-
tiation is a purine rich motif, the Shine-Dalgarno (SD) sequence (Kozak, 2005).  
In Tp. acidophilum the conserved core is represented as GGAGG, but varia-
tions including GTGA, GGTG, AGGT and GAGG are common and do not com-
promise the effectiveness of SD sequences as long as the base-pairing poten-
tial with the anti-SD sequence and its spacing from the start codon are efficient 
(Ma et al., 2002).  Actually, each motif can bind to the underlined part of the 16S 
rRNA sequence AUCACCUCC (Torarinsson et al., 2005).  The ctd gene has no 
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SD sequence, whereas the lpla gene has a slight variation, GAGG, 12 base 
pairs upstream of the start codon.  Although the presence of a SD sequence is 
beneficial for gene expression levels, genes without an SD sequence are com-
mon.  Tp. acidophilum has been found to have many leaderless transcripts and 
its genome is known to be low in SD motifs (Chang et al., 2006; Torarinsson et 
al., 2005; Karlin et al., 2005; Ma et al., 2002). 
 
In addition to translation motifs, the secondary structure of mRNA transcripts 
has been found to affect translation initiation (Kozak, 2005; Hall et al., 1982).  
As pointed out above, the ctd and lpla genes are connected via a 1 base pair 
overlap positioned in the ctd stop and lpla start codon.  Hence, if both genes 
were transcribed together, correct translation of the lpla gene would require a -1 
base pair frameshift.  Secondary mRNA structures have been shown to aid 
frameshifting by stalling the RNA polymerase (Giedroc and Cornish, 2008; Ko-
zak, 2005).  To assess any potential involvement of mRNA structures on ctd-
lpla translation, the last 127 base pairs of the ctd 3` end followed by the first 139 
base pairs of the lpla 5` end were analysed for the presence of mRNA secon-
dary structures.  This analysis indicated a possible stem-loop structure exactly 
downstream of the lpla SD sequence, with the overlap region between the ctd 
stop and lpla start codon forming part of the stem (Fig. 4.2 and Fig. 4.3).  The 
presence of such a structure in the stop-start-codon region has potential to 
cause stalling of the RNA polymerase at the ctd stop codon allowing reinitiation 
at the lpla start codon. 
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Fig. 4.3 Two-dimensional visualization of predicted secondary mRNA structures of a 
ctd-lpla transcript (Webservice pknotsRG, BiBiServ Bielefeld University bioinformatics 
Server, for description of algorithms see Reeder and Giegerich, 2004).  The submitted 
sequences consisted of the last 127 base pairs of the ctd 3`end followed by the first 
139 base pairs of the lpla 5` end.  The second base pair of the lpla is indicated as resi-
due 128.  The diagram illustrates the 12 base pair stem structure encompassing the 
stop codon of ctd and start codon of lpla.  The adenine shared by the ctd stop codon 
and lpla start codon is not paired with another residue in the stem structure. 
 
 
4.2.2 Protein sequence analysis of the Thermoplasma LplA (Tp. LplA) and 
its putative C-terminal domain (CTD) 
The predicted protein sequences of the lpla and ctd gene were analyzed for 
functional motifs and compared with LplAs whose structures have been depos-
ited in the Protein Data Bank (PDB).  The Tp. LplA protein sequence of 262 
amino acids is 22.3 – 24.5% shorter than other lipoate protein ligases whose 
crystal structures have been solved.  Despite differences in length and the pos-
sibility of shorter LplAs lacking functional domain parts, shorter LplAs have been 
found to be as active as their longer counterparts.  One example of a functional 
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LplA with only 270 amino acid residues is the LplA from Oryza Rice (Kang et al., 
2007). 
A Pfam search of the protein sequence of Tp. LplA revealed a BPL_LipA_LipB 
domain (Pfam-A motif PF03099, amino acids 47 – 169) (Fig. 4.4) which is in 
agreement with other LplAs (Reche, 2000).  A putative cAMP/cGMP-dependent 
protein kinase phosphorylation site motif is present in Tp. LplA (Fig. 4.4), which 
is thought to be directly involved in the formation of lipoyl-AMP intermediates 
from lipoic acid and ATP (Kang et al., 2007). 
 
1    MEGRLLLLET PGNTRMSLAY DEAIYRSFQY GDKPILRFYR HDRSVIIGYF QVAEEEVDLD
61 YMKKNGIMLA RRYTGGGAVY HDLGDLNFSV VRSSDDMDIT SMFRTMNEAV VNSLRILGLD
121 ARPGELNDVS IPVNKKTDIM AGEKKIMGAA GAMRKGAKLW HAAMLVHTDL DMLSAVLKVP 
181  DEKFRDKIAK STRERVANVT DFVDVSIDEV RNALIRGFSE TLHIDFREDT ITEKEESLAR 
241 ELFDKKYSTE EWNMGLLRKE VV
 
 
Fig. 4.4 Pfam analysis of Tp. LplA encoded by gene locus ta0514 (NP_393990.1; 262 
amino acids).  The residue number is given on the left.  The BPL_LipA_LipB domain is 
underlined. The putative cAMP dependent protein kinase phosphorylation site (RRYT) 
is shown in bold. 
 
 
In addition to the correlation of the BPL_LipA_LipB, a structural comparison of 
the crystal structures showed that the Tp. LplA has the same overall fold and 
aligns with the N-terminal domain of the S. pneumoniae LplA (Fig. 4.5.).  This 
comparison also highlights the lack of an individually folded C-terminal domain 
in the Tp. LplA. 
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A                                                        B 
N-terminal domain 
C-terminal domain 
 
 
Fig. 4.5 Structural comparison of the domain structure of lipoyl-protein ligases. A: The 
crystal structure of Tp. acidophilum LplA (PDB accession: 2ars).  B: The crystal struc-
ture of Streptococcus pneumoniae LplA showing the N- and C-terminal domains (PDB 
accession: 1vqz, Joint Center for Structural Genomics, to be published).  C: Overlay of 
A and B.  Structures were generated using PyMOL (DeLano Scientific LLC, San Car-
los, CA, USA. http://www.pymol.org). 
 
 
Since the start of this project, the Tp. acidophilum genome has been reanno-
tated resulting in two ORFs annotated as ta0513m and ta0513 (Fig. 4.6).  The 
ORF annotated as ta0513 codes for 94 amino acids, whereas ta0513m corre-
sponds to only 88 amino acids.  Moreover, two more start codons just down-
stream of ta0513m could also represent the ORF.  Based on the position of 
transcription initiation elements and the sequence alignments in which the CTD 
barely overlaps with the Tp. LplA but matches the S. pneumoniae LplA C-
terminal, it was concluded that the annotated ta0513m was the most likely can-
didate to be used in vivo and was cloned and expressed recombinantly for ac-
tivity studies. 
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I                                         II           III   IV
atggttctcaattatactatgcatatgatgtacagcaagaactgg 
M  V  L  N  Y  T  M  H  M  M  Y  S  K  N  W  
 
aaggcgaagaagggactcataagggtaacgctggatctggacggg 
K  A  K  K  G  L  I  R  V  T  L  D  L  D  G  
 
aatagaataaaggacatacacatttccggagatttcttcatgttt 
N  R  I  K  D  I  H  I  S  G  D  F  F  M  F  
 
ccggaagattccataaacagactagaagatatgctgaggggatcg 
P  E  D  S  I  N  R  L  E  D  M  L  R  G  S  
 
agcattgaaaagataaacgatattataagggatttctataatcag 
S  I  E  K  I  N  D  I  I  R  D  F  Y  N  Q  
 
ggcgtgataactcctggcgtagaacctgaggactttattcaggct 
G  V  I  T  P  G  V  E  P  E  D  F  I  Q  A  
 
ttgagggtgatctga    
L  R  V  I  *   
  
Fig. 4.6 Potential ORFs coding for CTD and the corresponding protein sequence.  Four 
possible start codons (ATG) of the ctd gene are shown in bold and numbered with Ro-
man numerals; the stop codon (TGA) is in bold and indicated by a star.  The reanno-
tated ORF ta0513, coding for 94 amino acids, starts at I.  The ORF ta0513m, coding for 
88 amino acids, starts at II and was expressed recombinantly for analysis. 
 
 
 
Fig. 4.7 Secondary structure prediction of CTD using PSIPRED (Jones, 1999). 
 
 
A Pfam search of the putative C-terminal domain of the Thermoplasma LplA 
identified the presence of a Lip_prot_lig_C domain (Pfam-A motif PF10437, 
amino acids 1 to 85).  This motif is also referred to as bacterial lipoate protein 
ligase C-terminus and is associated with the BPL_LipA_LipB motif (see Fig. 
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4.4).  This domain is thought to be stable and it has been hypothesised that it 
may recognise the lipoyl domain and/or transfer the lipoyl group from the inter-
mediate (McManus et al., 2006).  S. pneumoniae LplA also has this domain at 
its C-terminus, which may support a role of CTD as the C-terminal domain of 
the Tp. LplA in lipoylation.  In a sequence alignment (Fig 4.1) the CTD matched 
well with the C-terminal of S. pneumoniae LplA.  Assignment of the secondary 
structure elements to the CTD sequence using PSIPRED highlights the same 
position of secondary structure elements as found in the S. pneumoniae C-
terminal domains with solid confidence (Fig. 4.7). 
 
4.2.3 Attempts to solve the protein structure of CTD using NMR spectros-
copy and X-ray crystallography 
The protein sequence analyses of CTD suggested that it might adopt a fold 
similar to the C-terminal domain of other LplAs.  However, the reality may be 
different as we are proposing to study CTD as an individual protein.  Given the 
small size of CTD, NMR spectroscopy was deemed fit as a technique to try to 
investigate its structure.  In order to achieve sufficient signal to noise ratio for 
protein structure determination by NMR, a concentrated (approximately 1 mM) 
15N labelled protein solution is required.  15N labelled protein can be recombi-
nantly produced by growing the cells in M9 minimal medium (section 3.3.7) 
thereby compromising the yield of protein in comparison to expression in stan-
dard LB medium.  In the case of CTD, the His-tagged version gave a higher 
yield than its non-tagged counterpart.  NMR data on 15N His-CTD in 20 mM 
MES, pH 6.5, 100 mM NaCl were acquired at 37°C (Fig. 4.8, A).  Acquiring the 
1H–15N heteronuclear single quantum coherence (HSQC) spectrum took 3.25 h 
and was not suitable for any structural assignments.  The acquisition time was 
increased to 17 h to see if this gives a stronger overall signal, but it did not im-
prove the resolution of the spectrum (Fig. 4.8, B).  The main problem at this 
stage was a low protein concentration, which did not give a good signal to noise 
ratio in 30 min of acquisition.  Further, the peak overlap in the central part of the 
spectrum and the variation in peak intensity might have been a result of protein 
aggregation, conformational heterogeneity and/or impurities. 
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A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
Fig. 4.8 HSQC spectra of His-tagged CTD in 20 mM MES, pH 6.5, 100 mM NaCl at 
37°C. A: Acquisition time 3.25 h.  Number of scans: 48, proton spectral width: 8000 Hz, 
nitrogen spectral width: 1763 Hz.  B: Acquisition time 17 h. Number of scans: 256, pro-
ton spectral width: 8000 Hz, nitrogen spectral width: 1763 Hz. 
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The initial HSQC spectrum indicated that there was a population of folded 
molecules prone to aggregation and/or precipitation (Fig. 4.8).  As CTD is a 
thermophilic protein, the NMR experiment was repeated at 50°C to see the ef-
fect of temperature on protein stability and conformation (Fig. 4.9).  The change 
in temperature improved the signal dispersion in the HSQC spectrum but the 
degradation prevailed as the peak number and peak intensity still varied. 
 
 
 
Fig. 4.9 HSQC spectrum of His-tagged CTD in 20 mM MES, pH 6.5, 100 mM NaCl at 
50°C.  Number of scans: 320, proton spectral width: 8000 Hz, nitrogen spectral width: 
1763 Hz. 
 
 
3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) was 
used as an additive to try to prevent aggregation (Anglister et al., 1993).  Its ef-
fect on His-CTD HSQC spectra was tested at 37°C at pH 6.5 (Fig. 4.10, A).  
The effect of different pH conditions on the HSQC of His-CTD was also tested.  
His-CTD has a theoretical pI of 6.75.  Nonetheless, any pH value lower than pH 
6.5 caused rapid degradation and aggregation.  As His-CTD is stable during 
purification at pH 8.0, this pH value was chosen to acquire the HSQC spectrum 
in the presence of 20 mM CHAPS (Fig. 4.10, B). 
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Fig. 4.10 HSQC spectra of His-tagged CTD in the presence of 20 mM CHAPS at 37°C.  
A: His-tagged CTD in 20 mM MES, pH 6.5, 100 mM NaCl.  Number of scans: 272, pro-
ton spectral width: 8000 Hz, nitrogen spectral width: 1703 Hz.  B: Analysis of His-CTD 
in 20 mM Tris-HCl, pH 8.0, 300 mM NaCl, 20 mM CHAPS.  Number of scans: 304, 
proton spectral width: 8000 Hz, nitrogen spectral width: 1763 Hz. 
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Despite using different conditions, the signal dispersion and uniformity of His-
CTD HSQC spectra did not improve sufficiently to permit detailed NMR studies.  
As the His-tag of the His-CTD constitutes approximately 18% of the total size of 
the protein, it was considered worthwhile to assess whether nontagged CTD will 
give better NMR signal dispersion as the His-tag may be affecting stability and 
folding of the protein, causing aggregation and/or precipitation.  To generate 
sufficient amounts of ntCTD, the cell lysate was subjected to an ammonium sul-
phate cut with 1.5 M and 2.5 M concentrations (section 3.2.11). The 2.5 M su-
pernatant was found to contain the ntCTD.  As the theoretical pI of ntCTD is 
5.58, ntCTD was buffer exchanged into 50 mM Tris-HCl, pH 7.5, and subjected 
to ion-exchange chromatography using a HiTrap Q FF column and eluted with a 
linear NaCl gradient of 0 - 0.5 M.  This method resulted in 80% pure ntCTD for 
NMR analyses and the protein was dialyzed into 50 mM Tris-HCl, pH 7.5.  
HSQC spectra were recorded at 15°C, 25°C, 37°C and 50°C.  The HSQC spec-
tra recorded at all the temperatures showed very good signal dispersion with 
uniform peak intensity (Fig. 4.11), although the acquisition times were relatively 
long due to low sample concentration.  The protein was expected to yield 85 
backbone NH peaks (accounting for the three proline residues), but only ~ 55 
peaks were observed.  This can be attributed to low protein concentration or 
some parts of the protein being unstructured.  Nonetheless, the lack of change 
with temperature in the HSQC showed that the ntCTD conformation was largely 
stable over a wide range of temperature, confirming its thermostability. 
 
With little success in using NMR spectroscopy as a tool to look at the structure 
of CTD, attempts to crystallise the LplA-CTD complex were made by setting up 
crystal screens. Both sitting and hanging drop methods were employed and 
several known crystal screens have been set up.  At the time of writing this the-
sis there was no sign of any favourable conditions for crystallisation of the com-
plex and more conditions are being used. 
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Fig. 4.11 HSQC spectrum of non-tagged CTD at 15°C.  The spectrum was recorded for 
21.5 h. Number of scans: 320, proton spectral width: 8000 Hz, nitrogen spectral width: 
1702 Hz.  Only about 55 backbone NH peaks are observed.  Peaks in black and blue 
are from the backbone NH groups; the peak beyond 10 ppm corresponds to the single 
tryptophan residue.  Red peaks are from asparagine and glutamine side chain NH2 
groups. 
 
 
4.3 Discussion and conclusions 
A major feature of the gene and protein sequence analysis is that genes ta0514 
and ta0513m are likely to represent the N- and C-terminal domain of a full-
length Tp. acidophilum LplA, respectively.  BLASTP searches indicate that this 
arrangement is present in other archaea as well, the most closely related case 
being in Thermoplasma volcanium, suggesting that this two-gene-arrangement 
may have a functional significance.  Interestingly, this situation has been found 
in Euryarchaeota, whereas Crenarcheota have homologs of LipA and LipB or a 
full length LplA instead. 
 
The two ORFs overlap by 1 base pair of the ctd termination codon (TGA) and 
the A of the initiation codon of lpla (ATG) and the translation initiation signals for 
the lpla fall within the ctd gene sequence.  This is an interesting finding as the 
two gene products may reconstitute a full length lipoate protein ligase, although 
the genes are in reverse orientation to that seen in other lipoyl ligases.  The 1 
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base pair overlap does not exclude independent transcription of the lpla gene.  
Programmed frameshifting has been reported in several other organisms 
(Giedroc and Cornish, 2008), including the archaeon Sulfolobus solfataricus 
(Cobucci-Ponzano et al., 2006).  The presence of a stem-loop structure cover-
ing the frameshift region as well as the unpaired A residue shared by the stop 
and start codon within this stem structure strongly indicates the possibility of a 
programmed frameshift (Giedroc and Cornish, 2008).  At the transcriptional 
level, the formation of such a mRNA loop-structure could promote ribosome 
pausing and, together with the lpla SD sequence, allow programmed -1 
frameshifting to give correct initiation of translation for both genes (Cobucci-
Ponzano et al., 2006).  Such regulatory mechanism can be envisaged as tran-
scription elongation is not a continuous process but pausing, stalling and arrest 
have been reported to occur frequently (Borukhov and Nudler, 2008).  More-
over, if it is assumed that both gene products are required for full lipoylation ac-
tivity, this scenario implies a level of regulation of how much active enzyme is 
present in vivo.  If both proteins are required for full lipoate protein ligase activ-
ity, they must be individually stable in vivo and present in the correct 
stoichiometric ratio.  A close, coordinated transcription process could just en-
sure this. 
It can be concluded from the sequence analyses that both genes are potentially 
linked and controlled at the level of transcription and translation, which may help 
their association at the protein level.  Nonetheless, without experimental data, it 
is very difficult to predict the transcriptional regulation and translation efficiency 
of both genes.  More information can only be obtained from in vitro transcription 
and electromobility shift assays. 
 
More work is needed to elucidate the structure of CTD, which may throw new 
light on protein- protein interactions between CTD and LplA and how they work 
in tandem to bring about the lipoylation activity.  As the above analyses would 
predict that both, LplA and CTD are required for lipoylation, the next chapter 
describes the investigation of their lipoylation activity. 
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Chapter 5 
Lipoate protein ligase activity in Thermoplasma acidophilum 
 
5.1 Introduction 
The gene and protein sequence analysis presented in the previous chapter 
suggests that LplA and CTD may be needed in tandem to reconstitute a func-
tional lipoate protein ligase activity but no experimental evidence for this hy-
pothesis has been presented as yet.  The gel shift assay is a well-established 
qualitative assay for lipoylation and the E2lipD construct was carefully chosen 
as substrate to make sure that an acceptable assay could be established (Fuji-
wara et al., 1995). In the current chapter, the results from a functional gel shift 
assay and Western blot analysis to detect lipoylation activity are described. 
 
 
5.2 Results 
 
5.2.1 Lipoylation activity of Tp. acidophilum LplA and CTD 
The activity of the recombinant LplA and CTD was analyzed in a gel shift assay 
as described (section 3.2.15).  As a positive control for lipoylation activity, E. coli 
LplA and E. coli E2lipD were incubated as described for the Thermoplasma pro-
teins and lipoylation was assessed by a mobility shift of the E. coli E2lipD in 
non-denaturing PAGE.  Thermoplasma E2lipD incubated with only LplA or CTD 
in the presence of LA and ATP did not show any change of its mobility on a 
non-denaturing PAGE gel.  However, if LplA and CTD were incubated with 
E2lipD in the presence of LA and ATP, a clear downward shift of the E2lipD was 
detected (Fig 5.1 A, B).  Both His-tagged and non-tagged constructs of LplA 
and CTD yielded similar results.  Small amounts of a band corresponding to 
lipoylated E2lipD were present in the control reaction (Fig. 5.1 A, lane 5).  LplA 
has been shown to convert LplA and ATP into lipoyl-AMP in the absence of 
CTD (Kim et al., 2005).  Therefore, some of the recombinant LplA may have 
already catalyzed the formation of lipoyl-AMP during expression in the E. coli 
host and/or the purification process.  When mixed with CTD, lipoyl-AMP 
charged LplA is sufficient to carry out lipoylation of the E2lipD without the addi-
tion of ATP.  Interestingly, E. coli LplA failed to lipoylate Thermoplasma E2lipD. 
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Fig. 5.1 Non-denaturing PAGE gels (A, B) showing lipoylation of E2lipD and SDS-
PAGE gel (C) and Western blot (D) showing lipoylation of whole E2 by LplA and CTD.  
A: 250 µg of Thermoplasma E2lipD were used in the reaction (section 3.2.15).  Non-
lipoylated E2lipD was used as a negative control.  Reactions contained 50 µg His-LplA 
(lane 1, 2) or 50 µg His-CTD (lane 3, 4) or both proteins (lane 5, 6).  In lanes 1, 3 and 5 
ATP was omitted; lane 2, 4 and 6 reactions contained ATP.  B: Lipoylation activity of 
ntCTD (20 µg) and His-LplA (20 µg).  The reaction contained 100 µg E2lipD. non-
lipoylated E2lipD; lane 1, reaction contained no ATP; lane 2, reaction contained ATP.  
C: Lipoylation of whole E2 (50 µg).  Lanes 1 and 3, reactions contained no ATP; lanes 
2 and 4, reactions contained ATP.  Reactions contained 20 µg CTD and 5 µg LplA 
(lane 1 and 2) or 40 µg CTD and 10 µg LplA (lane 3 and 4).  Whole E2 indicated by 
arrow.  D: Western blot of C using anti-lipoic acid antibody.  Lanes 1 and 3, correspond 
to lanes 1 and 3 of C; lanes 2 and 4, correspond to lanes 2 and 4 of C. 
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It should be noted that the natural substrate of lipoate protein ligases is the E2 
protein and attempts have been made to test the lipoylation of whole E2 in a gel 
shift assay.  Whole E2 was not suitable for analysis by non-denaturing PAGE 
due to aggregation.  Instead, the whole E2 was tested for lipoylation by running 
it on SDS-PAGE (Fig. 5.1, C) and the resulting gel was subjected to a Western 
blot using anti-lipoic acid antibody (section 3.2.17).  This Western blot analysis 
showed that LplA and CTD lipoylated whole E2 as well (Fig. 5.1, D).  It was also 
observed that the degree of lipoylation increased with the amount of enzyme 
used in the assay.  For accuracy the experiment was reproduced three times.   
 
5.2.2 Quantification of lipoylation using mass spectrometry 
To quantitate the lipoylation of E2lipD, the lipoylated E2lipD was analysed for 
change in its total mass using quadrupole time of flight (Q-TOF) (section 3.2.18) 
(Chernushevich et al., 2001).  Based on a previous study (Heath et al., 2007) in 
Thermoplasma only one site located in the E2lipD, K42, is expected to be lipoy-
lated.  MS analysis of unmodified E2lipD yielded a molecular mass of 11,297 
Da (Fig. 5.2, A), which corresponded to the expected mass calculated from the 
amino acid sequence.  Analysis of the lipoylated E2lipD yielded a molecular 
mass of 11485.15 Da, a difference of 188.06 Da from the unmodified E2lipD 
(Fig. 5.2, B).  This change in molecular mass is in agreement with the expected 
result, if only one lipoyl-moiety (M = 188 Da) had been added to E2lipD. 
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Fig. 5.2 Mass spectra (Q-TOF) of E2lipD, non-lipoylated (A) and lipoylated (B) (section 
3.2.18). 
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5.2.3 Time course of lipoylation activity 
After establishing that both LplA and CTD are required to carry out lipoylation, 
and that Thermoplasma E2lipD is lipoylated at only one site as expected, a 
study to analyse the enzyme activity as a function of time was carried out.  The 
assay was set up as described previously (section 3.2.15) with His-LplA and 
His-CTD at 20°C (Fig. 5.3).  A clear mobility shift for E2lipD was observed within 
15 min.  If ntLplA and ntCTD were used, the reaction required 10 h at 20°C be-
fore a shift was visible; a clear shift was only visible after 18 h of incubation.  
Furthermore, with non-tagged proteins, the reaction did not reach completion 
within the observation time of the experiment (Fig. 5.4). 
 
1      2      3      4       5      6      7     8 9     10    11    12    13    14
E2lipD    0.25 h      0.5 h          1 h          2 h          4 h          7.5 h       16.25 h
 
 
Fig. 5.3 Gel shift assay testing for lipoylation activity of His-LplA and His-CTD.  Non-
lipoylated E2lipD was used as a control.  The reaction contained 100 µg E2lipD, 20 µg 
His-LplA and 20 µg His-CTD and LA; ATP was added to start the reaction (lanes 2, 4, 
6, 8, 10, 12, 14).  Lanes 1, 3, 5, 7, 9, 11 and 13 did not contain ATP.  The reaction was 
incubated at 20°C and samples were taken at different time points. 
 
 
1        2       3       4       5      6        7       8      9      10     11     12     13     14
0.25 h         0.5 h          1 h             3 h             7 h           18 h          22 h
 
 
Fig. 5.4 Gel shift assay testing for lipoylation activity of ntLplA (20 µg) and ntCTD (20 
µg).  Each reaction contained 200 µg E2lipD.  ATP was added to start the reaction 
(lanes 2, 4, 6, 8, 10, 12, 14).  Lanes 1, 3, 5, 7, 9, 11 and 13 did not contain ATP.  The 
reaction was incubated at 20°C and samples were taken at different time points. 
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5.2.4 Stoichiometry experiments 
The optimum molar ratio of LplA to CTD was also tested using in vitro gel shift 
assays.  The His-tagged constructs of the proteins were used for this purpose 
for ease of experiments.  The molar ratios of LplA:CTD or CTD:LplA were 1:1, 
1:2, 1:3 and 1:4 (Fig. 5.5).  The experiment indicated that a 1:1 ratio was opti-
mal for a complete shift of E2lipD under the given conditions, if 8 µM of the puri-
fied protein was used (Fig. 5.5, lane 10). 
 
LplA : CTD  CTD : LplA
1:1        1:2            1:3          1:4                  1:1          1:2          1:3         1:4
1     2     3     4      5      6     7     8     9     10    11   12     13   14  15    16    17 
 
 
Fig. 5.5 Stoichiometry experiments with His-LplA and His-CTD.  The lipoylation assay 
contained 50 µg E2lipD.  Lane 9, non-lipoylated E2lipD.  Reactions in lanes 1, 3, 5, 7, 
10, 12, 14 and 16 contained no ATP.  Reactions in lanes 2, 4, 6, 8, 11, 13, 15 and 17 
contained ATP. 
 
 
5.2.5 Lipoylation activity with the intermediate lipoyl-AMP 
Lipoyl-AMP (Fig. 5.6) is the reaction intermediate between the reactant lipoic 
acid and the lipoyl moiety (Fig. 1.5) that is covalently attached to the lysine resi-
due on the E2 lipoyl domain (Cronan et al., 2005).  The lipoylation reaction is 
usually carried out by a single polypeptide, lipoate protein ligase (Cronan et al., 
2005).  In the case of Tp. acidophilum, as discussed above, the lipoate protein 
ligase activity is constituted by two individual proteins.  A crystal structure of Tp. 
LplA with the intermediate lipoyl-AMP has been described and has been inter-
preted as a sign of partial enzyme activity (Kim et al., 2005).  In the light of our 
results, it is possible to hypothesise the functional roles of the two proteins, 
where Tp. LplA may be catalysing the formation of lipoyl-AMP and CTD may be 
responsible for carrying out the transfer of this intermediate to the acceptor pro-
tein (McManus et al., 2006).  To test this hypothesis, the substrate intermediate 
lipoyl-AMP was synthesised (section 3.2.16) and used instead of LA in the gel 
shift assay.  The final synthesis product was characterized using thin-layer 
chromatography (TLC), infrared spectroscopy (IR) and nuclear magnetic reso-
nance spectroscopy (NMR). 
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Fig. 5.6 Structure of lipoyl-AMP.  The ester bond between lipoic acid and AMP is indi-
cated by the arrow. 
 
 
5.2.5.1 Thin-layer chromatography of the lipoyl-AMP synthesis product 
TLC is a type of adsorption chromatography routinely used to analyse organic 
molecules.  The separation takes place due to the difference in the relative mo-
bility of different compounds in a given solvent (mobile phase) when silica is 
used as the stationary phase (Touchstone, 1978).  TLC is regularly employed 
as a first technique to check the progress and completion of a chemical reaction 
as the reactants and products are expected to have different relative mobilities 
in the same mobile phase. 
 
Fig. 5.7 shows the results of the TLC analysis of the lipoyl-AMP synthesis.  The 
lipoyl anhydride (Fig. 5.7, lane 1) shows the same relative mobility as LA (Fig. 
5.7, lane 3) on the TLC.  This is due to the conversion of lipoyl anhydride back 
to LA by reacting with moisture on the silica.  Fig. 5.7, lane 5 shows a species 
with a different relative mobility than any of the starting materials and synthesis 
intermediates thereby indicating the presence of a synthesis product that is ex-
pected to be lipoyl-AMP.  As it cannot be concluded from TLC alone that this 
synthesis product is lipoyl-AMP, its identity was further analysed. 
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Fig. 5.7 Thin-layer chromatography of synthesis components, synthesis intermediate 
and lipoyl-AMP.  Samples from the different synthesis steps were run on the TLC in 
methanol-chloroform (1:1 v/v).  Lane 1, lipoyl anhydride; lane 2, DCC; lane 3, LA; lane 
4, AMP; lane 5, lipoyl-AMP. 
 
 
5.2.5.2 Infrared spectroscopy of the lipoyl-AMP synthesis product 
The TLC analysis was complemented by infrared (IR) spectroscopy as this 
technique can give information about the functional groups that are present in a 
molecule.  Organic molecules are not solid structures; bonds between atoms 
are vibrating as they constantly change their length.  If molecules are exposed 
to electromagnetic radiation, different functional groups will absorb energy at a 
frequency that matches their frequency vibration; hence a change of functional 
groups can be detected using IR.  In lipoyl-AMP, LA and AMP are linked 
through an ester bond, which has a different predicted characteristic absorption 
frequency than either the AMP or the LA.  The IR spectra of LA and lipoyl-AMP 
are shown in Fig. 5.8; an IR spectrum of AMP is shown in Fig. 5.9.  An IR spec-
trum can be divided into two main regions: the finger print region, which is dis-
tinct for every compound (1500 – 600 cm-1) and the group frequency region 
(4000 – 1500 cm-1) in which functional groups have specific absorption bands 
(McMurry,1999; Harwood et al., 1999). 
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Fig. 5.8 IR spectrum of LA (A) and lipoyl-AMP (B).  The solid synthesis product was 
prepared by mulling with Nujol oil and the resulting viscous mixture was analysed using 
KBr plates. 
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Fig. 5.9 IR spectrum of adenosine monophosphate (AMP) (taken from Chemexper.com 
database). 
 
 
A comparison of the different IR spectra showed clear differences, especially in 
the fingerprint region.  As fingerprint regions are specific to compounds, this 
indicated that the synthesis product was not LA.  The lipoyl-AMP spectrum 
showed absorptions at 1154.6 cm-1 and 964.9 cm-1 that are absent from the LA 
spectrum.  The characteristic IR absorption of carbonyl compounds (carbon 
atom double-bonded to oxygen atom) is located at 1670 – 1780 cm-1 in IR spec-
tra (McMurry, 1999).  In the case of LA, it is a carboxylic acid group, whereas 
lipoyl-AMP is a carbonyl ester.  The LA IR spectrum showed a clear signal at 
1707.4 cm-1 whereas the lipoyl-AMP spectrum showed a signal at 1691.8 cm-1.  
This shift in wavelength can be associated with lower bond energy of the phos-
phoester bond in lipoyl-AMP.  Moreover, the obtained spectra are different from 
the AMP spectrum (Fig. 5.9). 
 
5.2.5.3 NMR analysis of the lipoyl-AMP synthesis product 
As a complementary test, NMR spectroscopy was carried out on lipoyl-AMP.  
NMR spectra for AMP (Appendix I) and LA (Appendix II) confirmed the purity of 
the starting material and provided reference spectra for comparison with the 
spectra of lipoyl-AMP.  A 31P NMR spectrum of AMP gave only one signal at 0 
ppm, whereas the signal in the 31P spectrum of lipoyl-AMP was seen shifted 
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upfield to -1 ppm.  This was expected due to the inductive effect of the attached 
lipoic acid part (Fig. 5.10).  The 1H NMR spectrum of lipoyl-AMP corresponded 
to a combination of the AMP and LA spectra (Fig. 5.11).  The critical proton sig-
nals from the different parts of the lipoyl-AMP molecule matched with the pre-
dicted values (ChemNMR, CambridgeSoft®), thereby providing further evidence 
for a successful synthesis (Fig. 5.11). 
 
5.2.5.4 Gel shift assay using the synthetic lipoyl-AMP 
Lipoyl-AMP was included in a gel shift assay replacing LA and ATP.  Despite 
several attempts, no clear results could be obtained as the protein samples 
seemed to precipitate in the wells.  This result could be due to the presence of 
solvent contaminants in lipoyl-AMP.  However, further attempts to avoid the use 
of such chemicals in the synthetic process by modifying the synthesis protocol 
using benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (Py-
Bop) did not yield the desired product for the gel shift assay. 
 
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
Fig. 5.10 31P NMR spectra of AMP (A) and lipoyl-AMP (B). 
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Fig. 5.11 1H NMR spectrum of lipoyl-AMP.  The protons in the lipoyl-AMP molecule and 
their corresponding signal in the NMR spectrum are indicated by the numbering. 
 
 
5.3 Discussion and conclusions 
The lipoylation gel shift assay presented in this chapter is the first report of an 
active lipoate protein ligase from an archaeon.  Also, it is a first report of a li-
poate protein ligase that requires two individual proteins to constitute a func-
tional enzyme.  The stoichiometry for constituting an active enzyme worked out 
to a 1:1 molar ratio of CTD to LplA.  The activity assays were carried out at 
20°C, which is 35°C lower than the optimum growth temperature of Tp. aci-
dophilum.  The effect of temperature on the reaction rate (k) can be described 
by the Arrhenius equation: k = A e (– Ea / RT), where A is a constant, Ea is the Ar-
rhenius activation energy, R is the universal gas constant and T is the tempera-
ture in Kelvin.  Based on this equation, even a small change in temperature has 
a significant effect on the overall rate of reaction.  As a rule of thumb, every 
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10°C increase in reaction temperature doubles the rate constant in the case of 
many enzymes (Vieille and Zeikus, 2001).  Based on this the time it took for 
lipoylation at 20°C is not unexpected if LplA and CTD were designed to be ac-
tive at 55°C. 
 
The role of the individual proteins in the reaction mechanism using lipoyl-AMP 
could not be established due to some unknown reasons possibly relating to the 
solvent impurities in synthetic lipoyl-AMP.  If LplA and CTD associate forming 
an overall lipoate protein ligase structure in a 1:1 stoichiometry, the active site 
may be formed by LplA and CTD.  Also CTD may act as a modifier of LplA cata-
lytic activity, changing LplA interactions with the substrate/intermediate thereby 
allowing the transfer to take place.  Such a scenario is not unlikely and explains 
the requirement of both the proteins for carrying out lipoylation, as well as the 
presence of lipoyl-AMP in the LplA crystal structure (Kim et al., 2005).  Gluta-
mate-cysteine ligase is an example of a heterodimer made up of a catalytic and 
modifier domain (Lee et al., 2006) and Tp. acidophilum lipoyl protein ligase 
could be another one.  In order to establish a possible interaction between the 
LplA, CTD and E2lipD, some biophysical studies were needed and are de-
scribed in the next chapter. 
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CHAPTER 6 
Biophysical analysis of protein interactions between 
Tp. acidophilum LplA, CTD and E2lipD 
 
6.1 Introduction 
After demonstrating that both LplA and CTD are required to carry out the lipoy-
lation reaction, the next step was to study the nature of interaction between 
these proteins.  In order to study the physical nature of the interaction a simple 
pull-down assay and gel permeation chromatography (GPC) were employed.  
Dynamic light scattering (DLS) was used to determine the size of any resultant 
assembly out of the interaction of LplA and CTD.  Surface plasmon resonance 
(SPR) and isothermal titration calorimetry (ITC) were used to study the thermo-
dynamics of the process. 
 
 
6.2 Results 
 
6.2.1 Pull down assays 
As per the procedure described in section 3.3.1, His-LplA was immobilized on a 
Ni2+ column as the bait and the column was washed to remove excess His-LplA 
with 20 mM Tris-HCl, pH 7.5, 150 mM NaCl.  ntCTD was passed over the same 
column in the same buffer and the column was extensively washed to remove 
any unbound ntCTD.  His-LplA and ntCTD were eluted together from the col-
umn by applying a linear gradient of imidazole (0 – 0.5 M) (Fig. 6.1, lane 9).  
Bands different to the ones corresponding to His-LplA and ntCTD can be ex-
plained by the presence of proteins that were already present in the initial 
ntCTD sample.  This His-LplA-ntCTD complex was found to be active when 
tested for lipoylation activity in a gel shift assay (Fig. 6.2). 
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Fig. 6.1 SDS-PAGE gel of the pull-down assay (section 3.3.1) using His-LplA as bait 
and ntCTD as prey.  M, protein marker (kDa); lanes 1 – 4, flowthrough of the His-LplA 
sample which has been injected over a 1 ml Ni2+ column and washes; lanes 5 – 7, flow-
through of the ntCTD sample which has been injected over a 1 ml Ni2+ column charged 
with His-LplA; lanes 8 – 10, fractions eluted with imidazole; lane 11, His-LplA; lane 12, 
ntCTD.  His-LplA and ntCTD are indicated by arrows. 
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Fig 6.2. Non-denaturing PAGE gel showing lipoylation acitivty of the His-LplA-ntCTD 
complex from the pull-down assay (Fig. 6.1).  The reaction mixture contained 250 µg 
E2lipD and was allowed to proceed at room temperature overnight (section 3.2.15).  
Different volumes of the complex mixture were added: 2 µl (lane 1, 2); 4 µl (lane 3, 4), 
10 µl (lane 5, 6).  ATP was omitted in lane 1, 3 and 5, whereas all assay components 
were present in lane 2, 4 and 6. 
 
 
As the substrate of the lipoylation reaction is also a protein, the E2lipD, the pos-
sible interaction between LplA and CTD with E2lipD was investigated in another 
set of pull-down assays.  If His-E2lipD was used as the bait, it was possible to 
retain both ntLplA and ntCTD separately (Fig. 6.3).  Using approximately 75% 
pure recombinant ntLplA or ntCTD in the pull-down assay showed that the in-
teraction between E2lipD and ntLplA (Fig. 6.3 A, lane 12) and between E2lipD 
and ntCTD (Fig. 6.3 B, lane 8) is specific. 
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Fig. 6.3 SDS-PAGE gels of the pull-down assays (section 3.3.1) using His-E2lipD as 
bait and ntLplA (A) and ntCTD (B) as prey.  M, protein marker (kDa).  A: lane 1, ntLplA; 
lane 2, E2lipD; lanes 3 – 6, flowthrough of the ntLplA sample which has been injected 
over a 1 ml Ni2+ column charged with His-E2lipD; lanes 7 – 10, column wash; lanes 11 
– 13, fractions eluted with imidazole.  Arrow indicates ntLplA.  B:  lane 1, ntCTD; lane 
2, E2lipD; lanes 3 and 4, flowthrough of the ntCTD sample which has been injected 
over the His-E2lipD charged Ni2+ column; lanes 5 – 7, wash of the column with buffer; 
lanes 8 – 10, fractions eluted with imidazole.  Arrow indicates ntCTD. 
 
 
As ntLplA and ntCTD had previously been successfully retained in a pull-down 
assay by His-E2lipD (Fig. 6.3), all three proteins were included in a modified 
pull-down experiment to try and understand the nature of any multi-protein 
complex they may be forming.  The non-tagged versions of LplA and CTD have 
previously shown a tendency to retain co-purified proteins.  To reduce the num-
ber of co-purified proteins during the experiment, it was decided to express, pu-
rify and prepare ntLplA, His-CTD and His-E2lipD (section 3.2) and His-CTD was 
treated with thrombin to cleave off the His-tag.  Attempts to cleave off the His-
tag from His-LplA using enteropeptidase proved difficult, as the yields were 
poor, grossly insufficient for pull-down assays.  All proteins were buffer ex-
changed into 20 mM Tris-HCl, pH 7.5.  His-E2lipD (30 mg/ml) was used as bait 
on a 1 ml HisTrap HP column.  A mixture of ntLplA and ntCTD (1:1 equal con-
centration) was then used as prey and loaded onto the column in the running 
buffer (20 mM Tris-HCl, 0.3 M NaCl, 20 mM imidazole, pH 8.0).  The column 
was extensively washed with running buffer to remove any non-specifically 
bound proteins.  The ternary complex, constituted of His-E2lipD, ntLplA and 
ntCTD, was eluted with a linear gradient of imidazole (0 – 0.5 M) in the running 
buffer (Fig. 6.4, lane 7). 
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Initial Coomassie stained SDS-PAGE gels of the pull-down were difficult to ana-
lyse due to the tendency of E2lipD to smear.  Therefore, less amount of protein 
was analysed on SDS-PAGE gels using silverstain (Fig. 6.4).  Silverstaining 
showed that E2lipD was present in excess and that the eluted fraction contain-
ing the majority of E2lipD also contained ntLplA and ntCTD (Fig. 6.4, lane 7).  
Therefore, an interaction between the three proteins appears to exist even in 
the absence of the substrate, LA.  The silverstain method also showed impuri-
ties in the ntLplA sample not visible on Coomassie stained gels.  However, the 
fraction containing ntLplA retained by E2lipD did not contain any of these impu-
rities.  This indicated a specific interaction of LplA and E2lipD and that the co-
purified proteins from the ntLplA sample may not be cross-interacting with 
E2lipD, LplA and/or CTD. 
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Fig. 6.4. Pull-down assay of a ternary E2lipD-LplA-CTD complex.  A: Chromatogram of 
the pull-down showing the change in absorbance at A280nm versus elution volume.  A 
HisTrap HP column (1 ml) was saturated with His-E2lipD (30 mg/ml).  Then a 1:1 mix-
ture of ntLplA and ntCTD (equal concentration) was loaded and the column was 
washed with running buffer (20 mM Tris-HCl, 0.3 M NaCl, 20 mM imidazole, pH 8.0) 
until the A280nm reading reached baseline.  A linear gradient of imidazole (0 – 0.5 M) 
was applied in the running buffer to elute His-E2lipD from the column.  Fractions C9 to 
C11 correspond to excess unbound LplA/CTD eluting from the column.  With increas-
ing imidazole concentration (green), protein is eluted off the column; majority of protein 
eluted in fraction C14.  B: SDS-PAGE gel (silverstain) of fractions from the pull-down. 
Lane 1, ntCTD; lane 2, ntLplA; lanes 3 and 4, unbound excess His-E2lipD; lane 5, frac-
tion C9; lane 6, fraction C13; 7, fraction C14; 8, fraction C15; M, protein marker (kDa).  
LplA, E2lipD and CTD are indicated by arrows. 
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6.2.2 Gel permeation chromatography – evidence for a ternary E2lipD-
LplA-CTD complex 
The pull-down assays indicated the possibility of a complex forming between 
His-LplA and ntCTD, His-E2lipD and ntLplA, His-E2lipD and ntCTD and be-
tween all three proteins.  As there is the possibility that there was a heteroge-
neous mixture of His-E2lipD bound to either ntLplA or ntCTD, which would elute 
together, the presence of this possible ternary complex was tested using gel 
permeation chromatography (GPC).  To study the ternary complex, fixed 
amounts of His-E2lipD (3 mg/ml), His-LplA (3 mg/ml) and His-CTD (1 mg/ml) in 
20 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM MgCl2, were mixed in a 1:1:1 mo-
lar ratio yielding a total of 3 mg protein.  This mixture was applied to a pre-
equilibrated Superdex 200 GPC column and eluted in 20 mM Tris-HCl, pH 7.5, 
150 mM NaCl as described in section 3.3.5.  Under these conditions an elution 
profile with two distinct peaks was obtained (Fig. 6.5, A).  SDS-PAGE revealed 
that the peaks correspond to complexes of His-LplA with His-CTD (Fig. 6.5, B 
lane 1) and His-LplA with His-E2lipD (Fig. 6.5, B lane 2).  The molecular size 
estimates from GPC corresponded to a 1:1 ratio of His-LplA to His-CTD and 
His-LplA to His-E2lipD (Table 6.1).  The experiment was repeated as described 
above, omitting NaCl from the running buffer.  In the absence of NaCl, the GPC 
profile had only one major peak (Fig. 6.6, A).  SDS-PAGE analysis of this peak 
revealed the presence of all the three proteins, His-LplA, His-CTD and His-
E2lipD (Fig 6.6, B lane 3).  Therefore, the presence or absence of NaCl seemed 
to have an effect on the formation of the protein complex.  The observed effect 
of NaCl was not a single event and GPC data were reproducible over three 
runs.  The molecular size estimates of the protein complexes, as per GPC, are 
summarized in Table 6.1. 
 
Fractions D4 to D5 were concentrated using Amicon Ultra-15 centrifugal filter 
devices (Millipore) prior to SDS-Page gel analysis.  The liquid flowing through 
the concentrator (filtrate) did not contain any protein, but all proteins, including 
the relatively small His-CTD, were retained in the concentrate.  Washes of the 
concentrator showed that the proteins did not get stuck to the filter membrane 
(Fig. 6.6, C). 
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Fig. 6.5 GPC of His-E2lipD, His-LplA and His-CTD and SDS-PAGE analysis.  A: GPC 
chromatogram.  His-E2lipD, His-LplA and His-CTD in 20 mM HEPES, pH 7.5, 150 mM 
NaCl, 5 mM MgCl2, were mixed in a 1:1:1 molar ratio.  This mixture was applied to a 
pre-equilibrated Superdex 200 GPC column and eluted in 20 mM Tris-HCl, pH 7.5, 150 
mM NaCl as described in section 3.3.5. The A280nm trace recorded two main peaks in 
the elution profile.  B: SDS-PAGE analysis of the protein peaks from GPC of a mixture 
of His-E2lipD, His-LplA and His-CTD. M, protein marker (kDa); lane 1, first peak: His-
LplA and His-CTD; lane 2, second peak: His-LplA and His-E2lipD.  His-LplA, His-CTD 
and His-E2lipD are indicated by arrows. 
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Fig. 6.6 GPC of His-E2lipD, His-LplA and His-CTD in the absence of NaCl (A) and 
SDS-PAGE gels of eluted fractions (B, C).  M, protein marker (kDa)  A: His-E2lipD, His-
LplA and His-CTD in 20 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM MgCl2, were mixed 
in a 1:1:1 molar ratio.  This mixture was applied to a pre-equilibrated Superdex 200 
GPC column and eluted in 20 mM Tris-HCl, pH 7.5, omitting NaCl.  The A280nm trace 
recorded one main peak in the elution profile.  B: Lane 1, protein mixture before load-
ing onto the GPC column; lanes 2 to 4 correspond to fractions D4 to D6, respectively.  
C: Concentrating GPC fractions (section 3.2.4).  Lane 1, D4 before concentrating; lane 
2, concentrated D4;  lane 5, D5 before concentrating;  lane 6, concentrated D5; lane 9, 
His-tagged LplA; lane 10, His-tagged E2lipD; lane 11, His-tagged CTD; lane 12, D6 
before concentrating; lane 13, concentrated D6.  Lanes 3, 7, and 14, filtrate; lanes 4, 8 
and 15, membrane washes. 
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Table 6.1 Molecular mass (M) estimates of protein species from GPC analysis.  The 
proteins were loaded either individually or as a mix as described (section 6.2.2) onto a 
Superdex 200 column.  The running buffer was 20 mM Tris-HCl, pH 7.5 with or without 
150 mM NaCl. The M values have been estimated from a standard curve prepared in 
the appropriate running buffer. 
 
Protein Expected M 
(kDa) 
M estimate (kDa) 
150 mM NaCl 
M estimate (kDa) 
No NaCl 
LplA 32.6 33 39.9 
CTD 12.6 11.8 22.8 
E2lipD 11.3 10.4 21.1 
LplA-CTD complex 44.6 47.1 - 
LplA-E2lipD com-
plex 
43.9 39.4 - 
E2lipD-CTD com-
plex 
23.9 - - 
Ternary complex 56.5 - 51 
 
 
6.2.2.1 Activity of the ternary complex 
Although it has been shown before that all the three proteins, LplA, CTD and 
E2lipD, are active in a gel shift assay, the ternary complex eluted from GPC 
(Fig. 6.6 C, lane 6) was also tested for activity to test its functional relevance.  A 
lipoylation assay with the concentrated fraction D5 was set up as previously 
described in section 3.2.15.  A clear shift in the activity assay confirmed that the 
proteins did not lose activity during the GPC analysis and that the purified ter-
nary complex carries out lipoylation (Fig. 6.7). 
 
1        2       3       4        5      6  
 
 
Fig. 6.7 Activity of the ternary complex isolated from GPC.  Lane 1, non-lipoylated 
E2lipD; lane 2, reaction mix without ATP; lane 3, reaction mix with ATP. 
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6.2.3 Dynamic light scattering of LplA and CTD 
After establishing the physical association of LplA and CTD, the proteins were 
analysed using dynamic light scattering (DLS) to determine their molecular 
sizes.  In DLS, a laser beam is passed through a protein solution and any parti-
cles present in this solution observably scatter the light in a time- and intensity-
dependent fashion.  These scattering profiles follow the principle of Brownian 
motion of the particles i.e. their random movement.  The velocity of the particles 
through a solution is expressed as the diffusion coefficient (D).  Based on the 
value of D, the hydrodynamic diameter of a particle can be calculated by apply-
ing the Stokes Einstein equation: 
 
d(H) = kT / 3 π η D 
 
where 
d(H) = hydrodynamic diameter 
D = translational diffusion coefficient 
k = Boltzmann’s constant 
T = absolute temperature 
η = viscosity of the solution 
 
The software supplied with the Malvern instrument applies the Stokes Einstein 
equation to calculate the hydrodynamic diameter.  As this DLS value refers to 
how a particle diffuses within a fluid i.e. hydrodynamic diameter, the diameter 
obtained by this technique represents the diameter of a sphere that has the 
same diffusion coefficient as the particle.  This assumption is applied to derive 
the Mr of protein molecules. 
 
For consistency and reliability, the samples were subjected to three DLS runs.  
Samples of purified His-LplA (~ 1 mg/ml) and His-CTD (~ 1 mg/ml) in 20 mM 
Tris-HCl, pH 8.0, 0.2 M NaCl were prepared for DLS analysis by centrifugation 
at 13,000 x g for 30 min at 20°C (section 3.3.3).  This step was necessary to 
remove large suspended particles or aggregates.  DLS measurements of His-
LplA at 25°C gave a molecular mass estimate of 35 kDa (± 1 SE).  This value is 
very close to the expected 33 kDa calculated from the amino acid sequence.  
Measurements of His-CTD gave a molecular mass estimate of 46 kDa (± 3.2 
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SE).  This estimate was approximately 4 times larger than the expected 13 kDa.  
The chromatograms of these measurements indicated polydispersity in the dis-
tribution of molecular species and the size distribution varied indicating different 
oligomerization states of His-CTD under the experimental conditions.  In order 
to rule out a role of the His-tag in this process, DLS measurements of ntCTD (1 
mg/ml) were carried out.  The samples were prepared by the method described 
previously (section 3.2.11).  DLS measurements of ntCTD gave an estimated 
79 kDa (± 7.5 SE).  This value exceeded the expected size (10 kDa) by ap-
proximately 7 times.  A possible reason for such a difference in the expected 
and calculated molecular mass could be oligomeric self-association of ntCTD in 
solution.  Further efforts to prevent potential protein self-association were made 
and a common detergent, Tween-20, was included in the protein samples.  
Analysis of ntCTD (1 mg/ml, ≥ 95% purity) in the presence of 0.5% (v/v) Tween-
20 gave 50 kDa (± 0.5 SE).  This molecular mass estimate was approximately 5 
times larger than the calculated 10 kDa.  Therefore, the results suggested that 
both His-CTD and ntCTD have a strong tendency for oligomeric self-
association. 
 
Further, the His-LplA-ntCTD complex from the pull-down assay was analysed 
using DLS, which gave M = 39 kDa (± 3.2 SE).  The expected molecular mass 
for a His-LplA-ntCTD complex in which LplA and CTD are present in a 1:1 ratio 
is approximately 44 kDa.  This result is in agreement with GPC data which also 
gave a size estimate of a LplA-CTD complex in a 1:1 ratio (Table 6.1).  DLS 
analysis of mixtures of His-LplA : ntCTD in a molar ratio of 1:8 and 1:4 gave 52 
kDa (± 0.6 SE) and 54 kDa (± 1.7 SE), respectively.  Therefore, it appeared that 
His-LplA-ntCTD complex samples containing excess CTD show a molecular 
mass further away from the expected mass of the complex (~ 44 kDa).  An ex-
planation could be the excess of CTD, which may be forming oligomers of itself, 
which causes a polydispersity in the solution and leading to the skew in the re-
sults.  Repeating the experiments in the presence of 0.5% (v/v) Tween-20 
yielded similar results.  Therefore, if oligomerization is taking place, Tween-20 is 
unable to break these interactions. 
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On the other hand, the sample from the pull-down assay gave a molecular 
mass much closer to the estimated value.  Hence, the presence of His-LplA 
may be preventing the self-association of ntCTD.  In other words, the His-LplA-
ntCTD complex may be energetically a more favourable species than oligomers 
of CTD.  Relatively small discrepancies in the molecular mass values using DLS 
can be attributed to the fact that DLS is a low resolution technique.  Polydisper-
sity and presence of large aggregates or particles do not allow for an accurate 
molecular mass estimation.  The reason for this is that the basic distribution ob-
tained from a DLS measurement is intensity and all other distributions (number, 
volume) are generated from this.  It cannot be excluded that a His-LplA-ntCTD 
complex was present in all the different mixtures tested, but the presence of 
ntCTD oligomers may have masked the signal from the HisLplA-ntCTD com-
plex. 
 
6.2.4 Surface plasmon resonance analysis of LplA, CTD and E2lipD inter-
action 
After establishing the association between the LplA, CTD and E2lipD, it was 
decided to employ surface plasmon resonance (SPR) to study their binding af-
finity.  SPR is a sensitive technique, routinely used to quantitatively study pro-
tein-protein interactions.  It exploits an optical phenomenon using a refractive 
index sensor.  If a beam of light excites mobile electrons on the surface of a 
metal film, it will cause oscillations.  These mobile electrons are also called 
plasma and hence these oscillating plasma waves are called surface plasmons.  
When the incident light and surface plasmon wavelength match, the electrons 
resonate, hence the term surface plasmon resonance.  This event uses energy 
which causes a decrease in the angle of the reflected light.  This angle is called 
surface plasmon angle (Θspr).  Any change on the side of the metal which is not 
in direct contact with the light, will have an effect on Θspr.  If the metal surface is 
immersed in an aqueous buffer, it will have a lower refractive index than when 
protein is bound to it.  Therefore, the binding of protein causes a detectable de-
crease in Θspr and this signal is presented as response units (RU) (Fig. 6.8).  
RU is an arbitrary unit chosen so that 1 RU corresponds to a shift in angle of 
about 10-4 degrees which equals a change in refractive index of about 10-6.  
From this, as a guideline for proteins on a CM5 sensor chip, 1 RU corresponds 
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to a change in surface concentration of approximately 1 pg/mm2 (Biacore® Con-
centration Analysis Handbook, 2001; O’Shannessy et al., 1993).  Hence, RU 
values are proportional to the amount of protein bound to the metal surface.  RU 
readings are presented graphically in a sensorgram which displays RU versus 
time (Biacore® Basics, Edition 2003). 
 
Ligand
Analyte
Flow of analyte
Sensor chip with 
gold film in flow cell
Polarized light Reflected light A 
B 
 
 
Fig. 6.8 Surface plasmon resonance (SPR). A: Example of a basic SPR set-up.  The 
ligand is immobilized on the chip surface.  Binding of the analyte to the ligand alters the 
angle of reflected light (dashed arrow) and this value can be presented in response 
units (RU) versus time.  B: Example of a sensorgram showing the binding of the ana-
lyte to the ligand and the kinetics of binding and dissociation (adapted from Varki et al., 
2009). 
 
 
6.2.4.1 SPR analysis of ntLplA and ntCTD interaction 
Initial interaction studies of His-LplA and ntCTD were carried out using a CM5 
chip, which had penta-His antibody immobilized on its surface (section 3.3.2).  
The antibody surface captured His-tagged LplA, creating a His-LplA surface.  
Next, ntCTD was passed over this chip in HBS-EP buffer, pH 7.4, and the spe-
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cific binding response was measured.  The sensorgram of His-LplA and ntCTD 
indicated an interaction between the two proteins (Fig. 6.9).  This interaction 
was via His-LplA as ntCTD was not recognized by the penta-His antibody.  As 
MgCl2 is required for enzyme function ([Online] available at 
http://www.uniprot.org/uniprot/Q9HKT1, accessed December 15th, 2008), 5 mM 
MgCl2 were added to the HBS-EP buffer, pH 7.4, and the experiment was re-
peated.  In the presence of 5 mM MgCl2 a higher RU was measured which indi-
cated that MgCl2 may stabilize the interaction of the His-LplA ligand with the 
CTD analyte.  Therefore, 5 mM MgCl2 was included in all subsequent experi-
ments. 
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Fig. 6.9 Binding of ntCTD to His-LplA in the presence and absence of MgCl2.  RU, Re-
sponse units; His-LplA was immobilized on a CM5 chip via penta-His antibody on the 
chip surface.  ntCTD was passed over this chip and the binding response was re-
corded.  This experiment was conducted in the absence and presence of 5 mM MgCl2. 
 
 
To characterize the binding affinity between the LplA and CTD, the non-tagged 
proteins were used to rule out any cross interaction of the His-tags.  Both, bind-
ing kinetics (Fig 6.10) and steady state analysis (Fig. 6.11) were employed. 
 
Kinetic analysis gives information on how fast the binding between the ligand 
and analyte is.  This is expressed by ka, the association constant, and is defined 
as the number of ligand-analyte complexes formed per unit time at unit concen-
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tration of ligand and analyte (standard units M-1s-1).  The typical range of ka val-
ues is 10-3 to 107 M-1s-1.  The stability of the complex in the kinetic experiment is 
described by the dissociation constant kd, which is defined as the number of 
ligand-analyte complexes that dissociate per unit time (standard units s-1).  The 
typical range of kd values is 10
-1 to 10-6 s-1. Measuring the kinetics of binding of 
protein interactions at different analyte concentrations can be employed to de-
termine the equilibrium binding affinity (KD), which equals kd/ka.  If the kinetic 
curves can be fitted, KD can be estimated without reaching steady state during 
the experiments. 
 
On the other hand, steady state analysis defines how strong an interaction is 
i.e. the affinity of the interaction at equilibrium.  To determine the equilibrium 
binding affinity constant (KD) at steady state, data points towards the end of 
analyte injection are taken for different analyte concentrations.  In a secondary 
plot, the obtained response measured at those points, referred to as Req, is plot-
ted against the analyte concentration.  From this plot Rmax can be determined, 
which gives the maximal signal in RU dependent on the number of binding 
places.  The concentration at which Rmax is Rmax/2 equals the affinity constant 
KD.  The typical range of KD is 1x10
-5 to 1x10-12 M.  If the steady state is not 
reached during the injection any KD determined this way will be an underesti-
mate of the true value. 
 
The interaction of ntCTD with ntLplA can be assumed to follow pseudo first-
order kinetics since the concentration of ntCTD is constant throughout the injec-
tion: 
ntLplA + ntCTD          ntLplA-ntCTD
ka
kd  
where ka is the association constant and kd the dissociation constant. 
ntLplA was immobilized onto a CM5 chip as described in section 3.3.2 and a 
number of different ntCTD concentrations were passed over the ntLplA surface 
(Fig. 6.10, Table 6.2).  The response was observed to be increasing with in-
creasing concentration of ntCTD.  For analysis, the binding data was fitted to a 
bivalent model (Table 6.2) which gave two KD values: KD1 = 1.46x10
-4 M and 
KD2 = 0.7 M.  Very often the bivalent analyte binding model fit is a result of slow 
dissociation of the ligand-analyte complex caused by multiple bond interactions.  
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Therefore, although the bivalent fit gives empirical values for relative rates and 
binding strengths, these values are not the physical constants (Biacore® kinetics 
and affinity analysis handbook, 2006). 
 
The value of KD1 indicates a weak interaction, whereas KD2 is a very weak affin-
ity constant indicating insignificant interaction between ntLplA and ntCTD.  
Nonetheless, the results of GPC, pull-down assay and DLS presented above 
showed that LplA and CTD interact specifically in a 1:1 ratio. 
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Fig. 6.10 Binding kinetics of ntCTD to ntLplA.  ntLplA was covalently immobilized on a 
CM5 chip.  The running buffer was HBS-EP buffer, pH 7.4, 5 mM MgCl2.  ntCTD (0.125 
– 4 mg/ml) was passed over the surface for 60 s at 30 µl/min.  Between different ntCTD 
concentrations, the ntLplA surface was regenerated with 10 mM NaOH, for 30 s. 
 
 
 
Table 6.2 Summary of the kinetic data for binding of ntCTD to immobilized ntLplA (Fig. 
6.10).  kt is the mass transport parameter, Rmax has been fitted locally.  The data fitted a 
bivalent model using the BIAevaluation software (Biacore®) which gave the following 
parameters: 
ka1 = 170.5 M
-1s-1, kd1 = 0.025 s
-1, KD1 = 1.46x10
-4 M, KD2 = 0.7 M, Chi
2 = 0.147 RU2  
 
Cycle [CTD ] 
mg/ml 
CTD (M) Rmax 
(RU) 
kt 
(RU/Ms) 
RI (RU) 
1 4 3.899x10-4 17.98 3.217x108 3.252 
2 2 1.949x10-4 15.98 3.217x108 1.522 
3 1 9.747x10-5 15.26 3.217x108 0.3805 
4 0.5 4.873x10-5 14.84 3.217x108 0.002825 
5 0.25 2.437x10-5 17.95 3.217x108 0.004994 
6 0.125 1.218x10-5 23.59 3.217x108 0.001298 
7 2 1.949x10-4 15.5 3.217x108 0.6095 
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The KD value was also determined by employing the steady state analysis (Fig. 
6.11).  The secondary plot from this steady state analysis (Fig. 6.12) gave a KD 
value of 6.3x10-4 M.  Therefore, both kinetic and steady state analyses gave KD 
values indicating a weak, yet specific, interaction. 
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Fig. 6.11 Steady state analysis of ntCTD binding to immobilized ntLplA.  The data 
points were taken towards the end of the injection (indicated by crosses) under the 
assumption that a steady state between association and dissociation exists.  The 
analysis was done using the BIAevaluation software (Biacore®).  The calculated pa-
rameters were: KD = 6.307 x 10
-4 M, Rmax = 42.46 RU, Chi
2 = 0.187 RU2 
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Fig. 6.12 Determination of KD from a secondary plot of Req (units RU) versus ntCTD 
concentration (M).  The values of Req were obtained from steady state analysis (Fig. 
6.11). 
 
 
Analysis of the kinetic binding (Fig 6.10, Table 6.2) and steady state (Fig. 6.11 
and 6.12) data gave different KD values, which indicated that the numerical KD 
values are not very reliable.  These results would require further validation.  
One obstacle during the kinetics experiment was the difficulty to saturate the 
binding of ntCTD to ntLplA.  To overcome this problem, the inverse approach 
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was applied by immobilising ntCTD.  In theory, this should give similar results 
as the previous approach but it seemed that ntCTD, once immobilised, could 
not interact with ntLplA anymore.  This may be due to the unavailability of the 
LplA binding site of CTD in the immobilised state and/or the proteins incompati-
bility with the sodium acetate buffer, pH 5.0, used during the immobilization 
process.  Moreover, kinetic analyses can be limited by mass transport effects 
(Nguyen et al., 2007).  Mass transport is solely dependent on diffusion and de-
scribes the movement of molecules from solution to a surface.  It can slow down 
association by limiting supply of analyte to the surface-bound ligand as well as 
dissociation of ligand-analyte complexes because the analyte is not sufficiently 
washed off the surface, allowing rebinding.  If data are heavily mass transport 
limited the ka and kd will be underestimated.  Therefore, if the protein-protein 
interaction is much faster than the diffusion of CTD to the LplA surface, the ob-
served binding will be limited entirely by the mass transport process. 
 
6.2.4.2 SPR analysis of the E2lipD, LplA and CTD ternary complex 
Previously, the pull-down experiments indicated the interaction between E2lipD 
with LplA and CTD.  SPR experiments were conducted to further investigate the 
interaction of all the three components.  A His-E2lipD surface was created by 
capturing the protein with penta-His antibody immobilized on a CM5 chip sur-
face.  After His-E2lipD had bound to the chip surface, ntLplA was passed over 
it.  ntLplA interacted with E2lipD yielding a specific response of approximately 
250 RU.  ntLplA (100 µg/ml) alone yielded the same response as a mixture of 
equal concentrations of ntLplA and ntCTD (100 µg/ml).  Interestingly, changing 
the concentration of LplA:CTD from 1:1 to 1:10, while keeping the LplA concen-
tration constant, decreased the initial response to about 225 RU (Fig. 6.13).  To 
establish if this drop in RU was due to the increase in ntCTD, the experiment 
was repeated with increasing concentration of CTD, keeping ntLplA constant 
(100 µg/ml).  A drop in the RU as a function of increasing ntCTD concentration 
was observed indicating that the presence of ntCTD may not allow LplA to in-
teract with E2lipD (Fig. 6.14).  The GPC data have previously shown the role of 
NaCl in breaking up a ternary complex into two separate complexes of LplA-
CTD and LplA-E2lipD.  During SPR experiments, the proteins were prepared in 
HBS-EP buffer, pH 7.4, which contained 150 mM NaCl.  Therefore, a prefer-
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ence for CTD to bind to LplA is not unexpected.  As LplA is still able to bind to 
E2lipD in the GPC experiments, the observed decrease in RU in the presence 
of ntCTD may indicate that the CTD-LplA interaction is more favourable in com-
parison to the LplA-E2lipD interaction or that CTD obstructs the binding site for 
E2lipD under the experimental conditions. 
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Fig 6.13 Interaction of His-E2lipD with ntLplA and ntCTD.  Analytes were ntLplA and 
ntCTD.  RU, response units. His-E2lipD (100 µg/ml) was immobilized on a CM5 chip 
surface via penta-His antibody at 210 RUs.  ntLplA (100 µg/ml) was mixed with ntCTD 
(100 µg/ml) in a 1:1 and 1:10 ratio before passing it over the His-E2lipD surface. 
 
 
-40
-20
0
20
40
60
80
100
120
-5 0 0 50 1 00 150 20 0 2 50 30 0 35 0 40 0 4 50
R U
sT im e (0  =  b ase l in e)
0
0.095
0 .19
0 .38
0 .76
1 .315
1 .972 5
2
0
[CTD]
mg/ml
 
 
Fig. 6.14 Competition of ntLplA and ntCTD to bind to His-tagged E2lipD.  The concen-
tration of ntLplA (100 µg/ml) was kept constant while increasing the concentration of 
ntCTD. 
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Although LplA has been suggested to be responsible for converting LA into li-
poyl-AMP (Kim et al., 2005), the results have proven that CTD is still required 
for the transfer of this intermediate to E2lipD.  Therefore, a critical role of CTD, 
as seen from our preliminary SPR studies, in the interaction between E2lipD 
and LplA is understandable.  Due to the problems with the immobilisation of 
CTD, it was decided not to pursue the work using SPR beyond this point.  
Moreover, to obtain more reliable ka, kd and KD values, the experimental set up 
requires optimization.  This includes the potential mass transport effect, as dis-
cussed above, which can be controlled by experimental conditions like increas-
ing the flow rate (Nguyen et al., 2007).  The scope of this project, time and ac-
cess constraints to the Biacore® instrument (Vernalis, Cambridge, UK) did not 
permit further optimization of the experimental conditions.  Due to the ambigui-
ties in the ka, kd and KD estimates it was not possible to determine the 
stoichiometry of the ntLplA-ntCTD complex from these data.  However, the SPR 
data agree qualitatively and validate the results from the pull-down and GPC 
experiments in that LplA and CTD interact specifically. 
 
6.2.5 Isothermal titration calorimetry (ITC) of His-LplA and His-CTD inter-
action 
ITC is another quantitative technique that can be used to directly measure en-
thalpy changes (∆H) involved in ligand binding and/or complex formation, bind-
ing affinity and binding stoichiometry.  This technique has an advantage over 
SPR as the interactions are analyzed in the solution phase.  SPR can be used 
to determine binding affinity and stoichiometry, under the assumption that the 
proteins themselves or their interactions are not altered by the immobilization 
process and/or steric hindrance.  If the proteins are not affected, SPR and ITC 
data are in good agreement (Nguyen et al., 2007).  During the ITC experiment, 
one of the molecules under study is kept in what is called the bomb (reaction 
vessel) and is referred to as titrate.  The interacting molecule (titrant) is injected 
into the bomb (reaction vessel) where the two molecules can interact and the 
change of heat within the bomb is measured.  Raw ITC data show the change 
in energy (µcal/sec) versus time.  Each injection is indicated by a peak, where 
the peak intensity is proportional to the change in energy.  This change in en-
ergy can be positive or negative, depending on the type of reaction.  In simple 
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terms, negative ∆H values indicate that the interaction of the molecules re-
leased energy i.e. it is an exothermic reaction.  Positive ∆H values show the 
requirement for energy to allow the interaction to occur.  This is referred to as 
an endothermic reaction.  In the beginning of a typical ITC experiment, ∆H is 
expected to be larger as the titrant can interact with any molecule in the bomb.  
Over time, this response is expected to decrease, levelling towards ∆H = 0, as 
the number of unbound molecules in the bomb is decreasing and all the inter-
acting molecules are saturated with binding partners. 
 
For ITC analysis His-LplA and His-CTD were dialysed into 20 mM HEPES, pH 
7.5, 150 mM NaCl, 5 mM MgCl2, the same buffer used in the gel shift assay.  
His-LplA (33 µM) was kept in the bomb (titrate) whereas His-CTD (2 µM) was 
titrated at different temperatures.  At 25°C the data were within the exothermic 
region (Fig. 6.15, A).  However, these responses were small, no saturation of 
interaction was observed and large endothermic reactions were observed to-
wards the end of the ITC experiment.  As LplA and CTD are proteins from a 
thermophilic organism, the temperature during the ITC experiment was in-
creased.  Although running the experiment at 40°C prevented an endothermic 
reaction, the interaction did not reach saturation (Fig. 6.15, B).  It was not pos-
sible to fit the data to a single site, multiple site or sequential binding model us-
ing the Microcal Origin Version 5.0. software. 
 
The presence of endothermic and exothermic reactions may be indicative of 
multiple interactions and not just the association of LplA and CTD.  As CTD has 
previously shown the tendency to self-associate/aggregate (section 6.2.3), it 
was decided to reduce its concentration.  His-CTD (0.6 µM) was kept in the 
bomb and His-LplA was titrated (32.6 µM) in 5 µl injections at 25°C (Fig. 6.16, 
A).  Under these conditions, still both endothermic and exothermic reactions 
were observed.  Next the molar ratio between His-LplA and His-CTD were in-
creased to 1:20 for LplA to CTD.  Under those conditions the raw ITC data indi-
cated an exothermic trend (Fig. 6.16, B).  Nonetheless, fitting these data to 
binding models proved unsuccessful. 
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Fig. 6.15 ITC results titrating His-CTD (2 µM) into His-LplA (33 µM).  The top panel 
shows the raw ITC data whereas the bottom panel shows the enthalpogram (∆H data).  
Each experiment had 30 injections, 5 µl each.  A: ITC at 25°C.  B: ITC at 40°C. 
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Fig. 6.16 ITC experiments titrating His-LplA into His-CTD at 25°C.  The top panel 
shows the raw ITC data whereas the bottom panel shows the enthalpogram (∆H data).  
Each experiment had 30 injections, 5 µl each. A: His-LplA (32.6 µM); His-CTD (0.6 
µM).  B: His-LplA (159 µM); His-CTD (7.9 µM). 
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6.3 Discussion and conclusions 
Understanding the protein-protein interactions of LplA and CTD gives informa-
tion on their possible mechanism.  Either both proteins associate and catalyse 
the lipoylation reaction, or CTD only interacts with the LplA when a transfer of 
lipoyl-AMP to E2lipD is required.  The latter is possible, as LplA has been 
shown to convert LA into lipoyl-AMP in the crystal structure (Kim et al., 2005).  
On the other hand, the structural information of other known LplAs places the 
active site sandwiched between the N- and C-terminal domains.  The sequence 
analyses and proposed three dimensional association of LplA and CTD antici-
pate a similar situation and is supported by the requirement of CTD for cataly-
sis.  These points suggest that LplA and CTD form a complex even in the ab-
sence of substrate and/or E2lipD. 
 
The GPC experiments revealed three complexes: LplA-CTD and LplA-E2lipD in 
the presence of 150 mM NaCl and a ternary complex of LplA-CTD-E2lipD if 
NaCl was omitted.  Hence, the ternary complex is weaker in nature and the in-
teraction can be separated by ionic strength.  This is expected from an enzy-
mological point of view.  The interaction with E2lipD should be specific for rec-
ognition and release of lipoyl-AMP, but not too strong to ensure a quick disso-
ciation after lipoyl-AMP has been transferred.  Pull-down experiments revealed 
that E2lipD is recognized by both, LplA or CTD. This would support the pres-
ence of a LplA-CTD complex, both proteins contributing to the active site and 
interacting with E2lipD.  GPC on the other hand did not show an E2lipD-CTD 
complex.  The presence of a LplA-E2lipD complex in the GPC experiments 
suggests that LplA is the main contributor in the recognition of the complex.  
Given the difference in size of LplA and CTD and that LplA makes up the major-
ity of the active site, this is not surprising.  Yet, the lipoylation activity assay 
shows that this is not enough for LplA to catalyze the reaction by itself. 
 
GPC could not distinguish between the strength of the LplA-CTD and LplA-
E2lipD complex.  Although SPR studies did not give KD constants of the interac-
tions they confirmed specific weak interaction of LplA and CTD.  DLS data 
complemented data on this interaction indicating the presence of a complex in a 
1:1 ratio.  Furthermore, the tendency of CTD to self-associate was suppressed 
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in the presence of LplA supporting that the LplA-CTD interaction is a stable and 
favourable protein-protein interaction. 
 
ITC experiments indicated that the interaction between LplA and CTD may be 
affected by side reactions.  Decreasing the CTD concentration in favour of LplA 
had a significant effect on the ITC data. The tendency of CTD to oligomer-
ize/aggregate, as observed during DLS, is thought to may have affected the ITC 
measurements.  It can be summarized as follows: 
 
LplA + [CTD]n  ⇋  LplA-CTD + [CTD]n-1 
 
where LplA is the monomer, [CTD]n is the oligomeric form containing n copies 
of CTD monomers and LplA-CTD the complex between the two protein mono-
mers.  It is assumed that the endothermic reactions observed during ITC may 
correspond to the energy required to dissociate CTD oligomers into CTD 
monomers.  The released CTD monomer can then interact with the LplA 
monomer and this interaction contributes to the exothermic response.  In other 
words, the overall measured -∆H is assumed to be the difference between the 
endothermic and exothermic reaction.  The CTD oligomers and free CTD 
monomer are assumed to exist in equilibrium.  The addition of LplA is thought to 
drive the formation of the LplA-CTD complex and the generation of CTD mono-
mers pushing the equilibrium in favour of the CTD monomer.  With increasing 
injections of LplA, the number of [CTD]n is thought to decrease and hence the 
observed -∆H increases as more CTD monomers are available to interact with 
LplA without further energy input.  This model may explain the increase in exo-
thermic release with increasing LplA injections (Fig. 6.16, B).  However, no in-
formation on how many CTD monomers may associate into oligomers, if they 
exist and how LplA effects their dissociation, is known.  Under these conditions, 
ITC was not suitable to determine the KD and stoichiometry of the LplA-CTD 
complex and therefore this technique was not pursued beyond this point. 
 
Overall, these results suggest that LplA and CTD form a complex, which may 
interact with E2lipD to carry out the lipoylation reaction.  This interaction may 
not depend on the presence of substrate or reaction intermediate, which sug-
gests that major substrate induced conformational changes are less likely to 
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play a role in the lipoylation reaction.  Therefore, it is possible that LplA and 
CTD may form a stable complex which may not dissociate after assembly, simi-
lar to other LplAs (Cronan et al., 2005; Fujiwara et al., 2005; Fujiwara et al., 
2007) which exist as one polypetide.  In the following chapter, an attempt has 
been made to produce a fusion protein consisting of LplA and CTD and its en-
zyme activity has been analyzed. 
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CHAPTER 7 
Design of a Thermoplasma acidophilum lipoate protein ligase 
and C-terminal fusion protein (LplA-CTD Fusion) 
 
7.1 Introduction 
In the previous chapters it was demonstrated that both LplA and CTD are re-
quired for lipoylation and that they physically associate to do so.  With reference 
to the protein sequence alignments, the Tp. acidophilum CTD shows approxi-
mately 30% sequence homology to the C-terminal domains of other lipoate pro-
tein ligases.  However, in the case of Tp. acidophilum, CTD is not part of the 
same polypeptide but is present as a separate gene directly upstream of the 
truncated lpla gene (chapter 4).  Consequently, it came into question if a fusion 
protein of Tp. acidophilum LplA and CTD would be active.  An answer to this 
question may help enhance our understanding of their activity and may provide 
a possible evolutionary link between the lipoate protein ligase from Tp. aci-
dophilum and that from other species.  As this is the first evidence for lipoylation 
in the Archaea, one has to be careful in making swift comparisons.  It might be 
possible that the Thermoplasma LplA protein, encoded by two genes rather 
than one, has a different structural arrangement that requires the two domains 
to be present as separate polypeptides to accommodate their association.  To 
evaluate this possibility, a fusion of both genes in the hypothetical N- to C- ter-
minal position, as indicated by sequence alignments (chapter 4), was designed 
and analysed for lipoylation activity. 
 
 
7.2 Results 
 
7.2.1 Design and cloning of a LplA-CTD Fusion protein 
Based on protein sequence identity of the individual LplA and CTD with the N- 
and C-terminal regions of other known LplAs respectively, the CTD gene was 
relocated downstream of the LplA gene.  The predicted fusion product was used 
in a three-dimensional structure model comparison with S. pneumoniae LplA 
(Fig. 7.1). 
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Fig. 7.1 Three-dimensional structure model comparison of the Thermoplasma LplA-
CTD Fusion protein with Streptococcus pneumonia LplA.  A: LplA-CTD Fusion model; 
the LplA (N-terminal domain) and CTD (C-terminal domain) are highlighted in magenta 
and yellow, respectively.  B: S. pneumoniae crystal structure (PDB accession 1VQZ) 
(green).  C: Overlay of the predicted Thermoplasma LplA-CTD Fusion (magenta) struc-
ture model with the S. pneumoniae LplA (green) structure.  The 3-D coordinates of the 
LplA-CTD Fusion were generated from its amino acid sequence using the program 
Quickphyre (Bennett-Lovsey et al., 2008; accessed July 10th, 2008) and from these 
data a 3-D model was generated using PyMOL (DeLano Scientific LLC, San Carlos, 
CA, USA. http://www.pymol.org). 
 
 
In order to express the Tp. LplA together with its hypothetical C-terminal domain 
in the proposed order, a physical association between the two genes, lpla 
(ta0514) and ctd (ta0513m), was created using overlap extension PCR 
(OEPCR) (Fig. 7.2).  In this design, the lpla stop codon and ctd start codon were 
deleted and the two genes fused without a linker.  The 3` region of lpla was 
fused with the 5` region of ctd by designing the reverse primer for lpla and the 
forward primer for ctd as homology primers.  The forward primer for lpla was 
5’-GCTAGCATGGAAGGCAGGCTTCTTTTACTAGAA-3’ (start codon in italics 
and NheI restriction site underlined) and the reverse homology primer was 
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5’-GTACATCATATGTACGACCTCTTTCCTCAGGAG-3’, where the black and 
the blue match the gene sequence coding for the 5` end of ctd and the 3´ end of 
lpla, respectively (Fig. 7.2).  The forward homology primer for ctd was 
5’-AGGAAAGAGGTCGTACATATGATGTACAGCAAG-3’, where the black and 
green match the DNA sequence coding for the 3`end of lpla and 5´end of ctd, 
respectively (Fig. 7.2), and the reverse primer was 
5’-CTCGAGTCAGATCACCCTCAAAGCCTGAAT-3’ (stop codon in bold and 
XhoI restriction site underlined).  The restriction sites were introduced for liga-
tion of the PCR product into the pET28a vector and for the addition of an N-
terminal His-tag.  In the first PCR reaction lpla and ctd were amplified individu-
ally. The use of homology primers allowed overlap and hence amplification of 
the two DNA sequences as a whole in a defined manner in a second PCR reac-
tion (Fig 7.2). 
 
C-terminal domain
1st PCR 
2nd PCR 
3‘
3‘
N-terminal domain
Homology 
primers
LplA Ta0513mctd (ta0513m) lpla (ta0514) 
 
 
Fig. 7.2 Diagram of the OEPCR reaction.  The gene sequences coding for Tp. LplA 
and the CTD were first amplified individually.  The PCR conditions were the same for 
both genes with denaturation at 98°C for 30 s followed by 30 cycles with denaturation 
at 98°C for 10 s, annealing at 64°C for 30 s and extension at 72°C for 30 s.  Final ex-
tension was allowed to take place at 72°C for 10 min.  In the second PCR, the purified 
PCR products (section 3.1.3), the forward primer for lpla and the reverse primer for ctd 
were added together.  Initial denaturation was at 98°C for 30 s and was followed by 
four cycles of denaturation at 98°C for 10 s, annealing at 60°C for 30 s and extension 
at 72°C for 2 min to allow overlap of the two PCR products at DNA regions created by 
the homology primers in the first PCR reaction.  The reaction was completed with 25 
subsequent cycles with denaturation at 98°C for 10 s, annealing at 67°C for 30 s and 
extension at 72°C for 30 s.  Final extension was done at 72°C for 10 min. 
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OEPCR successfully produced the desired lpla-ctd fusion gene (Fig. 7.3).  The 
lpla-ctd fusion gene was cloned into pGEM-T Easy vector and sent for sequenc-
ing.  A clone that had the correct sequence was ligated into the pET28a vector. 
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Fig. 7.3 PCR products of the individual PCRs and OEPCR (1% agarose gels).  Marker 
sizes are in kilo base pairs.  A: Individual amplification of ctd (lanes 1 – 5) and lpla (6 – 
10).  Lanes 1 – 3 and 6 – 8 are the controls in which DNA, the reverse primer and for-
ward primer were omitted, respectively.  Lanes 4, 5, 9 and 10 are the complete PCR 
mixtures. The amount of template DNA in reaction 4, 5, 9 and 10 was the same, but the 
reaction mixtures in lane 5 and 10 contained DMSO.  Both PCR products are of the 
correct size (yellow).  B: OEPCR.  Using the purified PCR products from A as template 
in a second PCR, a PCR product of the correct size (1080 bp) was obtained.  Lane 1, 2 
and 3 are the controls in which the DNA, reverse primer and forward primer were omit-
ted respectively.  The control in lane 3 gave some PCR product corresponding in size 
to the ctd.  Lane 4, 5, and 6 are the complete PCR mixtures.  The reaction mixtures in 
lane 5 contained twice the amount of template DNA.  Lane 6, reaction mixture included 
DMSO. 
 
 
7.2.2 Expression and purification of the LplA-CTD Fusion protein 
The lpla-ctd-fusion-pET28a plasmid was transformed into BL21(DE3) E. coli 
cells.  Cell cultures were grown in OvernightExpress autoinduction medium 
(Novagen) overnight at 37°C with shaking.  Cells were harvested and sonicated 
in lysis buffer (20 mM Tris-HCl, pH 8.0, 0.3 M NaCl, 20 mM imidazole) and the 
cell lysate was centrifuged at 75,000 x g for 20 min at 4°C.  The supernatant 
was subjected to Ni2+ affinity chromatography on a HisTrap FF column applying 
a linear gradient of imidazole (0.02 – 0.5 M).  The fractions containing the LplA-
CTD Fusion were diluted 10-fold in lysis buffer and the previous purification step 
was repeated.  The purified LplA-CTD Fusion had a relative electrophoretic mo-
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bility of approximately 45 kDa on SDS-PAGE gel, in agreement with the ex-
pected 42 kDa calculated from the amino acid sequence (Fig. 7.4). 
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Fig. 7.4 SDS-PAGE gel summarizing the Ni2+ affinity purification of LplA-CTD Fusion 
on a HisTrap FF column.  M, protein marker (kDa); lane 1, whole cell sample; lane 2, 
whole cell sample after induction with IPTG; lane 3, soluble fraction of the IPTG in-
duced whole cell sample (lane 2); lane 4, LplA-CTD Fusion from first Ni2+ affinity purifi-
cation; lanes 5 and 6; LplA-CTD Fusion from a second Ni2+ affinity purification step.  
LplA-CTD Fusion is indicated by the arrow. 
 
 
7.2.3 Lipoylation activity of the LplA-CTD Fusion protein 
A gel shift assay was set up with purified LplA-CTD Fusion as described (sec-
tion 3.2.15).  In the presence of the substrates LA and ATP, a clear shift in the 
relative mobility of E2lipD was observed, indicating that the LplA-CTD Fusion 
has lipoylation activity (Fig. 7.5).  The amount of E2lipD being lipoylated in-
creased with increasing the amount of LplA-CTD Fusion used in the assay. 
 
 
 
Fig. 7.5. Non-denaturing PAGE gel showing the lipoylation activity of LplA-CTD Fusion. 
The lipoylation reaction was set up as described (section 3.2.15).  Different amounts of 
LplA-CTD fusion were analysed: 10 µg (lane 1, 2), 25 µg (lane 3, 4), 50 µg (lane 5, 6) 
µg, 100 µg (lane 7, 8), 150 µg (lane 9, 10), 200 µg (lane 11, 12).  Lanes 1, 3, 5, 7, 8 
and 11 did not contain ATP.  Lanes 2, 4, 6, 8, 10, 12 were supplemented with ATP. 
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7.3 Discussion and conclusions 
Using OEPCR it was possible to design, express and purify a fusion protein with 
LplA as the N-terminal and CTD as the C-terminal domain of the protein.  Struc-
ture predictions suggested that the domains would fold as individual domains 
similar to the domains of the S. pneumoniae LplA, and it was anticipated that 
the domains would still fold properly after fusion.  The activity assays showed 
that the LplA-CTD Fusion carried out lipoylation of Thermoplasma E2lipD.  
Therefore, the physical association of LplA and CTD without a linker region did 
not impair enzyme activity.  As the absence of a linker domain between LplA 
and CTD did not impair enzyme activity, it suggested that the two proteins 
folded properly and that the arrangement of the fused LplA and CTD are likely 
to be the positions adopted by the individual LplA and CTD.  This in turn also 
indicated that the interaction between the two individual proteins may be similar 
to the interaction of the two domains if present in one polypeptide as found in 
other organisms. 
 
In the gel shift assay, 200 µg of LplA-CTD Fusion was sufficient to lipoylate 
about 70% of the E2lipD.  The LplA and CTD have been fused without a linker, 
which may explain a reduced activity in comparison with the two individual pro-
teins.  The design of fusion proteins with various size linkers and testing the 
effect of linker size on activity could give essential information on the flexibility 
requirement between the LplA and CTD domains.  If more time had been avail-
able, this work would have been included. 
 
Having established that Tp. acidophilum has a lipoylation machinery, which re-
sembles other lipoate protein ligases, the lack of BCOADHC activity in Tp. aci-
dophilum extracts needs to be explained.  The following chapter will describe 
evidence of in vivo lipoylation in Thermoplasma cell extracts. 
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CHAPTER 8 
In vivo lipoylation of E2 
 
8.1 Introduction 
Recombinant expression of the Tp. acidophilum oadhc genes in E. coli has 
been shown to produce a functional OADHC with substrate specificity for 
branched-chain 2-oxoacids and, to a minor degree, pyruvate (Heath et al., 
2007).  A recent report has also described the isolation of the BCOADHC com-
ponents from Thermoplasma cell extracts using glycerol density gradient ultra-
centrifugation coupled to two-dimensional gel electrophoresis and mass spec-
trometry (Sun et al., 2007).  This presence of BCOADHC components is some-
what contrary to the established fact that no in vivo OADHC activity in Tp. aci-
dophilum cell extracts has ever been detected.  As outlined in previous chap-
ters, lipoylation is a crucial step for overall OADHC activity.  The innate lipoyla-
tion machinery of Tp. acidophilum was the main focus in chapters 4 to 6 and the 
results showed that Tp. acidophilum has the two genes, which, if recombinantly 
expressed in E. coli, carry out lipoylation of E2lipD and whole E2 in vitro.  The 
presence of LplA in cell extracts has been confirmed (Sun et al., 2007, supple-
ment) but not the presence of CTD.  Therefore, lack of in vivo lipoylation may 
explain the absence of OADHC activity. 
 
The particular lipoate protein ligase from Tp. acidophilum, which has been 
characterized in previous chapters, requires externally supplied LA as a sub-
strate.  The standard growth medium, as used by Sun et al. (2007) and de-
scribed in section 3.1.5, was not supplemented with LA.  In the proteomics 
analysis by Sun et al. (2007) it was not mentioned whether E2 was lipoylated or 
not.  It is possible that the supply of LA induces the Tp. acidophilum lipoylation 
machinery, which in turn gives rise to an active BCOADHC.  The following work 
is the study of the growth of Tp. acidophilum in the presence of LA and its effect 
on in vivo lipoylation of native E2. 
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8.2 Results 
 
8.2.1 Growth of Tp. acidophilum cell cultures 
Two Tp. acidophilum cell cultures were grown as described in section 3.1.5.  
One culture was grown in standard DSM 158 medium.  To test the effect of LA 
on cell growth and viability, the second culture was grown in standard growth 
medium supplemented with 0.2 mM LA.  Cell viability was checked using the 
microscope.  The cell growth in the two cultures was measured at OD600nm and 
growth curves were generated (Fig. 8.1).  A comparison of the two growth 
curves showed that, despite the cell density of the standard cell culture being 
higher on average, both growth curves follow a similar trend.  The doubling time 
of the standard culture is 8 h and for the LA supplemented culture 8.5 h.  Per-
forming a one-way ANOVA analysis with a p-value of 0.704 showed that this 
difference in doubling time is not significant.  Therefore, it was concluded that 
LA supplement did not affect the growth of Thermoplasma cells cultures. 
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Fig. 8.1 Growth curves of Tp. acidophilum with and without lipoic acid (0.2 mM) sup-
plement.  100 ml cultures were grown as described (section 3.1.5).  Viability of the cells 
was checked under the microscope and cell density was measured at OD600nm. 
 
 
8.2.2 Western blot analysis of in vivo lipoylation 
From the growth studies it was concluded that LA supplementation did not inter-
fere with cell viability and growth.  However, to assess whether the LA supple-
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ment induced in vivo lipoylation, a Western blot of whole Tp. acidophilum cell 
extracts was carried out as described in section 3.2.17 (Fig. 8.2). 
 
As positive controls of lipoylation, E. coli extracts as well as the lipoylated 
Thermoplasma E2 from in vitro assays were included in the Western blot analy-
sis.  E. coli has a PDHC and OGDHC, each containing a lipoylated E2, which 
run with a relative mobility of 81 kDa and 51 kDa respectively on SDS-PAGE 
(Perham and Thomas, 1971).  The Western blot with anti-lipoic acid antibody 
revealed several lipoylated species in E. coli extract (Fig 8.2, B lane 1).  The 
estimated sizes corresponded to species running between 83 – 61 kDa (top 
band, Fig 8.2, B, lane 1), 50, 36 and 20 kDa.  The 50 kDa and ~ 83 kDa species 
could be the E2 component of the OGDHC and PDHC respectively.  The 
broadening of the band pattern on the PAGE for the PDHC E2 component may 
have been a result of overloading the E. coli cell extract on the SDS-PAGE gel.  
Moreover, previous reports show that freezing and thawing of E. coli cultures 
causes E2 degradation, the main degradation product with a size of 36 – 40 
kDa (Perham and Thomas, 1971).  It was very likely that E2 may have been 
degraded as a 36 kDa and 20 kDa species were detected by the anti-lipoic acid 
antibody in E. coli cell extracts. 
 
Lipoylated Thermoplasma E2 from the in vitro assay gave a strong signal on the 
Western blot (Fig. 8.2, B, lane 7) running on the SDS-PAGE gel with a relative 
mobility of approximately 55 kDa.  In addition, bands corresponding to LplA and 
CTD were visible on the Coomassie stained SDS-PAGE, but not on the West-
ern blot.  This result is consistent with the previous Western blot analysis of in 
vitro lipoylation of purified whole E2 (Fig. 5.1, D).  In addition to the 55 kDa spe-
cies, a band around 37 kDa was present on SDS-PAGE.  This band was de-
tected by anti-lipoic acid antibody in the Western blot analysis, and maybe the 
results of E2 degradation similar to that observed with E. coli E2 protein. 
 
The Tp. acidophilum cell extracts, whether grown in standard medium or on LA 
supplement, were similar in appearance on the SDS-PAGE gel (Fig. 8.2, A).  
Western blot analysis revealed a lipoylated protein species in cell cultures which 
had been supplement with LA for 13 days (Fig. 8.2, lane 6), whereas the cell 
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extract from cultures grown for 13 days on standard medium did not show any 
sign of lipoylation (Fig. 8.2, lane 2). The relative mobility of this lipoylated spe-
cies on SDS-PAGE was approximately 55 kDa, consistent with the relative mo-
bility of lipoylated E2.  The Western blot analysis was repeated three times. 
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Fig. 8.2 Western blot analysis of in vivo lipoylation in Tp. acidophilum.  All cell extracts 
were taken from cultures with an OD600nm ~ 0.5.  M, protein marker (kDa); Lane 1, E. 
coli whole cell extract; lane 2, Tp. acidophilum whole cell extract from cultures grown 
for 13 days in standard medium; lanes 3 – 6 Tp. acidophilum cell cultures grown con-
tinuously on LA since the first subculture into the supplemented medium for 6, 8, 11 
and 13 days, respectively; lane 7, in vitro lipoylation assay of whole E2 (section 5.2.1):  
A: SDS-PAGE of the whole cell extracts and lipoylated E2 control.  B: Western blot of 
A using anti-lipoic acid antibody. 
 
 
8.3 Discussion and conclusions 
Gene induction by the presence or absence of metabolites is a common phe-
nomenon (Dworking and Losick, 2001; Thevelein et al., 2008) and has been 
found to affect oadhc genes from Pseudomonas putida (Madhusudhan et al., 
1999).  Moreover, this phenomenon has been reported in the Archaea, for ex-
ample the induction of ß-glycosidase activity in Sulfolobus solfataricus in su-
crose minimal medium without added yeast extract (Haseltine et al., 1999).  As 
previous studies showed that the BCOADHC components are present in Ther-
moplasma cultures grown on standard medium (Sun et al., 2007) it was of in-
terest to see if the Thermoplasma lipoylation machinery could be induced by its 
substrate LA.  The growth studies did not show any effect of LA on cell viability 
or growth rate. 
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The Western blot analysis identified the presence of a lipoylated protein species 
in Thermoplasma cultures grown on LA for 13 days whereas the control culture 
grown on standard medium for 13 days did not contain any lipoylated species.  
The lipoylated protein species corresponded in electrophoretic mobility to re-
combinantly expressed and lipoylated Thermoplasma E2.  The size of the lipoy-
lated species, together with the limited targets of lipoylation, which only include 
the E2 component of OADHCs and the H-protein of the glycine cleavage sys-
tem (Cronan et al., 2005), led to the conclusion that it is indeed lipoylated whole 
E2.  This is the first report of in vivo lipoylation in the Archaea and shows that 
the presence of LA is required for this to happen.   
 
As LplA has been detected in glucose grown medium (Sun et al., 2007), it is 
interesting that the appearance of lipoylation took 13 days.  This may indicate 
that CTD, which is required for lipoylation (chapter 5), is not constitutively ex-
pressed.  The LA supplement may initiate changes at the transcriptional and/or 
translational level required to express the complete Thermoplasma lipoylation 
machinery.  A mechanism of gene regulation at the transcriptional level has 
been shown for other archaea (Tang et al., 1999; Haseltine et al., 1999; Jenal et 
al., 1993; Kanai et al., 2006).  This is an exciting new finding and holds clues to 
the lack of in vivo OADHC activity in Tp. acidophilum.  Sun et al. (2007) showed 
that the BCOADHC components are present in Tp. acidophilum cell extracts, 
although no assessment of the levels and physiological significance in the cell 
had been addressed.  Together with the findings presented in this chapter, it is 
possible that LA is required for LplA and CTD expression, which subsequently 
could carry out E2 lipoylation.  Alternatively, only basal levels of the BCOADHC 
may be present in the cells and LA could be a requirement for the biosynthesis 
of both, the lipoylation machinery as well as the BCOADHC.  To explore these 
possibilities, the next step is to measure BCOADHC activity in cell extracts from 
Thermoplasma cultures grown on LA.  Future avenues of study include MS 
analysis of the lipoylated protein species from cell extracts and microarray stud-
ies to monitor the effect of LA supplementation on gene expression to comple-
ment the current data. 
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CHAPTER 9 
Assembly of a BCOADHC from Tp. acidophilum 
 
9.1 Introduction 
Members of the OADHC family that have been characterized, have one thing in 
common: the E2 forms the catalytic and structural core of the complex (Perham 
2000).  In the case of PDHCs from Gram-negative bacteria and all OGDHCs 
and BCOADHCs, the E2 core is composed of 24 subunits with octahedral 
symmetry.  The PDHCs of eukaryotes and Gram-positive bacteria have E2 
cores made up of 60 subunits with icosahedral symmetry (Izard et al. 1999).  
Based on its substrate specificity, the Tp. acidophilum complex is a BCOADHC 
(Heath et al., 2007) and an octahedral E2 core would be envisaged.  Nonethe-
less, as no other archaeal OADHCs have been described yet, experimental 
data were required to confirm this assumption.  This chapter describes the de-
termination of the molecular mass of the complex proteins, the Tp. acidophilum 
E2 core and fully assembled complex and the effect of temperature on complex 
assembly using dynamic light scattering (DLS) and analytical ultracentrifugation 
(AUC). 
 
 
9.2 Results 
 
9.2.1 Optimization of NaCl concentration in DLS 
The DLS measurements were carried out as described in section 3.3.3.  The 
shown results are reproducible and were run at least in triplicate.  Initial DLS 
experiments with purified complex components resulted in a high polydispersity 
index, indicating the presence of large particles and/or different oligomerization 
states.  In such instances, DLS data are not reliable (section 6.2.3) and at-
tempts were made to prevent the protein self-oligomerization.  Presence of salt 
is known to prevent non-specific binding and oligomerzation by promoting pref-
erential hydration with the aqueous environment (Hofmeister effect) (Thomas 
and Elcock, 2006; Baldwin, 1996).  To assess the effect of salt, E1 was sub-
jected to DLS measurement with different NaCl concentrations (Fig. 9.1). 
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E1 with 100 mM NaCl measured at 55°C for 10 min gave a molecular mass es-
timate of 168 (± 6 SE) kDa.  This estimate is close to the expected molecular 
mass of 165 kDa, consistent with an α2β2 conformation (Heath et al., 2007).  
Depending on the source, E1 can exist as a homodimer (α2) (Schreiner et al., 
2005; Lessard and Perham, 1994).  If 100 mM NaCl were added after the heat 
incubation step, the M estimate was found to be 81.6 kDa.  The expected mo-
lecular mass for E1 in α2 conformation is 86 kDa, which is close to the meas-
ured estimate.  Although theoretically possible, an α2 conformation is thought to 
reflect a non-native oligomerization state under the given experimental condi-
tions as the α2β2 conformation has been found to be the only active E1 species 
(Heath et al., 2007).  Including 100 mM NaCl in the DLS measurements of E1 
gave highly reproducible data, distinct from the other NaCl concentrations.  
Therefore, it was concluded that 100 mM NaCl ensures sample stability by pre-
venting non-specific oligomerization.  Moreover, the determined molecular mass 
correlated well with the expected molecular mass of the assembled E1 (Fig. 
9.1). 
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Fig. 9.1 Estimation of optimum NaCl concentration for molecular mass estimates of E1 
by DLS.  All experiments were measured at 25°C.  Before the measurement, samples 
were filtered and incubated at 55°C for 10 min in the presence (blue) or absence (NaCl 
added after samples had cooled down) (red) of NaCl.  The expected molecular mass of 
E1, based on α2β2 assembly, is indicated (yellow line).  100 mM NaCl gave a molecular 
mass estimate closest to the expected value if the E1 sample had been heated in the 
presence of NaCl. 
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Next, the effect of 100 mM NaCl on the E2 and E3 samples was analyzed, to 
test if this NaCl concentration was suitable to measure their individual molecular 
mass.  E3 is reportedly a dimer with M = 99.7 kDa (Heath et al., 2007).  In the 
presence of 100 mM NaCl, independent of its presence or absence during the 
incubation step, DLS measurements at 25°C gave molecular mass estimates 
close to the expected value (Table 9.1).  DLS measurements at 55°C showed 
that E3 is the least affected by the presence of NaCl in the incubation step as 
consistent molecular mass estimates were obtained across all conditions (Table 
9.1). 
 
Table 9.1 Molecular mass estimates of E3.  Prior to all DLS measurements, E3 was 
incubated at 55°C for 10 min in the presence or absence of NaCl.  Samples that did not 
include 100 mM NaCl during the incubation step were supplemented with the NaCl 
after they had cooled down to 25°C.  DLS measurements were taken at 25°C and 
55°C.  The molecular mass estimate is given in kDa ± SE. 
 
Incubation step 25°C 55°C 
No NaCl 115 ± 2.7 121 ± 0.8 
E3 
(kDa) 
NaCl 117 ± 1.4 115 ± 1.7 
 
 
DLS analysis of the E2 component was consistent with the E1 and E3 results: 
the presence of 100 mM NaCl was optimum to get highly reproducible molecu-
lar mass estimates which were close to the expected molecular mass of the E2 
monomer (46,276 Da).  Interestingly, the molecular mass estimate of E2 was 
affected by the presence or absence of NaCl during the heat incubation step 
(Fig. 9.2).  If NaCl was absent from the heat incubation step and only added 
later, the molecular mass estimate (54,400 Da) was close to the mass of the E2 
monomer.  If NaCl was present during the heat incubation step, a molecular 
mass estimate of 1.2 x 106 Da was obtained.  The mass of this species did not 
change during the DLS measurements and was observed throughout under the 
given conditions.  If the Thermoplasma BCOADHC had a 24-mer E2 core, as 
predicted, the molecular mass of this core is expected to be 1128 kDa.  This 
value is close to the mass estimate of the E2 if 100 mM NaCl were included in 
the heat incubation step.  Therefore, this mass estimate was thought to repre-
sent the assembled E2 core of the Thermoplasma BCOADHC. 
 114 
0
200
400
600
800
1000
1200
1400
100 mM NaCl
k
D
a
47 kDa
1128 kDa
1172.3
54.4
k
D
a
 
 
Fig. 9.2 DLS molecular mass estimates of E2.  DLS measurements were done at 25°C.  
All proteins were incubated at 55°C for 10 min either with (blue) or without (magenta) 
100 mM NaCl.  100 mM NaCl were added to samples, which had not been incubated 
with NaCl at 55°C, after they had cooled down.  The expected molecular mass of the 
E2 monomer (47 kDa) and of a 24-mer core (1128 kDa) are indicated. 
 
 
9.2.2 Temperature dependence of E2 core and BCOADHC assembly 
Apart from the presence of NaCl, the other factor in the measurements was the 
temperature.  In the initial observation for the E2 core, the 100 mM NaCl had to 
be available at a temperature of 55°C, whereas 100 mM NaCl at 25°C gave the 
E2 monomer molecular mass. 
 
To investigate the effect of temperature, DLS readings of E2 supplemented with 
100 mM NaCl after the heat incubation step, were performed over a range of 
temperatures (25°C – 60°C).  The transition of the E2 monomer to a 1.0 (± 0.1) 
× 106 Da protein assembly was observed at a critical temperature of 40°C.  The 
size was maintained up to 60°C, but aggregation was observed above this tem-
perature.  The assembled E2 core remained stable and was maintained even 
when the sample was cooled down to 25°C.  This observed molecular mass can 
be explained by the assembly of a 24-mer E2 core.  Indeed, this correlates with 
the result from analytical ultracentrifugation (Heath et al., 2007). 
 
Based on the success of using DLS in estimating the size of E2 core assembly, 
the technique was extended to study the whole complex assembly at 25°C and 
55°C.  As the E2 core is crucial for the complex assembly, it was assumed that 
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the buffer conditions for the individual E2 core would give optimum conditions 
for overall complex assembly.  With a 24-mer E2 core, the assembled complex 
was expected to have a molecular mass of ~ 5 MDa.  Theoretically, if all 24 pe-
ripheral subunit binding domain sites were occupied with either E1 (165 kDa) or 
E3 (99.7 kDa) the average molecular mass estimate could be ~ 5 MDa and ~ 
3.3 MDa, respectively.  Mixtures containing all three BCOADHC proteins in a 
E1:E2:E3 molar ratio of 3:1:0.1 were prepared with and without NaCl during the 
heat incubation step, as well as mixing the three component proteins, which had 
been previously incubated with NaCl individually (Fig. 9.3).  At 25°C the esti-
mated mass of the whole complex varied greatly between 6.5x106 Da and 
11.3x106 Da, whereas DLS measurements at 55°C gave a molecular mass es-
timate for the whole complex centred around 5 MDa, independently of how the 
sample was prepared (Fig. 9.3 and Table 9.2). 
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Fig. 9.3 DLS analysis of BCOADHC assembly at 25°C and 55°C. The complex was 
assembled in the 3:1:0.1 (E1:E2:E3) molar ratio under three different conditions and 
analysed in DLS at 25°C or 55°C.  Complex A (yellow): Complex proteins were mixed 
and incubated at 55°C for 10 min without extra NaCl added; NaCl was supplemented 
prior to the DLS experiment.  Estimated mass: 7x106 Da (25°C) and 5x106 Da (55°C).  
Complex B (blue): Complex proteins were mixed and incubated at 55°C for 10 min 
with 100 mM NaCl. Estimated mass: 7.3x106 Da (25°C) and 5.3x106 Da (55°C).  Com-
plex C (red): Complex proteins were incubated individually at 55°C with 100 mM NaCl 
and then mixed in the 3:1:0.1 ratio.  Estimated mass: 11.2x106 Da (25°C) and 4.7x106 
Da (55°C). 
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Table 9.2 Summary of the molecular mass estimates of whole BCOADHC assembly.  
Complex A:  Proteins were mixed and incubated at 55°C for 10 min without NaCl. 100 
mM NaCl was added after the mixture had cooled down.  Complex B: Proteins were 
mixed and incubated at 55°C with 100 mM NaCl.  Complex C: Proteins were first incu-
bated at 55°C with 100 mM NaCl individually and then mixed.  DLS measurements 
were done at 25°C and 55°C.  Molecular mass estimates are in MDa ± SE. 
 
 
NaCl (100 mM) in 
heat incubation 
DLS measurement 
25°C 
DLS measure-
ment 
55°C 
Complex A Absent 7.0 ± 0.5 5.0 ± 0.2 
Complex B Present 7.3 ± 0.45 5.3 ± 0.1 
Complex C  Present 11.2 ± 0.3 5.5 ± 0.3 
 
 
The overall results from DLS indicated that temperature is essential to drive E2 
assembly and maintain whole complex assembly.  Moreover, the optimum tem-
perature for complex formation was 55°C, which matches the growth tempera-
ture of Tp. acidophilum. 
 
9.2.3 Analytical ultracentrifugation of the BCOADHC 
All previous attempts to characterise the Thermoplasma BCOADHC by analyti-
cal ultracentrifugation (AUC) were unsuccessful; the major obstacle was the 
presence of large amounts of individual complex components and/or protein 
self-oligomerization (Caroline Heath, University of Bath, personal communica-
tion).  The DLS results suggested that temperature is not only a driving factor in 
complex assembly, but also in maintaining the overall complex with an average 
molecular size of ~ 5 MDa.  The maximum permissible temperature for the AUC 
experiment on the available instrument was 40°C.  Since 40°C is the critical 
temperature at which E2 core assembly can take place, it was decided to run 
AUC at 40°C.  Furthermore, previous AUC analyses included 0.4 M NaCl which 
might have contributed to protein self-association as observed in DLS (Fig. 9.1).  
Therefore, the complex was prepared in the same conditions as for DLS (Fig. 
9.3, Table 9.2).  Complex A and B did not give sufficient data in AUC experi-
ments.  However, sedimentation velocity analysis at 40°C of complex C re-
vealed three discrete protein peaks with s°20w values of 50S (24% of total pro-
tein), 19S (8%) and 6S (68%) (Fig. 9.4).  Attempts to fit these data using the 
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finite element solution of the Lamm equation in Sedfit (Schuck, 1998) were un-
successful in producing Mr values for these proteins.  Using the relationship that 
s ∞ (Mr)
2/3 for globular proteins, and incorporating the values of Mr 6.1 x 10
6 and 
s°20w value 60S for the E. coli PDHC (Danson et al., 1979), an approximate 
value of Mr = 4.7x10
6 was calculated for what is assumed to be an assembled 
Tp. acidophilum  complex of 50S (Heath et al., 2007). 
 
 
 
Fig. 9.4 Sedimentation velocity pattern of the whole complex (black line).  Previous to 
AUC, proteins were incubated at 55°C with 0.1 M NaCl individually and then mixed in 
the molar ratio E1:E2:E3 of 3:1:0.1.  The area under the peaks represents the total 
amount of protein. 
 
 
9. 3 Discussion and conclusions 
DLS and AUC were successfully employed to determine the complex assembly 
of the Tp. acidophilum BCOADHC.  The DLS experiments revealed the need for 
high temperature to drive assembly of the E2 core and whole complex.  This is 
an observation that has not been reported for other thermophilic OADHCs as 
yet. On the contrary, the recombinantly expressed PDHC from Bacillus 
stearothermophilus assembles at 4°C in vitro (Domingo et al., 1999; Milne et al., 
2006) despite the organism’s optimum growth temperature of 60°C.  This spon-
taneous self-assembly along with structural features indicated that the B. 
stearothermophilus PDHC may resemble mesophilic counterparts (Witzmann 
and Bisswanger, 1998).  In contrast, the T. acidophilum complex requires a 
critical temperature that drives the assembly of the E2 core and maintains the 
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whole complex assembly.  In the DLS experiments with E2, which was not sub-
jected to heat-precipitation purification, it was observed that the temperature is 
required for assembly and, once assembled, the E2 core remains intact even at 
25°C.  This suggests that the interaction between the individual E2 subunits is 
stable and favourable.  The E2 core stability, as soon as it has assembled, is 
further illustrated by the observation that E2 purified from cell lysate by heat-
precipitation at 65°C for 5 min and kept at 4°C before AUC analyses was also 
found to be present as a 24-mer core at 20°C (Caroline Heath, Ph.D. Thesis, 
University of Bath, 2006).  Nonetheless, AUC analysis of the whole complex 
required a constant high temperature.  This suggests that the binding of the E1 
and E3 components to the E2 core may also be driven and/or maintained by 
temperature.  This indicates that these proteins can work well at 55°C, which is 
commensurate with the optimum growth temperature of the T. acidophilum. 
 
Several possibilities may explain the observed temperature dependence of E2 
core and complex assembly.  One explanation may be that the proteins are not 
in their proper structural conformation at lower temperatures which prevents 
subunit interactions.  Another aspect is that a higher temperature i.e. input of 
energy, may account for the enthalpy cost for expelling water molecules (desol-
vation barrier) between interacting protein subunits (Levy and Onuchi, 2006).  
Temperature dependent oligomerization has been reported for much smaller 
proteins from hyperthermophlic archaea including an L-isoaspartyl-O-
methyltransferase from Sulfolobus tododaii (Tanaka et al., 2004), a recombinant 
amidase from Sulfolobus solfataricus (Politi et al., 2009) and a glutamate dehy-
drogenase from Pyrococcus KOD1 (Rahman et al., 1997).  In these studies oli-
gomerization is assumed to enhance protein thermostabilitly.  Further investiga-
tions are required to establish how exactly temperature affects the E2 confor-
mation and subunit-subunit interactions of the Thermoplasma BCOADHC.  
Structural information is required to characterize these interactions. 
 
The molecular mass estimates of the complex obtained from DLS and AUC are 
in good agreement with each other.  Both techniques reveal a complex of ap-
proximately 5 MDa.  However, it is difficult to estimate the physiological ratio of 
E1:E2:E3 constituting the complex and experimental conditions have been 
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shown to affect the ratio of E1:E3 bound to the E2 core (Domingo et al., 1999).  
The optimum ratio for Thermoplasma OADHC activity has been determined to 
be 3:1:01 for E1:E2:E3 (Heath et al., 2007).  However, analytical gel filtration 
analysis of this active complex revealed that the majority of the E1 did not bind 
to the complex.  Instead an active complex in a ratio of 1:1:0.1 of E1:E2:E3 with 
a size of 5 x 106 Da was identified (Heath et al., 2007).  The size estimate from 
DLS and the AUC experiments are in agreement with this.  The large peak at 
6S (Fig. 9.4) is consistent with a Mr ~150 and is thought to be unbound E1.  Ex-
pression rates of the operon containing the complex genes can affect the ratio 
of assembled complex proteins in vivo.  Therefore, the ratio in which the com-
plex components assemble in vivo and how this corresponds to that identified 
as most active ratio of E1:E2:E3 of 3:1:0.1 in vitro (Heath et al., 2007) needs 
attention. 
 
Assembly of the E2 core was detected using lipoylated E2 previously (Heath et 
al., 2007).  In this work, DLS and AUC analyses of E2 core and whole complex 
assembly were conducted using non-lipoylated E2 and are in agreement with 
the result obtained using lipoylated E2.  Therefore, lipoylation does not appear 
to be a crucial factor in complex assembly.  This is not surprising, as lipoylation 
is a post-translational modification.  However, it would be of interest to deter-
mine if the lipoylated E2 monomers would show different dynamics of E2 core 
assembly.  An effect on the affinity of E1 and E3 to bind to lipoylated versus 
non-lipoylated E2 has been reported for the PDHC from the thermophilic pro-
karyote B. stearothermophilus (Domingo et al., 1999).  Whether lipoylation has 
an effect on the ratio of E1:E2:E3 in the complex of the Tp. acidophilum 
BCOADHC is an interesting aspect, which needs to be examined further.  Fur-
thermore, the ability of LplA-CTD to lipoylate the E2 monomer, the assembled 
E2 core and the whole assembled complex should be analyzed and compared. 
 
It can be concluded that the Tp. acidophilum BCOADHC assembles as pre-
dicted from mesophilic counterparts.  The temperature dependence of complex 
assembly suggests that this complex was designed to work at elevated tem-
peratures.  These data suggest that the complex is stable to work under native 
conditions and the presence of the bcoadhc operon along with the genes for a 
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lipoylation machinery suggests a potential physiological role of the BCOADHC 
in vivo. 
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CHAPTER 10 
Conclusions and future work 
 
The initial chapters in the thesis describe the cloning and expression of the Tp. 
acidophilum lpla and ctd genes.  Later, the purification and characterization of 
the corresponding proteins, LplA and CTD have been described.  A combination 
of both LplA and CTD have been shown to reconstitute the Thermoplasma li-
poylation machinery, which lipoylates the E2 component of the BCOADHC in 
vitro and possibly in vivo.  In addition to its lipoylation machinery, the tempera-
ture dependence of the Thermoplasma BCOADHC assembly has also been 
characterized.  These results constitute the first report of lipoylation in an ar-
chaeon, and indicate a potential physiological role of an archaeal OADHC.  
Based on the knowledge gained during the course of this work, the following are 
some aspects of considerations that may form the basis of future research in 
the area. 
 
10.1 Protein-protein interactions 
The temperature dependence of the BCOADHC assembly is a novel observa-
tion for this superfamily of protein complexes (chapter 9).  The identification of 
the specific protein subunit interactions, which determine the temperature de-
pendence, may be a very interesting area of research in the future.  With the 
availability of recombinantly expressed BCOADHC complex components, a 
model protein system has become available to study the effect of temperature 
on protein-protein interactions at high temperature.  Elucidation of temperature 
dependent protein-protein interactions may better our understanding of protein 
stability and lead to new ideas in protein design.  Apart from crystallography 
approach, which may be hampered by the large degree of flexibility in the com-
plex, one emerging technique to monitor structure and dynamics is multidimen-
sional NMR.  Recently, this technique has been successfully employed to 
measure the assembly of a similar sized (~ 5 MDa) protein complex (Chugh et 
al., 2008).  Also, electron spray ionization mass spectrometry (ESI-MS) has 
emerged as a technique to study stoichiometry and interactions of macromo-
lecular protein assemblies like the prokaryotic ribosome of over 2 MDa (Breuker 
and Mc Lafferty, 2008; Rose et al., 2008; Benesch and Robinson, 2006).  This 
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technique may be valuable in analyzing the E2 core and the E2 subunit-
interactions, given the similarity in their Mr. 
 
10.2 Gene order is contrary to the protein domain arrangement 
In Tp. acidophilum, the identified lipoylation machinery requires two gene prod-
ucts, LplA and CTD (chapter 5), which interact with each other (chapter 6).  The 
LplA-CTD fusion protein, in which the LplA and CTD are arranged as N- and C- 
terminal, respectively, as found in several other species (Cronan et al., 2005), 
carries out lipoylation (chapter 7).  Not only are the protein domains of the 
Thermoplasma lipoylation machinery encoded by two separate genes, but the 
gene order is also contrary to the expected protein domain order (chapter 4).  It 
is possible that the Tp. acidophilum LplA domains were once encoded by a sin-
gle gene, which later split up.  Splitting of genes has been previously implicated 
in aiding the decrease in the error rate of replication at high temperatures (Snel 
et al., 2000).  However, the debate on the significance of split genes in thermo-
philic organisms is still ongoing (Kummerfeld and Teichmann, 2005).  What 
cannot be denied from the presented evidence is that the LplA and CTD ar-
rangement appears to be finely adjusted with transcriptional regulatory ele-
ments for the lpla gene falling within the ctd gene (chapter 4).  This suggests 
that this arrangement did not happen at random, as outlined previously in chap-
ter 4, and may provide a potential mechanism for transcriptional regulation.  In 
this case, one has to assume that the Tp. acidophilum LplA has always been 
encoded by two separate genes.  The presence of several separate genes cod-
ing for the different domains of one protein, including proteins such as RNA po-
lymerase subunit B and alanyl-tRNA synthetase, have also been observed in 
the archaeon Nanorachaeum equitans (Randau et al., 2005).  Although it has 
become more accepted that the genomes of bacteria and archaea undergo dy-
namic changes (Koonin and Wolf, 2008), the reason for the presence of such 
split genes has been implicated in suggesting an ancestral evolutionary stage 
before the modern genes, which comprise all protein domains in one polypep-
tide (Di Giulio, 2006).  If the Thermoplasma LplA and CTD were indeed ances-
tral forms of modern lipoate protein ligases, this would not only suggest that 
archaeal organisms were one of the first to use lipoylation, but may also imply a 
physiological significance of the OADHC/lipoylation system.  How this correlates 
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to the emergence of ferredoxin oxidoreductases, the enzymes catalysing the 
same chemical reaction instead of OADHCs, in the overall evolutionary context 
would be an interesting question to pursue in future. 
 
Another intriguing fact is that the best alignment in BLASTP searches for LplA 
and CTD was found to be the Streptococcus pneumoniae LplA.  However, S. 
pneumoniae lacks OADHC activity and its E3 component is unique in having its 
own N-terminal lipoyl protein domain (Håkansson and Smith, 2007).  A similar 
case of a lipoyl-domain on the E3 component has been reported for My-
coplasma hyponeumoniae (Matic et al., 2003), but M. hyponeumoniae does 
have OADHC activity.  Together with the remarkable arrangement of the lpla 
and ctd genes, future work will concern the evolutionary aspect of the lipoylation 
machinery and the potential of gene transfers.  Structure determination of the 
complete Tp. acidophilum lipoylation machinery and comparison with other li-
poate protein ligases will be helpful in understanding the origin of these pro-
teins. 
 
10.3 Gene induction by lipoic acid 
Lack of lipoylation in Thermoplasma has been cited as a possible reason for the 
absence of OADHC activity in vivo.  Contrary to this, the Western blot analysis 
of Thermoplasma cultures grown for 37 generations in media supplemented 
with LA has shown in vivo lipoylation of E2 in an archaeon (chapter 8).  As 
BLASTP searches only identified LplA and CTD as putative lipoylation en-
zymes, and their lipoylation activity has been confirmed in vitro, the Western 
blot analysis suggests that LA supplement (in the media) may be the trigger for 
LplA-CTD activity.  In the archaeon S. solfataricus, the regulatory response of a 
ß-glycosidase revealed that gene induction occurred within one generation, 
whereas gene repression required 38 generations in this organism (Haseltine et 
al., 1999).  Without further probing the induction mechanisms, no conclusions 
can be drawn for Tp. acidophilum at this point.  To assess details at the gene 
level, a time course of up-regulation of LplA and CTD transcription and/or trans-
lation by LA, as well as a potential up-regulation of the OADHC, and how these 
genes are co-regulated should be attempted.  For the archaeon Sulfolobus sol-
fataricus, a genome wide transcription map has already been constructed 
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(Lundgren and Bernander, 2007).  Techniques like DNA microarray (Butte, 
2002; Nicholson et al., 2004), complemented with two-dimensional difference 
gel electrophoresis (Komatsu et al., 2006), can give the required insight into the 
required physiological conditions under which LplA, CTD and OADHC compo-
nents are present in the cell.  Similarly, if the presence of LA induces lipoylation 
and potentially BCOADHC activity, the interplay of the FORs becomes impor-
tant.  No information is available on how these two enzyme families, both of 
which catalyse the same chemical reaction, could co-exist.  This also needs to 
be investigated. 
 
10.4 Physiological role of lipoylation and BCOADHC in Tp. acidophilum 
In addition to the thermostability aspect, the confirmation of a functional Ther-
moplasma BCOADHC is expected to fuel the debate about the existence of 
these genes in the relatively small Tp. acidophilum genome despite apparent 
lack of in vivo activity.  Different Tp. acidophilum strains have been found in hot 
springs and self-heated coal refuse piles (Yasuda et al., 1995).  The difference 
and variability, as well as nutrient availability, in these growth environments may 
have conditioned the different Thermoplasma strains to respond differently to 
LA supply.  A comparison of different strains may give insight into the evolution-
ary aspects of the Tp. acidophilum OADHC/lipoylation machinery and why the 
genes for these proteins are retained despite the presence of active ferredoxin 
oxidoreductases. 
 
Some of the questions raised concerning the physiological significance of the 
OADHC/lipoylation system cannot be answered quickly and may require the 
development of new models.  In vivo reporter models to conduct gene knock-
out experiments can give insights into the physiological significance and regula-
tion of genes.  Although genetic manipulations have been successfully con-
ducted in S. solfataricus (Jonuscheit et al., 2003) it is one of the few archaeal 
reporter systems avaible.  With the isolation and characterization of plasmid 
pTA1 from Tp. acidophilum, the design of a genetic manipulation system has 
great potential as pointed out by Yamashiro et al. (2006). The development of 
such a system may aid in the understanding of the physiological role of the lpla, 
ctd, oadhc and other genes. 
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